Document_and_Entity_Informatio
Document and Entity Information Document and Entity Information (USD $) | 12 Months Ended | ||
Dec. 31, 2013 | Feb. 17, 2014 | Jun. 30, 2013 | |
Document and Entity Information [Abstract] | ' | ' | ' |
Entity Registrant Name | 'FEI CO | ' | ' |
Trading Symbol | 'FEIC | ' | ' |
Entity Central Index Key | '0000914329 | ' | ' |
Current Fiscal Year End Date | '--12-31 | ' | ' |
Entity Filer Category | 'Large Accelerated Filer | ' | ' |
Document Type | '10-K | ' | ' |
Document Period End Date | 31-Dec-13 | ' | ' |
Document Fiscal Year Focus | '2013 | ' | ' |
Document Fiscal Period Focus | 'FY | ' | ' |
Amendment Flag | 'false | ' | ' |
Entity Current Reporting Status | 'Yes | ' | ' |
Entity Voluntary Filers | 'No | ' | ' |
Entity Well-known Seasoned Issuer | 'Yes | ' | ' |
Entity Common Stock, Shares Outstanding | ' | 42,229,623 | ' |
Public Float, Share Price | ' | ' | $72.70 |
Entity Public Float | ' | ' | $3,026,352,547 |
Consolidated_Balance_Sheets
Consolidated Balance Sheets (USD $) | Dec. 31, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
Current assets: | ' | ' |
Cash and cash equivalents | $384,170 | $266,302 |
Short-term investments in marketable securities | 108,191 | 79,532 |
Short-term restricted cash | 18,798 | 14,522 |
Receivables, net of allowances for doubtful accounts of $2,969 and $2,718 | 194,418 | 211,160 |
Inventories | 181,725 | 192,540 |
Deferred tax assets | 15,114 | 12,245 |
Other current assets | 28,324 | 29,332 |
Total current assets | 930,740 | 805,633 |
Non-current investments in marketable securities | 47,278 | 29,179 |
Long-term restricted cash | 32,718 | 27,425 |
Property, plant and equipment, net of accumulated depreciation of $125,405 and $121,560 | 157,829 | 109,872 |
Intangible assets, net of accumulated amortization of $19,385 and $10,984 | 47,197 | 51,499 |
Goodwill | 136,152 | 131,320 |
Deferred tax assets | 1,751 | 5,092 |
Non-current inventories | 62,104 | 65,116 |
Other assets, net | 10,315 | 9,087 |
Total Assets | 1,426,084 | 1,234,223 |
Current liabilities: | ' | ' |
Accounts payable | 73,247 | 54,847 |
Accrued payroll liabilities | 45,146 | 39,100 |
Accrued warranty reserves | 12,705 | 12,049 |
Short-term deferred revenue | 91,563 | 74,736 |
Income taxes payable | 4,579 | 1,343 |
Convertible debt | 0 | 89,010 |
Other current liabilities | 46,374 | 47,718 |
Total current liabilities | 273,614 | 318,803 |
Long-term deferred revenue | 30,744 | 26,668 |
Deferred tax liabilities | 8,931 | 17,588 |
Other liabilities | 35,227 | 31,261 |
Commitments and contingencies | ' | ' |
Shareholders' Equity: | ' | ' |
Preferred stock - 500 shares authorized; none issued and outstanding | 0 | 0 |
Common stock - 70,000 shares authorized; 42,136 and 38,478 shares issued and outstanding, no par value | 637,482 | 516,907 |
Retained earnings | 392,958 | 284,440 |
Accumulated other comprehensive income | 47,128 | 38,556 |
Total Shareholders' Equity | 1,077,568 | 839,903 |
Total Liabilities and Shareholders' Equity | $1,426,084 | $1,234,223 |
Consolidated_Balance_Sheets_Pa
Consolidated Balance Sheets (Parentheticals) (USD $) | Dec. 31, 2013 | Dec. 31, 2012 |
In Thousands, except Per Share data, unless otherwise specified | ||
Assets: | ' | ' |
Allowance for doubtful accounts | $2,969 | $2,718 |
Accumulated depreciation | 125,405 | 121,560 |
Accumulated amortization | $19,385 | $10,984 |
Shareholders' Equity: | ' | ' |
Preferred stock, shares authorized | 500 | 500 |
Preferred stock, shares issued | 0 | 0 |
Preferred stock, shares outstanding | 0 | 0 |
Common stock, shares authorized | 70,000 | 70,000 |
Common stock, shares issued | 42,136 | 38,478 |
Common stock, shares outstanding | 42,136 | 38,478 |
Common stock, no par value | $0 | $0 |
Consolidated_Statements_of_Ope
Consolidated Statements of Operations (USD $) | 12 Months Ended | ||
In Thousands, except Per Share data, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Net sales: | ' | ' | ' |
Products | $709,438 | $691,496 | $654,599 |
Service | 218,016 | 200,242 | 171,827 |
Total net sales | 927,454 | 891,738 | 826,426 |
Cost of sales: | ' | ' | ' |
Products | 352,630 | 347,224 | 344,575 |
Service | 136,039 | 128,884 | 114,485 |
Total cost of sales | 488,669 | 476,108 | 459,060 |
Gross profit | 438,785 | 415,630 | 367,366 |
Operating expenses: | ' | ' | ' |
Research and development | 101,947 | 94,965 | 78,318 |
Selling, general and administrative | 179,560 | 169,719 | 158,782 |
Restructuring, reorganization, relocation and severance | 1,090 | 2,859 | 3,215 |
Total operating expenses | 282,597 | 267,543 | 240,315 |
Operating income | 156,188 | 148,087 | 127,051 |
Other expense: | ' | ' | ' |
Interest income | 428 | 1,606 | 2,361 |
Interest expense | -1,890 | -4,098 | -4,037 |
Other, net | -3,124 | -5,047 | -2,510 |
Total other expense, net | -4,586 | -7,539 | -4,186 |
Income before income taxes | 151,602 | 140,548 | 122,865 |
Income tax expense | 24,929 | 25,628 | 19,228 |
Net income | $126,673 | $114,920 | $103,637 |
Basic net income per share | $3.13 | $3.02 | $2.70 |
Diluted net income per share | $3.01 | $2.80 | $2.51 |
Cash dividends declared per share | $0.44 | $0.24 | $0 |
Shares used in per share calculations: | ' | ' | ' |
Basic (in shares) | 40,446 | 38,065 | 38,384 |
Diluted (in shares) | 42,395 | 41,728 | 42,047 |
Consolidated_Statements_of_Com
Consolidated Statements of Comprehensive Income (USD $) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Net income | $126,673 | $114,920 | $103,637 |
Other comprehensive income, net of taxes: | ' | ' | ' |
Change in cumulative translation adjustment | 9,975 | 9,922 | -20,022 |
Change in unrealized (loss) gain on available-for-sale securities | -15 | -14 | 23 |
Change in minimum pension liability | 267 | -796 | 0 |
Changes due to cash flow hedging instruments: | ' | ' | ' |
Net (loss) gain on hedge instruments | -2,492 | 2,487 | -910 |
Reclassification to net income of previously deferred losses (gains) related to hedge derivatives instruments | 837 | 2,502 | -3,641 |
Comprehensive income | $135,245 | $129,021 | $79,087 |
Consolidated_Statements_of_Sha
Consolidated Statements of Shareholders' Equity (USD $) | Total | Common Stock [Member] | Retained Earnings [Member] | Accumulated Other Comprehensive Income [Member] |
In Thousands, except Share data, unless otherwise specified | ||||
Balance, value, beginning of period at Dec. 31, 2010 | $633,174 | $509,145 | $75,024 | $49,005 |
Balance, shares, beginning of period at Dec. 31, 2010 | ' | 38,280,000 | ' | ' |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ' | ' | ' | ' |
Net income | 103,637 | ' | 103,637 | ' |
Employee purchases of common stock through employee share purchase plan, value | 5,458 | 5,458 | ' | ' |
Employee purchases of common stock through employee share purchase plan, shares | ' | 212,000 | ' | ' |
Restricted shares issued and stock options exercised related to employee stock-based compensation plans, value | 18,854 | 18,854 | ' | ' |
Restricted shares issued and stock options exercised related to employee stock-based compensation plans, shares | ' | 1,133,000 | ' | ' |
Stock-based compensation expense, value | 11,111 | 11,111 | ' | ' |
Restricted stock unit taxes for net share settlement, value | -3,789 | -3,789 | ' | ' |
Restricted stock unit taxes for net share settlement, shares | ' | -105,000 | ' | ' |
Repurchase of common stock, value | -50,000 | -50,000 | ' | ' |
Repurchase of common stock, shares | -1,654,000 | -1,654,000 | ' | ' |
Tax benefit of non-qualified stock option exercises and restricted stock unit vests, value | 2,918 | 2,918 | ' | ' |
Conversion of convertible debt, value | 1 | 1 | ' | ' |
Translation adjustment, value | -20,022 | ' | ' | -20,022 |
Unrealized gain (loss) on available for sale securities, value | 23 | ' | ' | 23 |
Minimum pension liability, net of taxes, value | 0 | ' | ' | ' |
Net adjustment for fair value of hedge derivatives, value | -4,551 | ' | ' | -4,551 |
Balance, value, end of period at Dec. 31, 2011 | 696,814 | 493,698 | 178,661 | 24,455 |
Balance, shares, end of period at Dec. 31, 2011 | ' | 37,866,000 | ' | ' |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ' | ' | ' | ' |
Net income | 114,920 | ' | 114,920 | ' |
Employee purchases of common stock through employee share purchase plan, value | 7,007 | 7,007 | ' | ' |
Employee purchases of common stock through employee share purchase plan, shares | ' | 195,000 | ' | ' |
Restricted shares issued and stock options exercised related to employee stock-based compensation plans, value | 5,714 | 5,714 | ' | ' |
Restricted shares issued and stock options exercised related to employee stock-based compensation plans, shares | ' | 551,000 | ' | ' |
Stock-based compensation expense, value | 14,154 | 14,154 | ' | ' |
Restricted stock unit taxes for net share settlement, value | -5,913 | -5,913 | ' | ' |
Restricted stock unit taxes for net share settlement, shares | ' | -113,000 | ' | ' |
Repurchase of common stock, value | -891 | -891 | ' | ' |
Repurchase of common stock, shares | -20,500 | -21,000 | ' | ' |
Tax benefit of non-qualified stock option exercises and restricted stock unit vests, value | 3,137 | 3,137 | ' | ' |
Conversion of convertible debt, value | 1 | 1 | ' | ' |
Translation adjustment, value | 9,922 | ' | ' | 9,922 |
Unrealized gain (loss) on available for sale securities, value | -14 | ' | ' | -14 |
Dividends declared on common stock, value | -9,141 | ' | -9,141 | ' |
Minimum pension liability, net of taxes, value | -796 | ' | ' | -796 |
Net adjustment for fair value of hedge derivatives, value | 4,989 | 0 | 0 | 4,989 |
Balance, value, end of period at Dec. 31, 2012 | 839,903 | 516,907 | 284,440 | 38,556 |
Balance, shares, end of period at Dec. 31, 2012 | 38,478,000 | 38,478,000 | ' | ' |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ' | ' | ' | ' |
Net income | 126,673 | ' | 126,673 | ' |
Employee purchases of common stock through employee share purchase plan, value | 8,618 | 8,618 | ' | ' |
Employee purchases of common stock through employee share purchase plan, shares | ' | 163,000 | ' | ' |
Restricted shares issued and stock options exercised related to employee stock-based compensation plans, value | 7,927 | 7,927 | ' | ' |
Restricted shares issued and stock options exercised related to employee stock-based compensation plans, shares | ' | 574,000 | ' | ' |
Stock-based compensation expense, value | 18,327 | 18,327 | ' | ' |
Restricted stock unit taxes for net share settlement, value | -9,658 | -9,658 | ' | ' |
Restricted stock unit taxes for net share settlement, shares | ' | -109,000 | ' | ' |
Repurchase of common stock, value | -900 | ' | ' | ' |
Repurchase of common stock, shares | 0 | ' | ' | ' |
Tax benefit of non-qualified stock option exercises and restricted stock unit vests, value | 6,424 | 6,424 | ' | ' |
Conversion of convertible debt, shares | 3,000,000 | 3,030,000 | ' | ' |
Conversion of convertible debt, value | 88,937 | 88,937 | ' | ' |
Translation adjustment, value | 9,975 | ' | ' | 9,975 |
Unrealized gain (loss) on available for sale securities, value | -15 | ' | ' | -15 |
Dividends declared on common stock, value | -18,155 | ' | -18,155 | ' |
Minimum pension liability, net of taxes, value | 267 | ' | ' | 267 |
Net adjustment for fair value of hedge derivatives, value | -1,655 | ' | ' | -1,655 |
Balance, value, end of period at Dec. 31, 2013 | $1,077,568 | $637,482 | $392,958 | $47,128 |
Balance, shares, end of period at Dec. 31, 2013 | 42,136,000 | 42,136,000 | ' | ' |
Consolidated_Statements_of_Sha1
Consolidated Statements of Shareholders' Equity (Parentheticals) (USD $) | 12 Months Ended | ||
Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | |
Statement of Stockholders' Equity (Parentheticals) [Abstract] | ' | ' | ' |
Cash dividends declared per share | $0.44 | $0.24 | $0 |
Consolidated_Statements_of_Cas
Consolidated Statements of Cash Flows (USD $) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Cash flows from operating activities: | ' | ' | ' |
Net income | $126,673 | $114,920 | $103,637 |
Adjustments to reconcile net income to net cash provided by operating activities: | ' | ' | ' |
Depreciation | 23,693 | 22,814 | 18,931 |
Amortization | 10,568 | 5,852 | 2,054 |
Stock-based compensation | 18,327 | 14,154 | 11,111 |
Asset impairments and write-offs of intangible assets | 0 | 0 | 1,434 |
Other | 27 | 9 | 3 |
Income taxes payable (receivable), net | 13,066 | -3,979 | 6,908 |
Deferred income taxes | -6,743 | 2,350 | -5,175 |
Decrease (increase), net of acquisitions, in: | ' | ' | ' |
Receivables | 12,982 | -22,077 | -5,389 |
Inventories | 1,486 | -24,309 | -42,337 |
Other assets | 3,781 | -2,949 | -11,072 |
Increase (decrease), net of acquisitions, in: | ' | ' | ' |
Accounts payable | 18,553 | 397 | 1,324 |
Accrued payroll liabilities | 5,429 | -12,685 | 15,832 |
Accrued warranty reserves | 660 | 176 | 3,077 |
Deferred revenue | 13,285 | -4,703 | -8,544 |
Accrued restructuring, reorganization, relocation and severance | -2,628 | 397 | -2,860 |
Other liabilities | -1,211 | -5,413 | 13,784 |
Net cash provided by operating activities | 237,948 | 84,954 | 102,718 |
Cash flows from investing activities: | ' | ' | ' |
(Increase) decrease in restricted cash | -7,894 | 25,083 | -5,059 |
Acquisition of property, plant and equipment | -62,414 | -22,111 | -13,775 |
Payments for acquisitions, net of cash acquired | -2,694 | -93,368 | -14,050 |
Purchase of investments in marketable securities | -227,119 | -173,908 | -146,571 |
Redemption of investments in marketable securities | 180,332 | 134,478 | 159,520 |
Other | -2,710 | -10,874 | -992 |
Net cash used in investing activities | -122,499 | -140,700 | -20,927 |
Cash flows from financing activities: | ' | ' | ' |
Dividends paid on common stock | -16,191 | -6,095 | 0 |
Redemption of 2.875% convertible note | -73 | 0 | 0 |
Withholding taxes paid on issuance of vested restricted stock units | -9,658 | -5,913 | -3,789 |
Proceeds from exercise of stock options and employee stock purchases | 16,545 | 13,131 | 24,382 |
Excess tax benefit for share based payment arrangements | 6,010 | 2,873 | 1,425 |
Repurchases of common stock | 0 | -891 | -50,000 |
Other financing activities | 0 | -1,869 | -1,367 |
Net cash (used in) provided by financing activities | -3,367 | 1,236 | -29,349 |
Effect of exchange rate changes | 5,786 | 451 | -9,698 |
Increase (decrease) in cash and cash equivalents | 117,868 | -54,059 | 42,744 |
Cash and cash equivalents: | ' | ' | ' |
Beginning of period | 266,302 | 320,361 | 277,617 |
End of period | 384,170 | 266,302 | 320,361 |
Supplemental Cash Flow Information: | ' | ' | ' |
Cash paid for income taxes, net | 10,917 | 23,802 | 9,391 |
Cash paid for interest | 1,322 | 3,559 | 3,539 |
Increase in fixed assets related to transfers with inventories | 11,091 | 21,239 | 9,034 |
Increase in goodwill from acquisition-related liabilities | 0 | 0 | 3,456 |
Dividends declared but not paid | 5,011 | 3,046 | 0 |
Conversion of 2.875% convertible notes | 88,937 | 0 | 0 |
Accrued purchases of plant and equipment | $1,014 | $1,120 | $1,099 |
Consolidated_Statements_of_Cas1
Consolidated Statements of Cash Flows (Parentheticals) (Convertible Subordinated Debt [Member], Convertible Subordinated Debt [Member]) | Dec. 31, 2013 |
Convertible Subordinated Debt [Member] | Convertible Subordinated Debt [Member] | ' |
Statement of Cash Flows [Abstract] | ' |
Convertible notes, stated interest rate | 2.88% |
Summary_of_Significant_Account
Summary of Significant Accounting Policies | 12 Months Ended | |||||||||||
Dec. 31, 2013 | ||||||||||||
Accounting Policies [Abstract] | ' | |||||||||||
Basis of Presentation and Summary of Significant Accounting Policies [Text Block] | ' | |||||||||||
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | ||||||||||||
Nature of Business | ||||||||||||
We are a leading supplier of scientific instruments for nanoscale applications and solutions for industry and science. We report our revenue based on a group structure organization, which we categorize as the Industry Group and the Science Group. | ||||||||||||
Our products include transmission electron microscopes, or TEMs; scanning electron microscopes, or SEMs; DualBeamTM systems which combine a SEM and a focused ion beam system, or FIB, on a single platform; stand-alone FIBs; high-performance optical microscopes, three-dimensional modeling software, and service and components to support the products. TEMs provide the highest resolution images of samples and their internal structure, down to the atomic level. SEMs provide detailed images of the surface and shape of samples. Optical microscopes provide a wider field of view than SEMs and TEMs. DualBeams and FIBs image, manipulate, mill and deposit material for a variety of purposes, including preparation of samples for TEMs. Substantially all of these product categories are sold into all of our markets. Individual models of our products are increasingly designed to provide specific solutions and applications in each of our markets. | ||||||||||||
Our DualBeam systems include models that have wafer handling capability and are purchased by semiconductor equipment manufacturers (“wafer-level DualBeam systems”) and models that have small stages and are sold to customers in several markets (“small-stage DualBeam systems”). | ||||||||||||
We have research and development and manufacturing operations in Hillsboro, Oregon; Eindhoven, The Netherlands; Brno, Czech Republic; Munich, Germany; and Delmont, Pennsylvania; and software development in Bordeaux, France; and Brisbane, Australia. Our sales and service operations are conducted in the United States (U.S.) and approximately 50 other countries around the world. We also sell our products through independent agents, distributors and representatives in additional countries. | ||||||||||||
Basis of Presentation | ||||||||||||
The consolidated financial statements include the accounts of FEI Company and our wholly-owned subsidiaries (collectively, “FEI”). All significant intercompany balances and transactions have been eliminated in consolidation. | ||||||||||||
Use of Estimates in Financial Reporting | ||||||||||||
The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. | ||||||||||||
Significant accounting policies and estimates underlying the accompanying consolidated financial statements include: | ||||||||||||
• | the timing of revenue recognition; | |||||||||||
• | the allowance for doubtful accounts; | |||||||||||
• | valuations of excess and obsolete inventory; | |||||||||||
• | the lives and recoverability of equipment and other long-lived assets such as goodwill; | |||||||||||
• | the valuations of intangible assets; | |||||||||||
• | restructuring, reorganization, relocation and severance costs; | |||||||||||
• | tax valuation allowances and unrecognized tax benefits; | |||||||||||
• | warranty liabilities; | |||||||||||
• | stock-based compensation; and | |||||||||||
• | accounting for derivatives. | |||||||||||
It is reasonably possible that management's estimates may change in the future. | ||||||||||||
Concentration of Credit Risk | ||||||||||||
Instruments that potentially subject the Company to concentration of credit risk consist principally of cash and cash equivalents, short-term investments and receivables. Our investment policy limits investments with any one issuer to 10% or less of the total investment portfolio, with the exception of money market funds and securities issued by the U.S. government or its agencies which may comprise up to 100% of the total investment portfolio. Our exposure to credit risk concentrations within our receivables balance is limited due to the large number of entities comprising our customer base and their dispersion across many different industries and geographies. | ||||||||||||
Dependence on Key Suppliers | ||||||||||||
Failure of critical suppliers of parts, components and manufacturing equipment to deliver sufficient quantities to us in a timely and cost-effective manner could negatively affect our business, including our ability to convert backlog into revenue. Although we currently use numerous vendors to supply parts, components and subassemblies for the manufacture and support of our products, some key parts may only be obtained from a single supplier or a limited group of suppliers. In particular, we rely on: VDL Enabling Technologies Group, NTS Group, Frencken Mechatronics B.V., Keller Technology and AZD Praha SRO for our supply of mechanical parts and subassemblies; Gatan, Inc., Edax Inc. and Bruker Corp. for critical accessory products; and Neways Electronics, N.V. for some of our electronic subassemblies. A portion of the subcomponents that make up the components and sub-assemblies supplied to us are proprietary in nature and are provided to our suppliers only from single sources. We monitor those parts subject to single or a limited source supply to seek to minimize factory down time due to unavailability of such parts, which could impact our ability to meet manufacturing schedules. | ||||||||||||
As a result of this concentration of key suppliers, our results of operations may be materially and adversely affected if we do not timely and cost-effectively receive a sufficient quantity of quality parts to meet our production requirements or if we are required to find alternative suppliers for these supplies. We may not be able to expand our supplier group or to reduce our dependence on single suppliers. If our suppliers are not able to meet our supply requirements, constraints may affect our ability to deliver products to customers in a timely manner, which could have an adverse effect on our results of operations. In addition, restrictions regulating the use of certain hazardous substances in electrical and electronic equipment in various jurisdictions may impact parts and component availability or our electronics suppliers’ ability to source parts and components in a timely and cost-effective manner. Overall, because we only have a few equipment suppliers, we may be more exposed to future cost increases for this equipment. | ||||||||||||
Cash and Cash Equivalents | ||||||||||||
Cash and cash equivalents include cash deposits in banks, money market funds and other highly liquid marketable securities with maturities of three months or less at the date of acquisition. | ||||||||||||
Restricted Cash | ||||||||||||
Our restricted cash balances are held in deposit accounts with banks that have issued guarantees and letters of credit to our customers for system sales transactions and customer advance deposits relating to prepayments for service contracts, mainly in Europe and Asia. This restricted cash can be drawn on by the bank if goods are not delivered or services are not properly performed. In addition, while the restricted cash is held in the bank it is earning interest. Given these deposit accounts require satisfaction of conditions other than a withdrawal demand for us to receive a return of principal, are interest bearing and are held for extended periods of time, we have concluded these balances are similar in nature to our other investments and that inclusion in investing activities on our statement of cash flows is appropriate and consistent with our treatment of other investments. Restricted cash balances securing bank guarantees that expire within 12 months of the balance sheet date are recorded as a current asset on our consolidated balance sheets. Restricted cash balances securing bank guarantees that expire beyond 12 months from the balance sheet date are recorded as long-term restricted cash on our consolidated balance sheets. | ||||||||||||
Allowance for Doubtful Accounts | ||||||||||||
The allowance for doubtful accounts is estimated based on collection experience and known trends with current customers. The large number of entities comprising our customer base and their dispersion across many different industries and geographies somewhat mitigates our credit risk exposure and the magnitude of our allowance for doubtful accounts. Our estimates of the allowance for doubtful accounts are reviewed and updated on a quarterly basis. Changes to the reserve may occur based upon changes in revenue levels and associated balances in accounts receivable and estimated changes in individual customers’ credit quality. Write-offs include amounts written off for specifically identified bad debts. Historically, we have not incurred significant write-offs of accounts receivable, however, an individual loss could be significant due to the relative size of our sales transactions. | ||||||||||||
Activity within our accounts receivable allowance was as follows (in thousands): | ||||||||||||
Year Ended | ||||||||||||
2013 | 2012 | 2011 | ||||||||||
Balance, beginning of period | $ | 2,718 | $ | 5,553 | $ | 5,685 | ||||||
Expense (reversal) | 473 | (154 | ) | (18 | ) | |||||||
Write-offs | (263 | ) | (2,732 | ) | (25 | ) | ||||||
Translation adjustments | 41 | 51 | (89 | ) | ||||||||
Balance, end of period | $ | 2,969 | $ | 2,718 | $ | 5,553 | ||||||
Investments | ||||||||||||
Our investments include marketable debt securities, certificates of deposit, commercial paper and government-backed securities with maturities greater than 90 days at the time of purchase. These investments are recorded on our balance sheet as available-for-sale securities at fair value based on quoted market prices. Unrealized gains/losses resulting from changes in the fair value are recorded, net of tax, in shareholders’ equity as a component of accumulated other comprehensive income (loss). | ||||||||||||
Certain long-term investments included in non-current investments in marketable securities consisted of mutual fund shares held to offset liabilities to participants in the Company's deferred compensation plan. The investments are classified as long-term because the related deferred compensation liabilities are not expected to be paid within the next year. These investments are classified as trading securities and are recorded at fair value with unrealized gains and losses reported in operating expenses, which are offset against gains and losses resulting from changes in corresponding deferred compensation liabilities to participants (see Note 7 the Notes to the Consolidated Financial Statements). Investments for which it is not practical to estimate fair value are included at cost and primarily consist of investments in privately-held companies. | ||||||||||||
Realized gains and losses on all investments are recorded on the specific identification method and are included in interest income (expense) or other income (expense) in the period incurred. Investments with maturities greater than 12 months from the balance sheet date are classified as non-current investments, unless they are expected to be liquidated within the next 12 months; in which case, the investment is classified as current. | ||||||||||||
Inventories | ||||||||||||
Inventories are stated at the lower of cost or market, with cost determined by standard cost methods, which approximate the first-in, first-out method. Inventory costs include material, labor and manufacturing overhead. Service inventories that exceed the estimated requirements for the next 12 months based on recent usage levels are reported as a long-term asset. Management has established inventory reserves based on estimates of excess and/or obsolete current and non-current inventory. | ||||||||||||
Manufacturing inventory is reviewed for obsolescence and excess quantities on a quarterly basis, based on estimated future use of quantities on hand, which is determined based on past usage, planned changes to products and known trends in markets and technology. Changes in support plans or technology could have a significant impact on obsolescence. | ||||||||||||
To support our world-wide service operations, we maintain service spare parts inventory, which consists of both consumable and repairable spare parts. Consumable service spare parts are used within our service business to replace worn or damaged parts in a system during a service call and are generally classified in current inventory as our stock of this inventory turns relatively quickly. However, if there has been no recent usage for a consumable service spare part, but the part is still necessary to support systems under service contracts, the part is considered to be non-current and included within non-current inventories within our consolidated balance sheet. Consumables are charged to cost of goods sold when issued during the service call. | ||||||||||||
We also maintain a substantial supply of repairable and reusable spare parts for possible use in future repairs and customer field service of our install base. We have classified this inventory as a long-term asset given these parts can be repaired and reused in the service business over many years. | ||||||||||||
As these service parts age over the related product group’s post-production service life, we reduce the net carrying value of our repairable and consumable spare part inventory to account for the excess that builds over the service life. The post-production service life of our systems is generally eight years and, at the end of the service life, the carrying value for these parts is reduced to zero. We also perform periodic monitoring of our installed base for premature or increased end of service life events. If required, we expense, through cost of goods sold, the remaining net carrying value of any related spare parts inventory in the period incurred. | ||||||||||||
Income Taxes | ||||||||||||
We account for income taxes using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and tax bases of the assets and liabilities. We record a valuation allowance to reduce deferred tax assets to the amount expected to “more likely than not” be realized in our future tax returns. Should we determine that we would not be able to realize all or part of our remaining net deferred tax assets in the future, increases to the valuation allowance for deferred tax assets may be required. Conversely, if we determine that certain tax assets that have been reserved for may be realized in the future, we may reduce our valuation allowance in future periods. | ||||||||||||
In the ordinary course of business, there is inherent uncertainty in quantifying our income tax positions. We assess our income tax positions and record tax benefits for all years subject to examination based upon management’s evaluation of the facts, circumstances and information available at the reporting date. For those tax positions where it is more likely than not that a tax benefit will be sustained, we have recorded the largest amount of tax benefit with a greater than 50% likelihood of being realized upon ultimate or effective settlement with a taxing authority that has full knowledge of all relevant information. For those income tax positions where it is not more likely than not that a tax benefit will be sustained, no tax benefit has been recognized in the financial statements. When applicable, associated interest and penalties have been recognized as a component of income tax expense. | ||||||||||||
Unrecognized tax benefits relate mainly to uncertainty surrounding various tax credits, transfer pricing and permanent establishment in foreign jurisdictions. Included in the liabilities for unrecognized tax benefits were accruals for interest and penalties. If recognized, the total unrecognized tax benefits would have an impact on the effective tax rate. See Note 13 of the Notes to the Consolidated Financial Statements for additional information. | ||||||||||||
Property, Plant and Equipment | ||||||||||||
Land is stated at cost. Buildings and improvements are stated at cost and depreciated over estimated useful lives of approximately 40 years using the straight-line method. Leasehold improvements are amortized over the shorter of their economic lives or the lease term. Machinery and equipment, including systems used in production and research and development activities, are stated at cost and depreciated over estimated useful lives of approximately three to seven years using the straight-line method. | ||||||||||||
Demonstration systems consist primarily of internally manufactured products and related accessories that we use for marketing purposes in our demonstration laboratories (“NanoPorts”) or for trade shows. These systems are long lived in nature and are recorded as a component of property, plant and equipment. The proceeds expected to be realized when the systems are sold is estimated and the net cost is depreciated using the straight-line method over their expected useful lives of approximately three to seven years with the expense being reflected as a component of selling, general and administrative. If sold, the net book value of the system is recorded as a component of cost of good sold. | ||||||||||||
Other fixed assets include computer software and hardware, automobiles and furnitures and fixtures. These assets are stated at cost and are depreciated over estimated useful lives of approximately three to seven years. Maintenance and repairs are expensed as incurred. | ||||||||||||
On occasion, we loan systems to customers on a temporary basis while they wait for their tool to be manufactured or for evaluation. These systems are included in our finished goods inventories and the lending/evaluation periods are typically for a time period of less than one year. The sale of disposable products or services is not typically included in these arrangements. Any expense associated with these systems is recorded as a component of cost of sales. | ||||||||||||
Additionally, we lease systems to customers as operating or sales-type leases where we are the lessor. Under the operating method, rental revenue is recognized over the lease period. The leased asset is depreciated over the life of the lease. In addition to the depreciation charge, maintenance costs and the cost of any other services rendered under the provision of the lease that pertain to the current accounting period are charged to expense. Under the sales-type method, revenue is recorded upfront with interest income recorded over the life of the lease. The related costs are recorded upfront to match the sales revenue. | ||||||||||||
Lives and Recoverability of Equipment and Other Long-Lived Assets | ||||||||||||
We evaluate the remaining life and recoverability of equipment and other assets that are to be held and used, including purchased technology and other intangible assets with finite useful lives, at least annually and whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. If there is an indication of impairment, we prepare an estimate of future, undiscounted cash flows expected to result from the use of the asset and its eventual disposition. If these cash flows are less than the carrying value of the asset, we adjust the carrying amount of the asset to its estimated fair value. Long lived assets to be disposed of by sale are valued at the lower of book value or fair value less cost to sell. | ||||||||||||
We estimate the fair value of an intangible asset or asset group using the income approach and internally developed discounted cash flow models. These models include, among others, the following assumptions: projections of revenue and expenses and related cash flows based on assumed long-term growth rates and demand trends; estimated royalty, income tax, and attrition rates; and estimated discount rates. We base these assumptions on our historical data and experience, third-party appraisals, industry projections, micro and macro general economic condition projections, and our expectations. | ||||||||||||
See Note 9 of the Notes to the Consolidated Financial Statements for information on impairments recognized in 2011. No impairments related to our equipment or other long-lived assets were recognized during 2013 or 2012. | ||||||||||||
Goodwill | ||||||||||||
Goodwill represents the excess purchase price over fair value of net assets acquired. Goodwill and other identifiable intangible assets with indefinite useful lives are not amortized, but instead, are tested for impairment at least annually during the fourth quarter. In 2011, we adopted ASU 2011-08, "Intangibles - Goodwill and Other (Topic 350), Testing Goodwill for Impairment", which allows an entity to perform a qualitative assessment of the fair value of its reporting units before calculating the fair value of the reporting unit in step one of the two-step goodwill impairment model. We perform our goodwill impairment analysis at the component level, which is defined as one level below our operating segments. If, through the qualitative assessment, the entity determines that it is more likely than not that a reporting unit's fair value is greater than its carrying value, the remaining impairment steps would be unnecessary. | ||||||||||||
If there are indicators that goodwill has been impaired and thus the two-step goodwill impairment model is necessary, step 1 is to determine the fair value of each reporting unit and compare it to the reporting unit's carrying value. Fair value is determined based on the present value of estimated cash flows using available information regarding expected cash flows of each reporting unit, discount rates and the expected long-term cash flow growth rates. Discount rates are determined based on the cost of capital for the reporting unit. If the fair value of the reporting unit exceeds the carrying value, goodwill is not impaired and no further testing is performed. The second step is performed if the carrying value exceeds the fair value. The implied fair value of the reporting unit’s goodwill must be determined and compared to the carrying value of the goodwill. If the carrying value of a reporting unit’s goodwill exceeds its implied fair value, an impairment loss equal to the difference will be recorded. No impairments were identified in our annual impairment analysis during the fourth quarter of 2013, 2012 and 2011. | ||||||||||||
Derivatives | ||||||||||||
We use a combination of forward contracts, zero cost collar contracts, option contracts and other instruments to hedge certain anticipated foreign currency exchange transactions. When specific hedge criteria have been met, changes in fair values of hedge contracts relating to anticipated transactions are recorded in other comprehensive income rather than net income until the underlying hedged transaction affects net income. One of the criteria for this accounting treatment is that the hedge contract amounts should not be in excess of specifically identified anticipated transactions. By their nature, our estimates of anticipated transactions may fluctuate over time and may ultimately vary from actual transactions. When anticipated transaction estimates or actual transaction amounts decrease below hedged levels, or when the timing of transactions changes significantly, we reclassify a portion of the cumulative changes in fair values of the related hedge contracts from other comprehensive income to other income (expense) during the quarter in which such changes occur. | ||||||||||||
We also use foreign forward exchange contracts to mitigate the foreign currency exchange impact of our cash, receivables and payables denominated in foreign currencies. These derivatives do not meet the criteria for hedge accounting and, accordingly, changes in the fair value are recognized in net income in the current period. | ||||||||||||
Segment Reporting | ||||||||||||
We have determined that we operate in two reportable operating segments: Industry Group and Science Group. There are no differences between the accounting policies used for our business segments compared to those used on a consolidated basis. | ||||||||||||
Revenue Recognition | ||||||||||||
We recognize revenue when persuasive evidence of a contractual agreement exists, delivery has occurred or services have been rendered, the seller’s price to the buyer is fixed and determinable, and collectability is reasonably assured. | ||||||||||||
For products demonstrated to meet our published specifications, revenue is recognized when the title to the product and the risks and rewards of ownership pass to the customer. For products produced according to a particular customer’s specifications, revenue is recognized when the product meets the customer’s specifications and when the title and the risks and rewards of ownership have passed to the customer. In each case, the portion of revenue related to installation, of which the estimated fair value is generally 4% of the net revenue of the transaction, is deferred until such installation at the customer site and final customer acceptance are completed. For new applications of our products where performance cannot be assured prior to meeting specifications at the customer's installation site, no revenue is recognized until such specifications are met. | ||||||||||||
We enter into arrangements with customers whereby they purchase products, accessories and service contracts from us at the same time. For sales arrangements containing multiple elements (products or services), revenue relating to the undelivered elements is deferred at the estimated selling price of the element as determined using the sales price hierarchy established in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification ("ASC") 605-25. To be considered a separate element, the deliverable in question must represent a separate element under the accounting guidance and fulfill the following criteria: the delivered item or items must have value to the customer on a standalone basis; and, if the arrangement includes a general right of return relative to the delivered item(s), delivery or performance of the undelivered item(s) is considered probable and substantially in our control. If the arrangement does not meet all criteria above, the entire amount of the transactions is deferred until all elements are delivered. | ||||||||||||
For sales arrangements that contain multiple deliverables (products or services), to the extent that the deliverables within a multiple-element arrangement are not accounted for pursuant to other accounting standards, revenue is allocated among the deliverables using the selling price hierarchy established in ASC 605-25 to determine the selling price of each deliverable. The selling price hierarchy allows for the use of an estimated selling price (“ESP”) to determine the allocation of arrangement consideration to a deliverable in a multiple-element arrangement in the absence of vendor specific objective evidence (“VSOE”) or third-party evidence (“TPE”). We determine the selling price in multiple-element arrangements using VSOE or TPE if available. VSOE is determined based on the price charged for the same deliverable when sold separately and TPE is established based on the price charged by our competitors or third parties for the same deliverable. If we are unable to determine the selling price because VSOE or TPE does not exist, we determine ESP for the purposes of allocating total arrangement consideration among the elements by considering several internal and external factors such as, but not limited to, historical sales of similar products, costs incurred to manufacture the product and normal profit margins from the sale of similar products, geographical considerations and overall pricing practices. | ||||||||||||
These factors are subject to change as we modify our pricing practices and such changes could result in changes to determination of VSOE, TPE and ESP, which could result in our future revenue recognition from multiple-element arrangements being materially different than our results in the current period. | ||||||||||||
Generally, revenue from all elements in a multiple-element arrangement is recognized within 18 months of the shipment of the first item in the arrangement. | ||||||||||||
We provide maintenance and support services under renewable, term maintenance agreements. Maintenance and support fee revenue is recognized ratably over the contractual term, which is generally 12 months, and commences from the start date. | ||||||||||||
Revenue from time and materials-based service arrangements is recognized as the service is performed. Spare parts revenue is generally recognized upon shipment. | ||||||||||||
Deferred Revenue | ||||||||||||
Deferred revenue represents customer deposits on equipment orders, orders awaiting customer acceptance and prepaid service contract revenue. Deferred revenue is recognized in accordance with our revenue recognition policies described above. | ||||||||||||
Warranty Liabilities | ||||||||||||
Our products generally carry a one-year warranty. A reserve is established at the time of sale to cover estimated warranty costs and certain commitments for product upgrades as a component of cost of sales on our consolidated statements of operations. Our estimate of warranty cost is primarily based on our history of warranty repairs and maintenance, as applied to systems currently under warranty. For our new products without a history of known warranty costs, we estimate the expected costs based on our experience with similar product lines and technology. While most new products are extensions of existing technology, the estimate could change if new products require a significantly different level of repair and maintenance than similar products have required in the past. Our estimated warranty costs are reviewed and updated on a quarterly basis. Changes to the reserve occur as volume, product mix and warranty costs fluctuate. | ||||||||||||
Research and Development Costs | ||||||||||||
Research and Development (“R&D”) costs include labor, materials, overhead and payments to third parties for research and development of new products and new software or enhancements to existing products and software and are expensed as incurred. We periodically receive funds from various organizations to subsidize our research and development. These funds are reported as an offset to research and development expense. During the 2013, 2012 and 2011 periods, we received subsidies of $5.3 million, $7.3 million and $5.3 million, respectively, from European governments for technological developments primarily for semiconductor and life sciences equipment. | ||||||||||||
Advertising Costs | ||||||||||||
Advertising costs are expensed as incurred and are included as a component of selling, general and administrative costs on our consolidated statements of operations. Advertising expense totaled $4.1 million, $3.9 million and $3.2 million in 2013, 2012 and 2011, respectively. | ||||||||||||
Restructuring, Reorganization, Relocation and Severance Costs | ||||||||||||
Restructuring, reorganization, relocation and severance costs are recognized and recorded at fair value as incurred. Such costs include severance and other costs related to employee terminations as well as facility costs related to future abandonment of various leased office and manufacturing sites. Also included are certain period costs to move our existing supply chain, as well as migration of certain IT systems to new platforms. Changes in our estimates could occur, and have occurred, due to fluctuations in exchange rates, the sublease of unused space, unanticipated voluntary departures before severance was required and unanticipated redeployment of employees to vacant positions. See Note 14 of the Notes to the Consolidated Financial Statements for additional information. | ||||||||||||
Stock-Based Compensation | ||||||||||||
We measure and recognize compensation expense for all stock-based payment awards granted to our employees and directors, including employee stock options, non-vested stock and stock purchases related to our employee share purchase plan based on the estimated fair value of the award on the grant date. We utilize the Black-Scholes valuation model for valuing our stock option awards. | ||||||||||||
The use of the Black-Scholes valuation model to estimate the fair value of stock option awards requires us to make judgments on assumptions regarding the risk-free interest rate, expected dividend yield, expected term and expected volatility over the expected term of the award. The assumptions used in calculating the fair value of stock-based payment awards represent management’s best estimates at the time they are made, but these estimates involve inherent uncertainties and the determination of expense could be materially different in the future. | ||||||||||||
We amortize stock-based compensation expense on a straight-line basis over the vesting period of the individual award with estimated forfeitures considered. Vesting periods are generally four years. The exercise price of issued options equals the grant date fair value of the underlying shares and the options generally have a legal life of seven years. | ||||||||||||
Compensation expense is only recognized on awards that ultimately vest. Therefore, we have reduced the compensation expense to be recognized over the vesting period for anticipated future forfeitures. Forfeiture estimates are based on historical forfeiture patterns. We update our forfeiture estimates quarterly and recognize any changes to accumulated compensation expense in the period of change. If actual forfeitures differ significantly from our estimates, our results of operations could be materially impacted. | ||||||||||||
Foreign Currency Translation | ||||||||||||
A large portion of our business is conducted outside of the U.S. through a number of foreign subsidiaries. Each of the foreign subsidiaries keeps its accounting records in its respective local currency. These local-currency-denominated accounting records are translated at exchange rates that fluctuate up or down from period to period and consequently affect our consolidated results of operations and financial position. | ||||||||||||
Assets and liabilities of foreign subsidiaries denominated in a foreign currency, where the local currency is the functional currency, are translated to U.S. dollars at the exchange rate in effect on the respective balance sheet date. Gains and losses resulting from the translation of assets, liabilities and equity are included in accumulated other comprehensive income on the consolidated balance sheet. Transactions representing revenues, costs and expenses are translated using an average rate of exchange for the period, and the related gains and losses are reported as other income (expense) on our consolidated statement of operations. | ||||||||||||
Reclassifications | ||||||||||||
Certain items previously reported in the Consolidated Balance Sheet have been reclassified to conform to current year financial statement presentation. These reclassifications had no effect on our results of operation, financial position, or cash flows. |
New_Accounting_Pronouncements
New Accounting Pronouncements | 12 Months Ended |
Dec. 31, 2013 | |
New Accounting Pronouncements and Changes in Accounting Principles [Abstract] | ' |
New Accounting Pronouncements | ' |
NEW ACCOUNTING PRONOUNCEMENTS | |
ASU 2013-02 | |
In February 2013, the FASB issued ASU No. 2013-02, "Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income" which added new disclosure requirements for items reclassified out of accumulated other comprehensive income. ASU No. 2013-02 effectively replaced the requirements previously outlined in ASU 2011-05 and ASU 2011-12. | |
ASU 2013-02 was adopted prospectively beginning in 2013. As ASU 2013-02 relates to disclosure requirements only, the adoption of this guidance did not have an impact on our financial position, results of operations or cash flows. | |
ASU 2013-11 | |
In July 2013, the FASB issued ASU No. 2013-11, “Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists” which provides explicit guidance on the financial statement presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. This guidance is effective for annual periods, and interim periods within those years, beginning after December 15, 2013. We early adopted this guidance and it did not have a material effect on our financial statements. |
Earnings_Per_Share
Earnings Per Share | 12 Months Ended | ||||||||||||||||||||||||||||||||
Dec. 31, 2013 | |||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | ' | ||||||||||||||||||||||||||||||||
Earnings Per Share | ' | ||||||||||||||||||||||||||||||||
EARNINGS PER SHARE | |||||||||||||||||||||||||||||||||
Following is a reconciliation of basic earnings per share (“EPS”) and diluted EPS (in thousands, except per share amounts): | |||||||||||||||||||||||||||||||||
Year Ended | |||||||||||||||||||||||||||||||||
2013 | 2012 | 2011 | |||||||||||||||||||||||||||||||
Net | Shares | Per Share | Net | Shares | Per Share | Net | Shares | Per Share | |||||||||||||||||||||||||
Income | Amount | Income | Amount | Income | Amount | ||||||||||||||||||||||||||||
Basic EPS | $ | 126,673 | 40,446 | $ | 3.13 | $ | 114,920 | 38,065 | $ | 3.02 | $ | 103,637 | 38,384 | $ | 2.7 | ||||||||||||||||||
Dilutive effect of 2.875% convertible debt | 780 | 1,287 | (0.08 | ) | 1,819 | 3,033 | (0.18 | ) | 1,808 | 3,033 | (0.15 | ) | |||||||||||||||||||||
Dilutive effect of stock options, restricted stock units, and shares issuable to Philips | — | 662 | (0.04 | ) | — | 630 | (0.04 | ) | — | 630 | (0.04 | ) | |||||||||||||||||||||
Diluted EPS | $ | 127,453 | 42,395 | $ | 3.01 | $ | 116,739 | 41,728 | $ | 2.8 | $ | 105,445 | 42,047 | $ | 2.51 | ||||||||||||||||||
The following table sets forth the schedule of anti-dilutive securities excluded from the computation of diluted EPS (number of shares, in thousands): | |||||||||||||||||||||||||||||||||
Year Ended | |||||||||||||||||||||||||||||||||
2013 | 2012 | 2011 | |||||||||||||||||||||||||||||||
Stock options | 142 | 279 | 358 | ||||||||||||||||||||||||||||||
Restricted stock units | 33 | 59 | 322 | ||||||||||||||||||||||||||||||
Changes_in_Accumulated_Other_C
Changes in Accumulated Other Comprehensive Income by Component (Notes) | 12 Months Ended | |||||||||||||||||||
Dec. 31, 2013 | ||||||||||||||||||||
Changes in Accumulated Other Comprehensive Income [Abstract] | ' | |||||||||||||||||||
Changes in Accumulated Other Comprehensive Income by Component | ' | |||||||||||||||||||
CHANGES IN ACCUMULATED OTHER COMPREHENSIVE INCOME BY COMPONENT | ||||||||||||||||||||
The following table illustrates the disclosure of changes in the balances of each component of accumulated other comprehensive income ("AOCI"), as well as details the effect of reclassifications out of AOCI on the line items in the Consolidated Statements of Operations by component (net of tax, in thousands): | ||||||||||||||||||||
Year Ended December 31, 2013 | ||||||||||||||||||||
Foreign Currency Items | Unrealized Gains and Losses on Available-for-Sale Securities | Defined Benefit Pension Items | Gains and Losses on Cash Flow Hedges | Total | ||||||||||||||||
Beginning Balance | $ | 38,890 | $ | 4 | $ | (819 | ) | $ | 481 | $ | 38,556 | |||||||||
Other comprehensive income before reclassifications | 9,975 | (15 | ) | 267 | (2,492 | ) | 7,735 | |||||||||||||
Amounts reclassified from AOCI to: | ||||||||||||||||||||
Revenue | — | — | — | (33 | ) | (33 | ) | |||||||||||||
Cost of goods sold | — | — | — | 790 | 790 | |||||||||||||||
Other income (expense) | — | — | — | 80 | 80 | |||||||||||||||
Total reclassifications out of AOCI | — | — | — | 837 | 837 | |||||||||||||||
Net current period other comprehensive income | 9,975 | (15 | ) | 267 | (1,655 | ) | 8,572 | |||||||||||||
Ending balance | $ | 48,865 | $ | (11 | ) | $ | (552 | ) | $ | (1,174 | ) | $ | 47,128 | |||||||
Factoring_of_Accounts_Receivab
Factoring of Accounts Receivable | 12 Months Ended |
Dec. 31, 2013 | |
Factoring of Accounts Receivable [Abstract] | ' |
Factoring of Accounts Receivable | ' |
FACTORING OF ACCOUNTS RECEIVABLE | |
In 2013, we entered into agreements under which we sold a total of $9.9 million of our accounts receivable at a discount to unrelated third party financiers without recourse. The transfers qualified for sales treatment and, accordingly, discounts related to the sale of the receivables, which were immaterial, were recorded on our Consolidated Statements of Operations as other expense. We sold no accounts receivable under these agreements during 2012. |
Inventories
Inventories | 12 Months Ended | |||||||
Dec. 31, 2013 | ||||||||
Inventory Disclosure [Abstract] | ' | |||||||
Inventories | ' | |||||||
INVENTORIES | ||||||||
Inventories consisted of the following (in thousands): | ||||||||
December 31, | ||||||||
2013 | 2012 | |||||||
Raw materials and assembled parts | $ | 61,235 | $ | 67,985 | ||||
Service inventories, estimated current requirements | 15,197 | 15,898 | ||||||
Work-in-process | 75,883 | 81,104 | ||||||
Finished goods | 29,410 | 27,553 | ||||||
Total current inventories | $ | 181,725 | $ | 192,540 | ||||
Non-current inventories | $ | 62,104 | $ | 65,116 | ||||
Investments
Investments | 12 Months Ended | |||||||||||||||||||||||||||||||
Dec. 31, 2013 | ||||||||||||||||||||||||||||||||
Investments [Abstract] | ' | |||||||||||||||||||||||||||||||
Investments Disclosure [Text Block] | ' | |||||||||||||||||||||||||||||||
INVESTMENTS | ||||||||||||||||||||||||||||||||
Investments held consisted of the following (in thousands): | ||||||||||||||||||||||||||||||||
December 31, 2013 | ||||||||||||||||||||||||||||||||
Amortized | Unrealized | Unrealized | Estimated | |||||||||||||||||||||||||||||
cost | gains | losses | fair value | |||||||||||||||||||||||||||||
Available for sale marketable securities: | ||||||||||||||||||||||||||||||||
U.S. treasury notes | $ | 10,130 | $ | — | $ | (2 | ) | $ | 10,128 | |||||||||||||||||||||||
Agency bonds(1) | 37,996 | — | (35 | ) | 37,961 | |||||||||||||||||||||||||||
Commercial paper | 39,987 | — | — | 39,987 | ||||||||||||||||||||||||||||
Certificates of deposit | 7,786 | — | — | 7,786 | ||||||||||||||||||||||||||||
Municipal bonds | 49,296 | 24 | (1 | ) | 49,319 | |||||||||||||||||||||||||||
Corporate bond | 5,002 | — | (1 | ) | 5,001 | |||||||||||||||||||||||||||
Total available for sale marketable securities | 150,197 | 24 | (39 | ) | 150,182 | |||||||||||||||||||||||||||
Trading Securities: | ||||||||||||||||||||||||||||||||
Equity securities - mutual funds | 5,287 | — | — | 5,287 | ||||||||||||||||||||||||||||
Cost Method Investments(2) | 608 | — | — | 608 | ||||||||||||||||||||||||||||
Total Investments | $ | 156,092 | $ | 24 | $ | (39 | ) | $ | 156,077 | |||||||||||||||||||||||
December 31, 2012 | ||||||||||||||||||||||||||||||||
Amortized | Unrealized | Unrealized | Estimated | |||||||||||||||||||||||||||||
cost | gains | losses | fair value | |||||||||||||||||||||||||||||
Available for sale marketable securities: | ||||||||||||||||||||||||||||||||
U.S. treasury notes | $ | 60,785 | $ | 4 | $ | (3 | ) | $ | 60,786 | |||||||||||||||||||||||
Agency bonds(1) | 31,153 | 4 | — | 31,157 | ||||||||||||||||||||||||||||
Commercial paper | 5,000 | — | — | 5,000 | ||||||||||||||||||||||||||||
Certificates of deposit | 5,494 | — | — | 5,494 | ||||||||||||||||||||||||||||
Municipal bonds | 3,227 | 1 | — | 3,228 | ||||||||||||||||||||||||||||
Total available for sale marketable securities | 105,659 | 9 | (3 | ) | 105,665 | |||||||||||||||||||||||||||
Trading Securities: | ||||||||||||||||||||||||||||||||
Equity securities - mutual funds | 3,046 | — | — | 3,046 | ||||||||||||||||||||||||||||
Cost Method Investments(2) | 608 | — | — | 608 | ||||||||||||||||||||||||||||
Total Investments | $ | 109,313 | $ | 9 | $ | (3 | ) | $ | 109,319 | |||||||||||||||||||||||
(1) | Agency bonds are securities backed by U.S. government-sponsored entities. | |||||||||||||||||||||||||||||||
(2) | Investments for which it is not practical to estimate fair value are included at cost and primarily consist of investments in privately-held companies. | |||||||||||||||||||||||||||||||
Realized gains and losses on sales of marketable debt securities were insignificant in 2013, 2012 and 2011. | ||||||||||||||||||||||||||||||||
We review available for sale investments in debt and equity securities for other than temporary impairment whenever the fair value of an investment is less than amortized cost and evidence indicates that an investment’s carrying amount is not recoverable within a reasonable period of time. In the evaluation of whether an impairment is “other-than-temporary,” we consider our ability and intent to hold the investment until the market price recovers, the reasons for the impairment, compliance with our investment policy, the severity and duration of the impairment and expected future performance. Unrealized losses on our corporate notes and bonds and government-backed securities are mainly due to interest rate movements, and no unrealized losses of any significance existed for a period in excess of 12 months. Our investments classified as trading securities, such as assets related to our deferred compensation plan, are carried on the balance sheet at fair value. | ||||||||||||||||||||||||||||||||
For investments in small privately-held companies, which are recorded at cost, it is often not practical to estimate fair value. In order to assess whether impairments exist that are “other-than-temporary,” we reviewed recent interim financial statements and held discussions with these entities’ management about their current financial conditions and future economic outlooks. We also considered our willingness to support future funding requirements as well as our intention and/or ability to hold these investments long-term. At December 31, 2013 and 2012, we had $0.6 million in cost-method investments on our balance sheet. Refer to Note 22 the Notes to the Consolidated Financial Statements for additional information. | ||||||||||||||||||||||||||||||||
Investments were included in the following captions on the balance sheet as follows (in thousands): | ||||||||||||||||||||||||||||||||
December 31, 2013 | December 31, 2012 | |||||||||||||||||||||||||||||||
Short-term | Long-term | Other | Total | Short-term | Long-term | Other | Total | |||||||||||||||||||||||||
investments | investments | assets | investments | investments | assets | |||||||||||||||||||||||||||
Available for sale marketable securities: | ||||||||||||||||||||||||||||||||
U.S. treasury notes | $ | 10,128 | $ | — | $ | — | $ | 10,128 | $ | 60,786 | $ | — | $ | — | $ | 60,786 | ||||||||||||||||
Agency bonds | 10,995 | 26,966 | — | 37,961 | 10,148 | 21,009 | — | 31,157 | ||||||||||||||||||||||||
Commercial paper | 39,987 | — | — | 39,987 | 5,000 | — | — | 5,000 | ||||||||||||||||||||||||
Certificates of deposit | 5,802 | 1,984 | — | 7,786 | 3,598 | 1,896 | — | 5,494 | ||||||||||||||||||||||||
Municipal bonds | 41,279 | 8,040 | — | 49,319 | — | 3,228 | — | 3,228 | ||||||||||||||||||||||||
Corporate bond | — | 5,001 | — | 5,001 | — | — | — | — | ||||||||||||||||||||||||
Total fixed maturity securities | 108,191 | 41,991 | — | 150,182 | 79,532 | 26,133 | — | 105,665 | ||||||||||||||||||||||||
Trading Securities: | ||||||||||||||||||||||||||||||||
Equity securities - mutual funds | — | 5,287 | — | 5,287 | — | 3,046 | — | 3,046 | ||||||||||||||||||||||||
Cost Method Investments | — | — | 608 | 608 | — | — | 608 | 608 | ||||||||||||||||||||||||
Total Investments | $ | 108,191 | $ | 47,278 | $ | 608 | $ | 156,077 | $ | 79,532 | $ | 29,179 | $ | 608 | $ | 109,319 | ||||||||||||||||
Contractual maturities or expected liquidation dates of available-for-sale fixed maturity securities at December 31, 2013 were as follows (in thousands): | ||||||||||||||||||||||||||||||||
Amortized Cost | Fair Value | |||||||||||||||||||||||||||||||
Due in 1 year or less | $ | 108,183 | $ | 108,191 | ||||||||||||||||||||||||||||
Due in 1-5 years | 42,014 | 41,991 | ||||||||||||||||||||||||||||||
Total | $ | 150,197 | $ | 150,182 | ||||||||||||||||||||||||||||
Property_Plant_and_Equipment
Property, Plant and Equipment | 12 Months Ended | |||||||
Dec. 31, 2013 | ||||||||
Property, Plant and Equipment [Abstract] | ' | |||||||
Property, Plant and Equipment Disclosure [Text Block] | ' | |||||||
PROPERTY, PLANT AND EQUIPMENT | ||||||||
Property, plant and equipment consisted of the following (in thousands): | ||||||||
December 31, | ||||||||
2013 | 2012 | |||||||
Land | $ | 25,535 | $ | 7,806 | ||||
Buildings and improvements | 36,778 | 21,645 | ||||||
Leasehold improvements | 23,948 | 16,503 | ||||||
Machinery and equipment | 103,180 | 108,982 | ||||||
Demonstration systems | 44,700 | 29,986 | ||||||
Other fixed assets | 49,093 | 46,510 | ||||||
Gross property, plant and equipment | 283,234 | 231,432 | ||||||
Accumulated depreciation | (125,405 | ) | (121,560 | ) | ||||
Total property, plant and equipment, net | $ | 157,829 | $ | 109,872 | ||||
Goodwill_and_Other_Intangible_
Goodwill and Other Intangible Assets | 12 Months Ended | |||||||||||||||
Dec. 31, 2013 | ||||||||||||||||
Goodwill and Intangible Assets Disclosure [Abstract] | ' | |||||||||||||||
Goodwill and Other Intangible Assets | ' | |||||||||||||||
GOODWILL AND OTHER INTANGIBLE ASSETS | ||||||||||||||||
Goodwill | ||||||||||||||||
The roll-forward of activity related to our goodwill was as follows (in thousands): | ||||||||||||||||
Year Ended | ||||||||||||||||
2013 | 2012 | |||||||||||||||
Balance, beginning of period | $ | 131,320 | $ | 58,053 | ||||||||||||
Additions | 3,268 | 69,398 | ||||||||||||||
Goodwill adjustments | 1,564 | 3,869 | ||||||||||||||
Balance, end of period | $ | 136,152 | $ | 131,320 | ||||||||||||
Additions to goodwill represent goodwill from an acquisition made during the period. Adjustments to goodwill include translation adjustments resulting from a portion of our goodwill being recorded on the books of our foreign subsidiaries as well as an adjustment related to the finalization of the purchase price allocation of the acquisition of ASPEX Corporation in 2012. | ||||||||||||||||
Acquisition of nanoTechnology Systems Pty. Ltd. | ||||||||||||||||
On August 9, 2013, we acquired 100% of the outstanding shares of nanoTechnology Systems Pty. Ltd. (NTS) of Melbourne, Australia, which had operated as our exclusive distributor in Australia and New Zealand for approximately 10 years. The total purchase price of the acquisition was approximately $3.6 million. | ||||||||||||||||
No pro forma or disclosure has been provided for this acquisition as it is insignificant. | ||||||||||||||||
Other Intangible Assets | ||||||||||||||||
Patents, trademarks and other are amortized under the straight-line method over their estimated useful lives of 2 to 15 years. Customer relationships are amortized under the straight-line method over their estimated useful lives of 5 to 10 years. Developed technology is amortized under the straight-line method over the estimated useful life of the related technology, which ranges from 5.5 to 10 years. Note issuance costs were amortized over the life of the related debt, which was 7 years. | ||||||||||||||||
Asset Impairment Charges | ||||||||||||||||
As part of our annual impairment test of long-lived intangible assets performed in the fourth quarter of 2011, we determined that the carrying value of certain intellectual property was not recoverable as we no longer intend to use the associated technology. As a result, we recorded an impairment charge of $1.4 million to write-off the remaining net book value of the intellectual property. The impairment loss is recorded within the selling, general and administrative expense line of our Consolidated Statements of Operations and is reported under the Science Group. There were no impairment charges recorded during 2013 or 2012. | ||||||||||||||||
The gross amount of our other intangible assets and the related accumulated amortization were as follows (in thousands): | ||||||||||||||||
December 31, | ||||||||||||||||
2013 | 2012 | |||||||||||||||
Patents, trademarks and other | $ | 24,327 | $ | 22,047 | ||||||||||||
Accumulated amortization | (9,296 | ) | (5,743 | ) | ||||||||||||
Net patents, trademarks and other | 15,031 | 16,304 | ||||||||||||||
Customer relationships | 21,650 | 20,305 | ||||||||||||||
Accumulated amortization | (3,547 | ) | (1,171 | ) | ||||||||||||
Net customer relationships | 18,103 | 19,134 | ||||||||||||||
Developed technology | 18,161 | 17,686 | ||||||||||||||
Accumulated amortization | (4,098 | ) | (1,771 | ) | ||||||||||||
Net developed technology | 14,063 | 15,915 | ||||||||||||||
Note issuance costs | 2,445 | 2,445 | ||||||||||||||
Accumulated amortization | (2,445 | ) | (2,299 | ) | ||||||||||||
Net note issuance costs | — | 146 | ||||||||||||||
Total intangible assets included in other long-term assets | $ | 47,197 | $ | 51,499 | ||||||||||||
Amortization expense was as follows (in thousands): | ||||||||||||||||
Year Ended | ||||||||||||||||
2013 | 2012 | 2011 | ||||||||||||||
Patents, trademarks and other | $ | 3,553 | $ | 1,993 | $ | 1,342 | ||||||||||
Customer relationships | 2,376 | 1,168 | 3 | |||||||||||||
Developed technology | 2,327 | 1,716 | 55 | |||||||||||||
Note issuance costs | 146 | 350 | 350 | |||||||||||||
Total amortization expense | $ | 8,402 | $ | 5,227 | $ | 1,750 | ||||||||||
Expected amortization, without consideration for foreign currency effects, is as follows over the next five years and thereafter (in thousands): | ||||||||||||||||
Patents, | Customer Relationships | Developed Technology | Total | |||||||||||||
Trademarks | ||||||||||||||||
and Other | ||||||||||||||||
2014 | $ | 3,234 | $ | 2,420 | $ | 2,291 | $ | 7,945 | ||||||||
2015 | 3,019 | 2,420 | 2,291 | 7,730 | ||||||||||||
2016 | 2,757 | 2,420 | 2,291 | 7,468 | ||||||||||||
2017 | 2,214 | 2,072 | 2,010 | 6,296 | ||||||||||||
2018 | 1,646 | 1,988 | 1,847 | 5,481 | ||||||||||||
Thereafter | 2,161 | 6,783 | 3,333 | 12,277 | ||||||||||||
Total future amortization expense | $ | 15,031 | $ | 18,103 | $ | 14,063 | $ | 47,197 | ||||||||
Credit_Facilities_and_Restrict
Credit Facilities and Restricted Cash | 12 Months Ended | |||
Dec. 31, 2013 | ||||
Credit Facilities And Restricted Cash | ' | |||
Credit Facilities and Restricted Cash | ' | |||
CREDIT FACILITIES AND RESTRICTED CASH | ||||
Multibank Credit Agreement | ||||
We have a multibank credit agreement (the “Credit Agreement”), which provides for a $100.0 million secured revolving credit facility, including a $50.0 million subfacility for the issuance of letters of credit. The credit agreement expires in April 2016. We may, upon notice to JPMorgan Chase Bank, N.A. (the “Agent”), request to increase the revolving loan commitments by an aggregate amount of up to $50.0 million with new or additional commitments subject only to the consent of the lender(s) providing the new or additional commitments, for a total secured credit facility of up to $150.0 million. In connection with this loan agreement, we incurred loan origination fees which are being amortized as additional interest expense over the term of the loan. | ||||
The Credit Agreement contains quarterly commitment fees that vary based on borrowings outstanding. | ||||
The revolving loans under the Credit Agreement will generally bear interest, at our option, at either (i) the alternate base rate, which is defined as a rate per annum equal to the higher of (a) the Prime Rate in effect on such day, (b) the Federal Funds Effective Rate in effect on such day plus 1/2 of 1%, and (c) the LIBO Rate for an Interest Period of one month plus 1.50%, or (ii) a floating per annum rate based on LIBOR (based on one, two, three or six-month interest periods) plus a margin equal to between 1.00% and 2.00%, depending on our leverage ratio as of the fiscal quarter most recently ended. A default interest rate shall apply on all obligations during an event of default under the Credit Agreement, at a rate per annum equal to 2.00% above the applicable interest rate. Revolving loans may be borrowed, repaid and reborrowed and voluntarily prepaid at any time without premium or penalty. | ||||
The obligations under the Credit Agreement are guaranteed by our present and future material domestic subsidiaries. In addition, obligations outstanding under the Credit Agreement are secured by substantially all of our assets and the assets of our material domestic subsidiaries. | ||||
The Credit Agreement contains customary covenants for a credit facility of this size and type, that include, among others, covenants that limit our ability to incur indebtedness, create liens, merge or consolidate, dispose of assets, make investments, enter into swap agreements, pay dividends or make distributions, enter into transactions with affiliates, enter into restrictive agreements and enter into sale and leaseback transactions. The Credit Agreement provides for financial covenants that require us to maintain a minimum interest coverage ratio and limit the maximum leverage that we can maintain at any one time. | ||||
The Credit Agreement contains customary events of default for a credit facility of this size and type that include, among others, non-payment defaults, inaccuracy of representations and warranties, covenant defaults, cross-defaults to certain other material indebtedness, bankruptcy and insolvency defaults, material judgments defaults, defaults for the occurrence of certain ERISA events and change of control defaults. The occurrence of an event of default could result in an acceleration of the obligations under the Credit Agreement. | ||||
As of December 31, 2013, there were no revolving loans or letters of credit outstanding under the Credit Agreement, we were in compliance with all covenants and we were not in default under the Credit Agreement. | ||||
Restricted Cash | ||||
As part of our contracts with certain customers, we are required to provide letters of credit or bank guarantees which these customers can draw against in the event we do not perform in accordance with our contractual obligations. Restricted cash balances securing bank guarantees that expire within 12 months of the balance sheet date are recorded as a current asset on our consolidated balance sheets. Restricted cash balances securing bank guarantees that expire beyond 12 months from the balance sheet date are recorded as long-term restricted cash on our consolidated balance sheets. | ||||
The following table sets forth information related to guarantees and letters of credit (in thousands): | ||||
December 31, | ||||
2013 | ||||
Guarantees and letters of credit outstanding | $ | 51,892 | ||
Amount secured by restricted cash deposits: | ||||
Current | $ | 18,798 | ||
Long-term | 32,718 | |||
Total secured by restricted cash | $ | 51,516 | ||
Warranty_Reserves
Warranty Reserves | 12 Months Ended | |||||||||||
Dec. 31, 2013 | ||||||||||||
Product Warranties Disclosures [Abstract] | ' | |||||||||||
Warranty Reserves | ' | |||||||||||
WARRANTY RESERVES | ||||||||||||
The following is a summary of warranty reserve activity (in thousands): | ||||||||||||
Year Ended | ||||||||||||
2013 | 2012 | 2011 | ||||||||||
Balance, beginning of period | $ | 12,049 | $ | 11,683 | $ | 8,648 | ||||||
Reductions for warranty costs incurred | (13,058 | ) | (11,958 | ) | (8,991 | ) | ||||||
Warranties issued | 13,677 | 12,302 | 12,229 | |||||||||
Translation and changes in estimates | 37 | 22 | (203 | ) | ||||||||
Balance, end of period | $ | 12,705 | $ | 12,049 | $ | 11,683 | ||||||
Convertible_Notes
Convertible Notes | 12 Months Ended | |||||||||||||||
Dec. 31, 2013 | ||||||||||||||||
Convertible Subordinated Debt [Abstract] | ' | |||||||||||||||
Convertible Notes | ' | |||||||||||||||
CONVERTIBLE NOTES | ||||||||||||||||
2.875% Convertible Subordinated Notes | ||||||||||||||||
On May 19, 2006, we issued $115.0 million aggregate principal amount of convertible subordinated notes with an interest rate of 2.875%, payable semi-annually. The notes were due on June 1, 2013, and were subordinated to all previously existing and future senior indebtedness, and effectively subordinated to all indebtedness and other liabilities of our subsidiaries. The cost of this transaction, including underwriting discounts and commissions and offering expenses, totaled $3.1 million and was recorded on our balance sheet in other long-term assets and amortized over the life of the notes. The amortization of these costs totals $0.1 million per quarter and is reflected as additional interest expense in our Consolidated Statements of Operations through the date of conversion. | ||||||||||||||||
Prior to conversion, we redeemed the following amounts of our 2.875% Convertible Subordinated Notes: | ||||||||||||||||
Date | Amount | Redemption | Redemption | Related Note | ||||||||||||
Redeemed | Price | Discount | Issuance Costs | |||||||||||||
Written Off | ||||||||||||||||
Feb-09 | $ | 15,000,000 | 86.5 | % | $ | 2,025,000 | $ | 250,154 | ||||||||
24-Jun-10 | 7,940,000 | 98.9 | 89,325 | 90,904 | ||||||||||||
29-Jun-10 | 1,200,000 | 99 | 12,000 | 13,703 | ||||||||||||
8-Jul-10 | 1,848,000 | 99.25 | 13,860 | 20,546 | ||||||||||||
Total for 2010 | 10,988,000 | 115,185 | 125,153 | |||||||||||||
Total | $ | 25,988,000 | $ | 2,140,185 | $ | 375,307 | ||||||||||
Additionally, during 2012, one of our note holders converted a $1,000 note into 34 shares of FEI common stock and in 2011, one of our note holders converted a $1,000 note into 34 shares of FEI common stock. | ||||||||||||||||
Debt Conversion | ||||||||||||||||
On June 1, 2013, the remaining $89.0 million of these notes were due. Prior to maturity, holders of $88.9 million of these notes converted their notes into 3.0 million shares of FEI common stock. At maturity, holders of $0.1 million of these notes did not elect to convert into FEI common stock and those notes were settled with a cash payment. |
Income_Taxes
Income Taxes | 12 Months Ended | |||||||||||
Dec. 31, 2013 | ||||||||||||
Income Tax Disclosure [Abstract] | ' | |||||||||||
Income Taxes | ' | |||||||||||
INCOME TAXES | ||||||||||||
Income before income taxes included the following components (in thousands): | ||||||||||||
Year Ended | ||||||||||||
2013 | 2012 | 2011 | ||||||||||
U.S. | $ | 32,549 | $ | 26,640 | $ | 14,189 | ||||||
Foreign | 119,053 | 113,908 | 108,676 | |||||||||
Total | $ | 151,602 | $ | 140,548 | $ | 122,865 | ||||||
Income tax expense consisted of the following (in thousands): | ||||||||||||
Year Ended | ||||||||||||
2013 | 2012 | 2011 | ||||||||||
Current: | ||||||||||||
Federal | $ | (851 | ) | $ | 8,173 | $ | 7,767 | |||||
State | 419 | 475 | 395 | |||||||||
Foreign | 16,513 | 13,870 | 18,559 | |||||||||
Total current income tax expense | 16,081 | 22,518 | 26,721 | |||||||||
U.S. deferred expense (benefit) | 12,645 | 4,285 | (6,266 | ) | ||||||||
Foreign deferred benefit | (3,797 | ) | (1,175 | ) | (1,227 | ) | ||||||
Income tax expense | $ | 24,929 | $ | 25,628 | $ | 19,228 | ||||||
The effective income tax rate applied to net income varied from the U.S. federal statutory rate due to the following (in thousands): | ||||||||||||
Year Ended | ||||||||||||
2013 | 2012 | 2011 | ||||||||||
Tax expense at U.S. federal statutory rates | $ | 53,061 | $ | 49,192 | $ | 43,003 | ||||||
Increase (decrease) resulting from: | ||||||||||||
State income taxes, net of federal benefit | 857 | 1,126 | 723 | |||||||||
Foreign tax benefit | (25,263 | ) | (26,181 | ) | (20,515 | ) | ||||||
Research and experimentation benefit | (5,966 | ) | (758 | ) | (2,908 | ) | ||||||
Foreign tax credit benefit | (2,152 | ) | (2,738 | ) | (4,465 | ) | ||||||
Tax audit settlements and lapses of statutes of limitations | (70 | ) | (439 | ) | (509 | ) | ||||||
Stock compensation | 2,658 | 2,134 | 1,683 | |||||||||
Non-deductible items | 2,132 | 3,100 | 1,597 | |||||||||
Other | (328 | ) | 192 | 619 | ||||||||
Income tax expense | $ | 24,929 | $ | 25,628 | $ | 19,228 | ||||||
Our 2013 tax expense reflected comparatively lower tax rates in foreign jurisdictions where we earn most of our profits. The tax provision also included a benefit for the reduction of unrecognized tax benefits relating to positions on prior year returns after completion of audits in various jurisdictions. | ||||||||||||
Current taxes payable were reduced for excess tax benefits recorded to common stock and related to stock compensation of $6.4 million, $3.1 million and $2.9 million, respectively, in 2013, 2012 and 2011. | ||||||||||||
Deferred Income Taxes | ||||||||||||
Net deferred tax assets (liabilities) were classified on the balance sheet as follows (in thousands): | ||||||||||||
December 31, | ||||||||||||
2013 | 2012 | |||||||||||
Deferred tax assets – current | $ | 15,114 | $ | 12,245 | ||||||||
Deferred tax assets – non-current | 1,751 | 5,092 | ||||||||||
Deferred tax liabilities – current | (9 | ) | (93 | ) | ||||||||
Deferred tax liabilities – non-current | (8,931 | ) | (17,588 | ) | ||||||||
Net deferred tax assets (liabilities) | $ | 7,925 | $ | (344 | ) | |||||||
Valuation allowance | $ | 2,723 | $ | 2,081 | ||||||||
The tax effects of temporary differences that gave rise to significant portions of deferred tax assets and deferred tax liabilities were as follows (in thousands): | ||||||||||||
December 31, | ||||||||||||
2013 | 2012 | |||||||||||
Deferred tax assets: | ||||||||||||
Accrued liabilities and reserves | $ | 15,804 | $ | 13,239 | ||||||||
Revenue recognition | 340 | 3,707 | ||||||||||
Tax credit and loss carryforwards | 8,063 | 8,497 | ||||||||||
Fixed assets and intangibles | 546 | 765 | ||||||||||
Unrealized investment | 765 | 2,538 | ||||||||||
Stock compensation | 2,151 | 1,815 | ||||||||||
Other assets | 1,501 | 665 | ||||||||||
Gross deferred tax assets | 29,170 | 31,226 | ||||||||||
Valuation allowance | (2,723 | ) | (2,081 | ) | ||||||||
Net deferred tax assets | 26,447 | 29,145 | ||||||||||
Deferred tax liabilities: | ||||||||||||
Fixed assets and intangibles | (17,965 | ) | (20,697 | ) | ||||||||
Revenue recognition | (19 | ) | (4,991 | ) | ||||||||
Other liabilities | (538 | ) | (3,801 | ) | ||||||||
Total deferred tax liabilities | (18,522 | ) | (29,489 | ) | ||||||||
Net deferred tax assets (liabilities) | $ | 7,925 | $ | (344 | ) | |||||||
Deferred tax benefit of $1.1 million, $3.0 million and $3.0 million was recorded in other comprehensive income in 2013, 2012 and 2011, respectively. | ||||||||||||
As of December 31, 2013 and 2012, our valuation allowance on deferred tax assets totaled $2.7 million and $2.1 million, respectively. In assessing the realizability of deferred tax assets, we utilize a more likely than not standard. If it is determined that it is “more likely than not” that deferred tax assets will not be realized, a valuation allowance must be established against the deferred tax assets. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which the associated temporary differences become deductible. We consider the scheduled reversal of deferred tax liabilities, historical operating performance, projected future taxable income and tax planning strategies in making this assessment. | ||||||||||||
U.S. net operating loss carryforwards as of December 31,2013 were $0.2 million and expire in 2031. Foreign net operating loss carryforwards as of December 31, 2013 were $14.6 million and do not expire. | ||||||||||||
U.S. research and development tax credit carryforwards as of December 31, 2013 were $2.9 million and expire between 2014 and 2033. Foreign research and development tax credit carryforwards as of December 31, 2013 were $0.2 million and do not expire. Alternative minimum tax credit carryforwards as of December 31, 2013 were $0.7 million and do not expire. | ||||||||||||
As of December 31, 2013, U.S. income taxes have not been provided for approximately $331.3 million of cumulative undistributed earnings of several non-U.S. subsidiaries, as our current intention is to reinvest these earnings indefinitely outside the U.S. Foreign tax provisions have been provided for these cumulative undistributed earnings. Upon distribution of those earnings in the form of dividends or otherwise, we would be subject to both U.S. income taxes (subject to an adjustment for foreign tax credits) and withholding taxes payable to the various foreign countries. Similarly, we have not provided deferred taxes on the cumulative translation adjustment related to those non-U.S. subsidiaries. | ||||||||||||
Unrecognized Tax Benefits and Other Tax Contingencies | ||||||||||||
A rollforward of our unrecognized tax benefits, including interest and penalties, was as follows (in thousands): | ||||||||||||
Year Ended | ||||||||||||
2013 | 2012 | 2011 | ||||||||||
Unrecognized tax benefits, beginning of period | $ | 25,135 | $ | 16,041 | $ | 7,156 | ||||||
Increases for tax positions taken in current period | 1,197 | — | 542 | |||||||||
Increases for tax positions taken in prior periods | 1,701 | 9,965 | 10,502 | |||||||||
Decreases for tax positions taken in prior periods | (3,997 | ) | (620 | ) | (1,723 | ) | ||||||
Decreases for lapses in statutes of limitations | (70 | ) | (251 | ) | (436 | ) | ||||||
Unrecognized tax benefits, end of period | $ | 23,966 | $ | 25,135 | $ | 16,041 | ||||||
During 2013, we effectively settled matters with the Internal Revenue Service and certain foreign jurisdictions. The result of effective settlements was a reduction of $3.7 million of unrecognized tax benefits, all of which resulted in a tax benefit. This reduction was offset by accruals for positions taken on current and prior year tax returns and related mainly to uncertainty surrounding transfer pricing and permanent establishment. | ||||||||||||
Non-current unrecognized tax benefits as of December 31, 2013 and 2012 of $23.8 million and $15.7 million were classified on the balance sheet as a component of Other Liabilities. | ||||||||||||
The entire balance of unrecognized tax benefits, if recognized, would reduce our effective tax rate. We believe it is reasonably possible that our unrecognized tax benefits could decrease, in the next 12 months, between zero and $4.0 million due to lapses of statutes of limitations and as the result of settlements with taxing authorities. | ||||||||||||
We recognize interest and penalties related to unrecognized tax benefits in income tax expense. The liability for unrecognized tax benefits included accruals for interest and penalties of $3.7 million and $2.0 million as of December 31, 2013 and 2012, respectively. | ||||||||||||
Tax expense included the following relating to interest and penalties (in thousands): | ||||||||||||
Year Ended | ||||||||||||
2013 | 2012 | 2011 | ||||||||||
Benefit for lapses of statutes of limitations and settlement with taxing authorities | $ | (24 | ) | $ | (88 | ) | $ | (124 | ) | |||
Accruals for current and prior periods | 1,698 | 652 | 293 | |||||||||
Total interest and penalties | $ | 1,674 | $ | 564 | $ | 169 | ||||||
For our major tax jurisdictions, the following years were open for examination by the tax authorities as of December 31, 2013: | ||||||||||||
Jurisdiction | Open Tax Years | |||||||||||
U.S. | 2010 and forward | |||||||||||
The Netherlands | 2011 and forward | |||||||||||
Czech Republic | 2011 and forward |
Restructuring_Reorganization_R
Restructuring, Reorganization, Relocation and Severance | 12 Months Ended | |||||||||||||||||||||||
Dec. 31, 2013 | ||||||||||||||||||||||||
Restructuring and Related Activities [Abstract] | ' | |||||||||||||||||||||||
Restructuring, Reorganization, Relocation and Severance | ' | |||||||||||||||||||||||
RESTRUCTURING, REORGANIZATION, RELOCATION AND SEVERANCE | ||||||||||||||||||||||||
Group Structure Reorganization | ||||||||||||||||||||||||
In January 2013, we announced our intention to reorganize the company into a group structure in order to enable us to efficiently execute our growth strategy. The reorganization was completed in the first quarter of 2013. The costs associated with the reorganization include primarily severance costs and resulted in the termination of certain positions throughout the company. In anticipation of this reorganization, we incurred $2.9 million of severance costs during the fourth quarter of 2012. We recorded an additional 1.1 million of severance costs during 2013. We do not expect to incur any additional charges related to the reorganization. | ||||||||||||||||||||||||
Manufacturing Transfer | ||||||||||||||||||||||||
In 2008 we entered into an arrangement to outsource aspects of our manufacturing processes. In 2011, we notified our largest contract manufacturer, accounting for approximately 10% of our revenue, that we were terminating the arrangement and that we would transfer the manufacturing process back to FEI. The termination contract was signed during the fourth quarter of 2011 and the manufacturing process was transitioned back to FEI as of April 2, 2012. The costs associated with the termination of the outsourcing arrangement were accrued in the fourth quarter of 2011. No additional costs were incurred in 2012 or 2013 and we do not expect to incur any significant additional costs associated with the termination of this arrangement. | ||||||||||||||||||||||||
April 2010 Restructuring | ||||||||||||||||||||||||
On April 12, 2010, we announced a restructuring program to consolidate the manufacturing of our small DualBeam product line by relocating manufacturing activities currently performed at our facility in Eindhoven, The Netherlands to our facility in Brno, Czech Republic. The balance of our small DualBeam product line is already based in Brno. The move, which has been substantially completed, resulted in severance costs, costs to transfer the product line, costs to train Brno employees and costs to build-out the existing Brno facility to add capacity for the additional small DualBeam production. In addition to the product line move, the April 2010 restructuring plan involved organizational changes designed to improve the efficiency of our finance, research and development and other corporate programs and improve our market focus. Costs incurred in connection with this plan were related to the consolidation of the manufacturing of our small DualBeam product line in Brno. | ||||||||||||||||||||||||
Information for costs related to the April 2010 restructuring plan is as follows (in thousands): | ||||||||||||||||||||||||
Year Ended | ||||||||||||||||||||||||
Costs Incurred | 2013 | 2012 | 2011 | Life of Plan | ||||||||||||||||||||
Severance costs related to work force reduction and reorganization | $ | — | $ | — | $ | 184 | $ | 6,617 | ||||||||||||||||
Product line transfer, training of Brno employees and facility build-out in Brno | — | — | 963 | 1,835 | ||||||||||||||||||||
Total costs incurred | $ | — | $ | — | $ | 1,147 | $ | 8,452 | ||||||||||||||||
All of the costs incurred resulted in cash expenditures. We do not expect to incur significant additional costs associated with this plan. | ||||||||||||||||||||||||
Restructuring, Reorganization, Relocation and Severance Accrual | ||||||||||||||||||||||||
The following tables summarize the charges, expenditures, write-offs and adjustments related to our restructuring, reorganization, relocation and severance accrual (in thousands): | ||||||||||||||||||||||||
Year Ended December 31, 2013 | Group Structure Reorganization | Total | ||||||||||||||||||||||
Beginning accrued liability | $ | 2,692 | $ | 2,692 | ||||||||||||||||||||
Charged to expense, net | 1,090 | 1,090 | ||||||||||||||||||||||
Expenditures | (3,782 | ) | (3,782 | ) | ||||||||||||||||||||
Write-offs and adjustments | 50 | 50 | ||||||||||||||||||||||
Ending accrued liability | $ | 50 | $ | 50 | ||||||||||||||||||||
Year Ended December 31, 2012 | Severance, outplacement and related benefits for terminated employees | Manufacturing Transfer | Group Structure Reorganization | Total | ||||||||||||||||||||
Beginning accrued liability | $ | 113 | $ | 2,100 | $ | — | $ | 2,213 | ||||||||||||||||
Charged to expense, net | — | — | 2,859 | 2,859 | ||||||||||||||||||||
Expenditures | — | (2,100 | ) | (254 | ) | (2,354 | ) | |||||||||||||||||
Write-offs and adjustments | (113 | ) | — | 87 | (26 | ) | ||||||||||||||||||
Ending accrued liability | $ | — | $ | — | $ | 2,692 | $ | 2,692 | ||||||||||||||||
Year Ended December 31, 2011 | Product line transfer and training of Brno employees | Severance, outplacement and related benefits for terminated employees | IT system upgrades | Abandoned leases, leasehold improvements and facilities | Manufacturing Transfer | Total | ||||||||||||||||||
Beginning accrued liability | $ | — | $ | 4,832 | $ | 20 | $ | 32 | $ | — | $ | 4,884 | ||||||||||||
Charged to expense, net | 963 | 184 | — | (32 | ) | 2,100 | 3,215 | |||||||||||||||||
Expenditures | (963 | ) | (5,083 | ) | — | — | — | (6,046 | ) | |||||||||||||||
Write-offs and adjustments | — | 180 | (20 | ) | — | — | 160 | |||||||||||||||||
Ending accrued liability | $ | — | $ | 113 | $ | — | $ | — | $ | 2,100 | $ | 2,213 | ||||||||||||
Commitments_and_Contingencies
Commitments and Contingencies | 12 Months Ended |
Dec. 31, 2013 | |
Commitments and Contingencies Disclosure [Abstract] | ' |
Commitments and Contingencies | ' |
COMMITMENTS AND CONTINGENCIES | |
From time to time, we may be a party to litigation arising in the ordinary course of business. Currently, we are not a party to any litigation that we believe would have a material adverse effect on our financial position, results of operations or cash flows. | |
Purchase Obligations | |
We have commitments under non-cancelable purchase orders, primarily relating to inventory, totaling $81.1 million at December 31, 2013. These commitments expire at various times through the second quarter of 2016. |
Lease_Obligations
Lease Obligations | 12 Months Ended | |||
Dec. 31, 2013 | ||||
Lease Obligations [Abstract] | ' | |||
Lease obligations [Text Block] | ' | |||
LEASE OBLIGATIONS | ||||
We have operating leases for various vehicles and equipment, as well as for certain of our manufacturing and administrative facilities that extend through 2033. The facilities lease agreements generally provide for payment of base rental amounts plus our share of property taxes and common area costs as well as renewal options at current market rates. | ||||
Rent expense is recognized on a straight-line basis over the term of the lease. Rent expense was $7.4 million in 2013, $8.5 million in 2012 and $7.5 million in 2011. | ||||
The approximate future minimum rental payments due under these agreements as of December 31, 2013, were as follows (in thousands): | ||||
Minimum Rental Payment | ||||
2014 | $ | 10,997 | ||
2015 | 8,171 | |||
2016 | 6,883 | |||
2017 | 5,803 | |||
2018 | 4,811 | |||
Thereafter | 48,722 | |||
Total | $ | 85,387 | ||
Shareholders_Equity
Shareholders' Equity | 12 Months Ended |
Dec. 31, 2013 | |
Stockholders' Equity Attributable to Parent [Abstract] | ' |
Shareholders' Equity [Text Block] | ' |
SHAREHOLDERS’ EQUITY | |
Preferred Stock Rights Plan | |
On July 21, 2005, the Board of Directors adopted a Preferred Stock Rights Plan. Pursuant to the Preferred Stock Rights Plan, we distributed Rights as a dividend at the rate of one Right for each share of our common stock held by shareholders of record as of the close of business on August 12, 2005. The Rights expire on August 12, 2015, unless redeemed or exchanged. | |
The Rights are not exercisable until the earlier of: (1) 10 days (or such later date as may be determined by the Board of Directors) following an announcement that a person or group has acquired beneficial ownership of 20% of our common stock or (2) 10 days (or such later date as may be determined by the Board of Directors) following the announcement of a tender offer which would result in a person or group obtaining beneficial ownership of 20% or more of our outstanding common stock, subject to certain exceptions (the earlier of such dates being called the Distribution Date). The Rights are initially exercisable for one-thousandth of a share of our Series A Preferred Stock at a price of $120 per one-thousandth share, subject to adjustment. However, if: (1) after the Distribution Date we are acquired in certain types of transactions, or (2) any person or group (with limited exceptions) acquires beneficial ownership of 20% of our common stock, then holders of Rights (other than the 20% holder) will be entitled to receive, upon exercise of the Right, common stock (or in case we are completely acquired, common stock of the acquirer) having a market value of two times the exercise price of the Right. Philips Business Electronics International B.V., or any of its affiliates, shall not be considered for the 20% calculation so long as it does not acquire 30% or more of our common shares. | |
We are entitled to redeem the Rights, for $0.001 per Right, at the discretion of the Board of Directors, until certain specified times. We may also require the exchange of Rights, at a rate of one share of common stock for each Right, under certain circumstances. We also have the ability to amend the Rights, subject to certain limitations. | |
PEO Combination | |
On February 21, 1997, we acquired substantially all of the assets and liabilities of the electron optics business of Koninklijke Philips Electronics N.V. (the “PEO Combination”), in a transaction accounted for as a reverse acquisition. As part of the PEO Combination, we agreed to issue to Philips additional shares of our common stock whenever stock options that were outstanding on the date of the closing of the PEO Combination are exercised. Any such additional shares are issued at a rate of approximately 1.22 shares to Philips for each share issued on exercise of these options. We receive no additional consideration for these shares issued to Philips under this agreement. We did not issue any shares in 2013, 2012 or 2011 to Philips under this agreement. As of December 31, 2013, 165,000 shares of our common stock are potentially issuable and reserved for issuance as a result of this agreement. | |
Share Repurchases | |
A plan to repurchase up to a total of 4.0 million shares of our common stock was approved by our Board of Directors in September 2010, re-authorized in December 2012, and does not have an expiration date. The amount and timing of specific repurchases are subject to market conditions, applicable legal requirements and other factors. The purchases are funded from existing cash resources and may be suspended or discontinued at any time at our discretion without prior notice. | |
During 2012 we repurchased 20,500 shares for a total of $0.9 million, or an average of $43.41 per share and during 2011 we repurchased 1,654,000 shares for a total of $50.0 million, or an average of $30.19 per share. We did not repurchase any shares during 2013. As of December 31, 2013, 2,119,800 shares remained available for purchase pursuant to this plan. | |
Dividends to Shareholders | |
In June 2012 we announced our plan to initiate a quarterly dividend and our Board has declared dividends each quarter since the plan's inception. The declaration and payment of dividends to shareholders in the future is subject to the discretion of our Board of Directors. |
StockBased_Compensation
Stock-Based Compensation | 12 Months Ended | |||||||||||
Dec. 31, 2013 | ||||||||||||
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | ' | |||||||||||
Stock-Based Compensation | ' | |||||||||||
STOCK-BASED COMPENSATION | ||||||||||||
Employee Share Purchase Plan | ||||||||||||
In 1998, we implemented an Employee Share Purchase Plan (“ESPP”). At our 2013 Annual Meeting of Shareholders, which was held on May 9, 2013, our shareholders approved an amendment to our Employee Share Purchase Plan to increase the number of shares of our common stock reserved for issuance under the plan from 3,700,000 to 3,950,000. | ||||||||||||
Under the ESPP, employees may elect to have compensation withheld and placed in a designated stock subscription account for purchase of FEI common stock. Each ESPP offering period consists of one six-month purchase period. The purchase price in a purchase period is set at a 15% discount to the lower of the market price on either the first day of the applicable offering period or the purchase date. The ESPP allows a maximum purchase of 500 shares per six-month offering period. | ||||||||||||
A total of 163,143 shares were purchased pursuant to the ESPP during 2013 at a weighted average purchase price of $52.60 per share, which represented a weighted average discount of $27.36 per share compared to the fair market value of our common stock on the dates of purchase. At December 31, 2013, 911,568 shares of our common stock remained available for purchase and were reserved for issuance under the ESPP. | ||||||||||||
1995 Stock Incentive Plan | ||||||||||||
Also at our 2013 Annual Meeting of Shareholders, our shareholders approved an amendment to our 1995 Stock Incentive Plan (the “1995 Plan”) to increase the number of shares of our common stock reserved for issuance under the plan from 10,750,000 to 11,000,000. | ||||||||||||
We maintain stock incentive plans for selected directors, officers, employees and certain other parties that allow the Board of Directors to grant options (incentive and nonqualified), stock and cash bonuses, stock appreciation rights, restricted stock units (“RSUs”), performance RSUs and restricted shares. The Board of Directors’ ability to grant options under the 1995 Plan will terminate, if the plan is not amended, when all shares reserved for issuance have been issued and all restrictions on such shares have lapsed, or earlier, at the discretion of the Board of Directors. | ||||||||||||
The following table sets forth certain information regarding the 1995 Plan: | ||||||||||||
December 31, | ||||||||||||
2013 | ||||||||||||
Shares available for grant | 1,998,881 | |||||||||||
Shares of common stock reserved for issuance | 3,487,290 | |||||||||||
The following table sets forth certain information regarding all options outstanding and exercisable: | ||||||||||||
December 31, 2013 | ||||||||||||
Options Outstanding | Options Exercisable | |||||||||||
Number | 751,853 | 232,828 | ||||||||||
Weighted average exercise price | $ | 50.18 | $ | 31.8 | ||||||||
Aggregate intrinsic value | $ 29.5 million | $ 13.4 million | ||||||||||
Weighted average remaining contractual term | 5.1 years | 3.8 years | ||||||||||
The following table sets forth certain information regarding all RSUs nonvested and expected to vest: | ||||||||||||
December 31, 2013 | ||||||||||||
RSUs Nonvested | RSUs Expected to Vest | |||||||||||
Number | 745,060 | 637,692 | ||||||||||
Weighted average grant date per share fair value | $ | 57.6 | $ | 56.75 | ||||||||
Aggregate intrinsic value | $ 65.8 million | $ 57.0 million | ||||||||||
Weighted average remaining term to vest | 1.7 years | 1.6 years | ||||||||||
As of December 31, 2013, unrecognized stock-based compensation related to outstanding, but unvested stock options and RSUs was $47.7 million, which will be recognized over the weighted average remaining vesting period of 2 years. | ||||||||||||
Activity under these plans was as follows (share amounts in thousands): | ||||||||||||
Year Ended December 31, 2013 | ||||||||||||
Shares Subject to Options | Weighted Average Exercise Price | |||||||||||
Balance, beginning of period | 870 | $ | 35.81 | |||||||||
Granted | 198 | 82.11 | ||||||||||
Forfeited | (47 | ) | 37.38 | |||||||||
Expired | (4 | ) | 15.56 | |||||||||
Exercised | (265 | ) | 29.69 | |||||||||
Balance, end of period | 752 | 50.18 | ||||||||||
Year Ended December 31, 2013 | ||||||||||||
Restricted Stock Units | Weighted Average Grant Date Per Share Fair Value | |||||||||||
Balance, beginning of period | 871 | $ | 41.69 | |||||||||
Granted | 244 | 83.58 | ||||||||||
Forfeited | (61 | ) | 41.14 | |||||||||
Vested | (309 | ) | 37 | |||||||||
Balance, end of period | 745 | 57.6 | ||||||||||
Stock-Based Compensation Expense | ||||||||||||
Certain information regarding our stock-based compensation was as follows (in thousands): | ||||||||||||
Year Ended | ||||||||||||
2013 | 2012 | 2011 | ||||||||||
Weighted average grant-date fair value of stock options granted | $ | 16,283 | $ | 12,279 | $ | 11,703 | ||||||
Weighted average grant-date fair value of restricted stock units | 20,415 | 20,461 | 15,499 | |||||||||
Total intrinsic value of stock options exercised | 13,169 | 6,293 | 10,550 | |||||||||
Fair value of restricted stock units vested | 11,452 | 9,113 | 8,120 | |||||||||
Cash received from stock options exercised and shares purchased under all stock-based arrangements | 16,545 | 13,131 | 24,382 | |||||||||
Tax benefit realized for stock options | 6,495 | 3,137 | 2,918 | |||||||||
Our stock-based compensation expense was included in our Consolidated Statements of Operations as follows (in thousands): | ||||||||||||
Year Ended | ||||||||||||
2013 | 2012 | 2011 | ||||||||||
Cost of sales | $ | 2,427 | $ | 1,858 | $ | 1,511 | ||||||
Research and development | 2,156 | 1,903 | 1,873 | |||||||||
Selling, general and administrative | 13,744 | 10,393 | 7,727 | |||||||||
Total stock-based compensation | $ | 18,327 | $ | 14,154 | $ | 11,111 | ||||||
Stock-based compensation costs related to inventory or fixed assets were not significant in the years ended December 31, 2013, 2012 and 2011. | ||||||||||||
Stock-Based Compensation Assumptions | ||||||||||||
The following weighted average assumptions were used in determining fair value pursuant to the Black-Scholes option pricing model: | ||||||||||||
Year Ended | ||||||||||||
2013 | 2012 | 2011 | ||||||||||
Risk-free interest rate | 0.07% - 1.72% | 0.13% - 0.81% | 0.06% - 2.02% | |||||||||
Dividend yield | 0.44% - 0.59% | 0% - 0.72% | — | % | ||||||||
Expected term: | ||||||||||||
Option plans | 3.1 - 5.1 years | 5.3 - 5.5 years | 5.5 - 5.7 years | |||||||||
Employee share purchase plan | 6 months | 6 months | 6 months | |||||||||
Volatility | 23% - 43% | 36% - 55% | 36% - 55% | |||||||||
Discount for post vesting restrictions | — | % | — | % | — | % | ||||||
The risk-free rate used is based on the U.S. Treasury yield over the expected term of the options granted. The expected term for options is estimated based on historical exercise data and for the ESPP, it is based on the life of the purchase period. The expected volatility is calculated based on the historical volatility of our common stock. |
Employee_Benefit_Plans
Employee Benefit Plans | 12 Months Ended |
Dec. 31, 2013 | |
Compensation and Retirement Disclosure [Abstract] | ' |
Employee benefit plans [Text Block] | ' |
EMPLOYEE BENEFIT PLANS | |
Pension Plans | |
Employee retirement plans have been established in some foreign countries in accordance with the legal requirements and customs in the countries involved. The majority of employees in Europe and Asia are covered by defined benefit, multi-employer or defined contribution pension plans. The benefits provided by these plans are based primarily on years of service and employees’ compensation near retirement. Employees in the U.S. are covered by a profit sharing 401(k) plan, which is a defined contribution plan. | |
Employees in The Netherlands participate with other companies in making collectively-bargained payments to the Metal-Electro Industry pension fund. We are responsible for the employer contributions to this fund, but are not obligated to make additional payments to cover any underfunded portions. Pension costs relating to this multi-employer plan were $6.5 million, $5.6 million and $4.7 million in 2013, 2012 and 2011, respectively. | |
Outside the U.S. and The Netherlands, employees are covered under various defined contribution and defined benefit plans as required by local law. | |
Plan costs for our defined contribution plans outside the U.S. and The Netherlands totaled $3.6 million in 2013, $3.6 million in 2012 and $2.2 million in 2011. | |
Profit Share and Variable Compensation Programs | |
We maintain an Employee Profit Share Plan and a Management Variable Compensation Plan for management-level employees to reward achievement of corporate and individual objectives. The Compensation Committee of the Board of Directors generally determines the structure of the overall incentive program at the beginning of each year. In setting the structure and the amount of the overall target incentive pool, the Compensation Committee considers potential size of the pool in relation to our earnings and other financial estimates, the achievability of the corporate targets under the plan, historical payouts under the plan and other factors. The total cost of these plans was $12.8 million in 2013, $13.2 million in 2012 and $24.7 million in 2011. | |
Profit Sharing 401(k) Plan | |
We maintain a profit sharing 401(k) plan that covers substantially all U.S. employees. Employees may elect to defer a portion of their compensation, and we may contribute an amount approved by the Board of Directors. We match 100% of employee contributions to the 401(k) plan up to 3% of each employee’s eligible compensation. Employees must meet certain requirements to be eligible for the matching contribution. We contributed $2.1 million in 2013, $1.8 million in 2012 and $1.5 million in 2011 to this plan. Our 401(k) plan does not allow for the investment in shares of our common stock. | |
Deferred Compensation Plan | |
We maintain a deferred compensation plan (the “Plan”), which permits certain employees to defer payment of a portion of their annual compensation. We do not match deferrals or make any additional contributions to the Plan. Distributions from the Plan are generally payable as a lump sum payment or in multi-year installments as directed by the participant according to the Plan provisions. Undistributed amounts under the Plan are subject to the claims of our creditors. As of December 31, 2013 and 2012, the invested amounts under the Plan totaled $5.3 million and $3.0 million, respectively, and were recorded on our balance sheets as non-current investments in marketable securities and as a long-term liability to recognize undistributed amounts due to employees. |
RelatedParty_Activity
Related-Party Activity | 12 Months Ended | |||||||||||
Dec. 31, 2013 | ||||||||||||
Related Party Transactions [Abstract] | ' | |||||||||||
Related-Party Activity | ' | |||||||||||
RELATED-PARTY ACTIVITY | ||||||||||||
Related parties with which we had transactions during 2013 were as follows: | ||||||||||||
• | one of the members of our Board of Directors serves on the Board of Directors of Applied Materials, Inc. and Lattice Semiconductor Corporation; | |||||||||||
• | our Chief Financial Officer is on the Board of Directors of Cascade Microtech, Inc.; | |||||||||||
• | one of the members of our Board of Directors serves on the Supervisory Board of TMC BV; and | |||||||||||
• | our Chief Executive Officer is on the Board of Trustees for the Oregon Health and Science University Foundation. | |||||||||||
Transactions with these related parties were as follows (in thousands): | ||||||||||||
Year Ended | ||||||||||||
Sales to Related Parties | 2013 | 2012 | 2011 | |||||||||
Product sales: | ||||||||||||
Applied Materials, Inc. | $ | 4,656 | $ | 981 | $ | 3,594 | ||||||
Lattice Semiconductor Corporation | 5 | — | 122 | |||||||||
Cascade Microtech, Inc. | — | 4 | — | |||||||||
Oregon Health and Science University | 555 | — | — | |||||||||
Total product sales to related parties | 5,216 | 985 | 3,716 | |||||||||
Service sales: | ||||||||||||
Applied Materials, Inc. | 719 | 554 | 459 | |||||||||
Lattice Semiconductor Corporation | 12 | — | — | |||||||||
Cascade Microtech, Inc. | 33 | 33 | 39 | |||||||||
Oregon Health and Science University | 85 | — | — | |||||||||
Total service sales to related parties | 849 | 587 | 498 | |||||||||
Total sales to related parties | $ | 6,065 | $ | 1,572 | $ | 4,214 | ||||||
Purchases from Related Parties | ||||||||||||
TMC BV | $ | 580 | $ | 127 | $ | 109 | ||||||
Cascade Microtech, Inc. | — | — | 1 | |||||||||
Oregon Health and Science University | 353 | — | — | |||||||||
Total purchases from related parties | $ | 933 | $ | 127 | $ | 110 | ||||||
Amounts due from (to) related parties were as follows (in thousands): | ||||||||||||
December 31, | ||||||||||||
2013 | ||||||||||||
Applied Materials, Inc. | $ | 46 | ||||||||||
Cascade Microtech, Inc. | 8 | |||||||||||
Oregon Health and Science University | 1 | |||||||||||
TMC BV | (403 | ) | ||||||||||
Due to related parties, net | $ | (348 | ) |
Segment_and_Geographic_Informa
Segment and Geographic Information | 12 Months Ended | |||||||||||||||||||||||||||||
Dec. 31, 2013 | ||||||||||||||||||||||||||||||
Segment Reporting [Abstract] | ' | |||||||||||||||||||||||||||||
Segment Information | ' | |||||||||||||||||||||||||||||
SEGMENT AND GEOGRAPHIC INFORMATION | ||||||||||||||||||||||||||||||
Segment Information | ||||||||||||||||||||||||||||||
Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker, or decision making group, in deciding how to allocate resources and in assessing performance. Our chief operating decision maker is our Chief Executive Officer. | ||||||||||||||||||||||||||||||
Beginning with the first quarter of 2013, we reorganized our corporate structure. We currently report our segments based on a group structure organization. Our segments are the Industry Group and the Science Group. | ||||||||||||||||||||||||||||||
The following tables summarize various financial amounts for each of our business segments (in thousands): | ||||||||||||||||||||||||||||||
Year Ended | ||||||||||||||||||||||||||||||
2013 | 2012 | 2011 | ||||||||||||||||||||||||||||
Sales to External Customers: | ||||||||||||||||||||||||||||||
Industry Group | $ | 427,731 | $ | 433,424 | $ | 376,533 | ||||||||||||||||||||||||
Science Group | 499,723 | 458,314 | 449,893 | |||||||||||||||||||||||||||
Total | $ | 927,454 | $ | 891,738 | $ | 826,426 | ||||||||||||||||||||||||
Gross Profit: | ||||||||||||||||||||||||||||||
Industry Group | $ | 222,675 | $ | 220,267 | $ | 185,156 | ||||||||||||||||||||||||
Science Group | 216,110 | 195,363 | 182,210 | |||||||||||||||||||||||||||
Total | $ | 438,785 | $ | 415,630 | $ | 367,366 | ||||||||||||||||||||||||
December 31, | December 31, | |||||||||||||||||||||||||||||
2013 | 2012 | |||||||||||||||||||||||||||||
Goodwill: | ||||||||||||||||||||||||||||||
Industry Group | $ | 51,532 | $ | 53,572 | ||||||||||||||||||||||||||
Science Group | 84,620 | 77,748 | ||||||||||||||||||||||||||||
Total | $ | 136,152 | $ | 131,320 | ||||||||||||||||||||||||||
Total Assets: | ||||||||||||||||||||||||||||||
Industry Group | $ | 297,987 | $ | 293,115 | ||||||||||||||||||||||||||
Science Group | 365,571 | 401,795 | ||||||||||||||||||||||||||||
Corporate and Eliminations | 762,526 | 539,313 | ||||||||||||||||||||||||||||
Total | $ | 1,426,084 | $ | 1,234,223 | ||||||||||||||||||||||||||
Market segment disclosures are presented to the gross profit level as this is the primary performance measure for which the segment general managers are responsible. Selling, general and administrative, research and development and other operating expenses are managed and reported at the corporate level and, given allocation to the market segments would be arbitrary, have not been allocated to the market segments. See our Consolidated Statements of Operations for reconciliations from gross profit to income before income taxes. These reconciling items are not included in the measure of profit and loss for each reportable segment. | ||||||||||||||||||||||||||||||
In 2013 one customer in our Industry segment represented approximately $96.0 million, or 10.4%, in total sales. None of our customers represented 10% or more of our total sales during 2012 or 2011. | ||||||||||||||||||||||||||||||
Geographical Information | ||||||||||||||||||||||||||||||
A significant portion of our net sales has been derived from customers outside of the U.S., which we expect to continue. We evaluate geographical performance for three regions: U.S. and Canada, Europe and the Asia-Pacific Region and Rest of World. Our European region also includes Central America, South America, Africa (excluding South Africa), the Middle East and Russia. | ||||||||||||||||||||||||||||||
The following table summarizes sales by geographic region (in thousands): | ||||||||||||||||||||||||||||||
Year Ended | ||||||||||||||||||||||||||||||
2013 | 2012 | 2011 | ||||||||||||||||||||||||||||
Product Sales | Service Sales | Total | Product Sales | Service Sales | Total | Product Sales | Service Sales | Total | ||||||||||||||||||||||
U.S. and Canada | $ | 167,876 | $ | 92,759 | $ | 260,635 | $ | 200,778 | $ | 90,942 | $ | 291,720 | $ | 179,126 | $ | 78,118 | $ | 257,244 | ||||||||||||
Europe | 205,857 | 64,803 | 270,660 | 185,598 | 59,124 | 244,722 | 206,994 | 54,319 | 261,313 | |||||||||||||||||||||
Asia-Pacific Region and Rest of World | 335,705 | 60,454 | 396,159 | 305,120 | 50,176 | 355,296 | 268,479 | 39,390 | 307,869 | |||||||||||||||||||||
Consolidated net sales | $ | 709,438 | $ | 218,016 | $ | 927,454 | $ | 691,496 | $ | 200,242 | $ | 891,738 | $ | 654,599 | $ | 171,827 | $ | 826,426 | ||||||||||||
Our long-lived assets were geographically located as follows (in thousands): | ||||||||||||||||||||||||||||||
December 31, | December 31, | |||||||||||||||||||||||||||||
2013 | 2012 | |||||||||||||||||||||||||||||
United States | $ | 77,639 | $ | 74,319 | ||||||||||||||||||||||||||
The Netherlands | 65,570 | 32,679 | ||||||||||||||||||||||||||||
The Czech Republic | 22,950 | 12,019 | ||||||||||||||||||||||||||||
Other | 42,272 | 46,258 | ||||||||||||||||||||||||||||
Total | $ | 208,431 | $ | 165,275 | ||||||||||||||||||||||||||
Fair_Value_Measurements_of_Ass
Fair Value Measurements of Assets and Liabilities | 12 Months Ended | ||||||||||||
Dec. 31, 2013 | |||||||||||||
Fair Value Disclosures [Abstract] | ' | ||||||||||||
Fair Value Measurements of Assets and Liabilities | ' | ||||||||||||
FAIR VALUE MEASUREMENTS OF ASSETS AND LIABILITIES | |||||||||||||
Factors used in determining the fair value of our financial assets and liabilities are summarized into three broad categories: | |||||||||||||
• | Level 1 – quoted prices in active markets for identical securities as of the reporting date; | ||||||||||||
• | Level 2 – other significant directly or indirectly observable inputs, including quoted prices for similar securities, interest rates, prepayment speeds and credit risk; and | ||||||||||||
• | Level 3 – significant inputs that are generally less observable than objective sources, including our own assumptions in determining fair value. | ||||||||||||
The factors or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities. | |||||||||||||
Following are the disclosures related to the fair value of our financial assets and (liabilities) (in thousands): | |||||||||||||
December 31, 2013 | Level 1 | Level 2 | Level 3 | Total | |||||||||
Available for sale marketable securities: | |||||||||||||
U.S. treasury notes | $ | 10,128 | $ | — | $ | — | $ | 10,128 | |||||
Agency bonds | — | 37,961 | — | 37,961 | |||||||||
Commercial paper | — | 39,987 | — | 39,987 | |||||||||
Certificates of deposit | — | 7,786 | — | 7,786 | |||||||||
Municipal bonds | — | 49,319 | — | 49,319 | |||||||||
Corporate bond | — | 5,001 | — | 5,001 | |||||||||
Trading securities: | |||||||||||||
Equity securities – mutual funds | 5,287 | — | — | 5,287 | |||||||||
Derivative contracts, net | — | (1,113 | ) | — | (1,113 | ) | |||||||
Total | $ | 15,415 | $ | 138,941 | $ | — | $ | 154,356 | |||||
December 31, 2012 | Level 1 | Level 2 | Level 3 | Total | |||||||||
Available for sale marketable securities: | |||||||||||||
U.S. treasury notes | $ | 60,786 | $ | — | $ | — | $ | 60,786 | |||||
Agency bonds | — | 31,157 | — | 31,157 | |||||||||
Commercial paper | — | 5,000 | — | 5,000 | |||||||||
Certificates of deposit | — | 5,494 | — | 5,494 | |||||||||
Municipal bonds | — | 3,228 | — | 3,228 | |||||||||
Trading securities: | |||||||||||||
Equity securities – mutual funds | 3,046 | — | — | 3,046 | |||||||||
Derivative contracts, net | — | 1,655 | — | 1,655 | |||||||||
Total | $ | 63,832 | $ | 46,534 | $ | — | $ | 110,366 | |||||
Agency bonds are securities backed by U.S. government-sponsored entities. | |||||||||||||
We use an income approach to value the assets and liabilities for outstanding derivative contracts using current market information as of the reporting date, such as spot rates, interest rate differentials and implied volatility. | |||||||||||||
There were no transfers between fair value categories or changes to our valuation techniques during the year ended December 31, 2013. | |||||||||||||
We believe the carrying amounts of cash and cash equivalents, accounts receivable, accounts payable and other current liabilities are a reasonable approximation of the fair value of those financial instruments because of the nature of the underlying transactions and the short-term maturities involved. |
Derivative_Instruments
Derivative Instruments | 12 Months Ended | |||||||||||||||||||
Dec. 31, 2013 | ||||||||||||||||||||
Derivative Instruments and Hedging Activities Disclosure [Abstract] | ' | |||||||||||||||||||
Derivative Instruments | ' | |||||||||||||||||||
DERIVATIVE INSTRUMENTS | ||||||||||||||||||||
In the normal course of business, we are exposed to foreign currency risk and we use derivatives to mitigate financial exposure from movements in foreign currency exchange rates. | ||||||||||||||||||||
The aggregate notional amount of outstanding derivative contracts were as follows (in thousands): | ||||||||||||||||||||
December 31, | December 31, | |||||||||||||||||||
2013 | 2012 | |||||||||||||||||||
Cash flow hedges | $ | 208,446 | $ | 165,000 | ||||||||||||||||
Balance sheet hedges | 172,947 | 225,924 | ||||||||||||||||||
Total outstanding derivative contracts | $ | 381,393 | $ | 390,924 | ||||||||||||||||
The outstanding contracts at December 31, 2013 have varying maturities through the second quarter of 2015. We do not enter into derivative financial instruments for speculative purposes. | ||||||||||||||||||||
We attempt to mitigate derivative credit risk by transacting with highly rated counterparties. We have evaluated the credit and nonperformance risks associated with our derivative counterparties and believe them to be insignificant and not warranting a credit adjustment at December 31, 2013. In addition, there are no credit contingent features in our derivative instruments. | ||||||||||||||||||||
Balance Sheet Related | ||||||||||||||||||||
In countries outside of the U.S., we transact business in U.S. dollars and in various other currencies. We attempt to mitigate our currency exposures for recorded transactions by using forward exchange contracts to reduce the risk that our future cash flows will be adversely affected by changes in exchange rates. We enter into forward sale or purchase contracts for foreign currencies to economically hedge specific cash, receivables or payables positions denominated in foreign currencies. | ||||||||||||||||||||
Changes in fair value of derivatives entered into to mitigate the foreign exchange risks related to these balance sheet items are recorded in other income (expense) together with the transaction gain or loss from the respective balance sheet position as follows (in thousands): | ||||||||||||||||||||
Year Ended | ||||||||||||||||||||
2013 | 2012 | 2011 | ||||||||||||||||||
Foreign currency loss, inclusive of the impact of derivatives | $ | (2,808 | ) | $ | (5,675 | ) | $ | (2,222 | ) | |||||||||||
Cash Flow Hedges | ||||||||||||||||||||
We use zero cost collar contracts and option contracts to hedge certain anticipated foreign currency exchange transactions. The foreign exchange hedging structure is set up, generally, on a twenty-four month time horizon. The hedging transactions we undertake primarily limit our exposure to changes in the U.S. dollar/euro and the U.S. dollar/Czech koruna exchange rate. The zero cost collar contract hedges are designed to protect us as the U.S. dollar weakens, but also provide us with some flexibility if the dollar strengthens. | ||||||||||||||||||||
These derivatives meet the criteria to be designated as hedges and, accordingly, we record the change in fair value of the effective portion of these hedge contracts relating to anticipated transactions in other comprehensive income rather than net income until the underlying hedged transaction affects net income. Gains and losses resulting from the ineffective portion of the hedge contracts, if any, are recognized as a component of net income. Gains and losses related to cash flow derivative contracts not designated as hedging instruments are recorded as a component of net income. | ||||||||||||||||||||
Summary | ||||||||||||||||||||
Our derivative instruments are subject to master netting arrangements and are presented net in our balance sheet. We do not have any financial collateral related to these netting arrangements. The effect of these netting arrangements on our balance sheet is as follows (in thousands): | ||||||||||||||||||||
Offsetting of Derivative Assets | Offsetting of Derivative Liabilities | |||||||||||||||||||
December 31, 2013 | Gross Amounts of Recognized Assets | Gross Amounts Offset in the Balance Sheet | Net Amounts Presented in Other Current Assets | Gross Amounts of Recognized Liabilities | Gross Amounts Offset in the Balance Sheet | Net Amounts Presented in Other Current Liabilities | ||||||||||||||
Foreign exchange contracts designated as hedging instruments | $ | — | $ | — | $ | — | $ | 4,362 | $ | (3,042 | ) | $ | 1,320 | |||||||
Foreign exchange contracts not designated as hedging instruments | 2,171 | (698 | ) | 1,473 | 2,916 | (1,650 | ) | 1,266 | ||||||||||||
Total | $ | 2,171 | $ | (698 | ) | $ | 1,473 | $ | 7,278 | $ | (4,692 | ) | $ | 2,586 | ||||||
Offsetting of Derivative Assets | Offsetting of Derivative Liabilities | |||||||||||||||||||
December 31, 2012 | Gross Amounts of Recognized Assets | Gross Amounts Offset in the Balance Sheet | Net Amounts Presented in Other Current Assets | Gross Amounts of Recognized Liabilities | Gross Amounts Offset in the Balance Sheet | Net Amounts Presented in Other Current Liabilities | ||||||||||||||
Foreign exchange contracts designated as hedging instruments | $ | 3,019 | $ | (1,492 | ) | $ | 1,527 | $ | — | $ | — | $ | — | |||||||
Foreign exchange contracts not designated as hedging instruments | 2,725 | (1,589 | ) | 1,136 | 4,289 | (3,281 | ) | 1,008 | ||||||||||||
Total | $ | 5,744 | $ | (3,081 | ) | $ | 2,663 | $ | 4,289 | $ | (3,281 | ) | $ | 1,008 | ||||||
The effect of derivative instruments was as follows (in thousands): | ||||||||||||||||||||
Year Ended | ||||||||||||||||||||
Foreign Exchange Contracts in Cash Flow Hedging Relationships | 2013 | 2012 | 2011 | |||||||||||||||||
Amount of gain/(loss): | ||||||||||||||||||||
Recognized in OCI (effective portion) | $ | (1,934 | ) | $ | 8,032 | $ | 108 | |||||||||||||
Reclassified from accumulated OCI into revenue (effective portion) | 33 | — | — | |||||||||||||||||
Reclassified from accumulated OCI into cost of sales (effective portion) | (790 | ) | (2,511 | ) | 3,558 | |||||||||||||||
Recognized in other, net (ineffective portion and amount excluded from effectiveness testing) | (80 | ) | 9 | 83 | ||||||||||||||||
Foreign Exchange Contracts Not in Cash Flow Hedging Relationships | ||||||||||||||||||||
Amount of gain/(loss): | ||||||||||||||||||||
Recognized in other, net | $ | (4,802 | ) | $ | (4,882 | ) | $ | (6,181 | ) | |||||||||||
The unrealized losses at December 31, 2013 are expected to be reclassified to net income during the next twenty-four months as a result of the underlying hedged transactions also being recorded in net income. |
Subsequent_Event
Subsequent Event | 12 Months Ended |
Dec. 31, 2013 | |
Subsequent Events [Abstract] | ' |
Subsequent Event | ' |
SUBSEQUENT EVENT | |
On February 5, 2014, we acquired 100% of the outstanding shares of Lithicon AS of Trondheim, Norway and Canberra, Australia. Lithicon provides digital rock technology services and pore-scale micro computed tomography (microCT) equipment to oil and gas companies. In conjunction with the acquisition we have obtained the helical scan microCT product and associated software from the Australian National University, through a licensing and development agreement. The total purchase price of the acquisition was $68.0 million. As of the date of this filing, the allocation of the purchase price is in process and, accordingly, the applicable disclosures cannot be made and the acquisition is not significant for the purposes of pro-forma disclosures. |
Summary_of_Significant_Account1
Summary of Significant Accounting Policies (Policies) | 12 Months Ended |
Dec. 31, 2013 | |
Accounting Policies [Abstract] | ' |
Basis of Presentation, Policy [Policy Text Block] | ' |
The consolidated financial statements include the accounts of FEI Company and our wholly-owned subsidiaries (collectively, “FEI”). All significant intercompany balances and transactions have been eliminated in consolidation. | |
Use of Estimates, Policy [Policy Text Block] | ' |
The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. | |
Cash and Cash Equivalents, Policy [Policy Text Block] | ' |
Cash and cash equivalents include cash deposits in banks, money market funds and other highly liquid marketable securities with maturities of three months or less at the date of acquisition. | |
Restricted Cash, Policy [Policy Text Block] | ' |
Our restricted cash balances are held in deposit accounts with banks that have issued guarantees and letters of credit to our customers for system sales transactions and customer advance deposits relating to prepayments for service contracts, mainly in Europe and Asia. This restricted cash can be drawn on by the bank if goods are not delivered or services are not properly performed. In addition, while the restricted cash is held in the bank it is earning interest. Given these deposit accounts require satisfaction of conditions other than a withdrawal demand for us to receive a return of principal, are interest bearing and are held for extended periods of time, we have concluded these balances are similar in nature to our other investments and that inclusion in investing activities on our statement of cash flows is appropriate and consistent with our treatment of other investments. Restricted cash balances securing bank guarantees that expire within 12 months of the balance sheet date are recorded as a current asset on our consolidated balance sheets. Restricted cash balances securing bank guarantees that expire beyond 12 months from the balance sheet date are recorded as long-term restricted cash on our consolidated balance sheets. | |
Allowance for Doubtful Accounts, Policy [Policy Text Block] | ' |
The allowance for doubtful accounts is estimated based on collection experience and known trends with current customers. The large number of entities comprising our customer base and their dispersion across many different industries and geographies somewhat mitigates our credit risk exposure and the magnitude of our allowance for doubtful accounts. Our estimates of the allowance for doubtful accounts are reviewed and updated on a quarterly basis. Changes to the reserve may occur based upon changes in revenue levels and associated balances in accounts receivable and estimated changes in individual customers’ credit quality. Write-offs include amounts written off for specifically identified bad debts. Historically, we have not incurred significant write-offs of accounts receivable, however, an individual loss could be significant due to the relative size of our sales transactions. | |
Investments, Policy [Policy Text Block] | ' |
Our investments include marketable debt securities, certificates of deposit, commercial paper and government-backed securities with maturities greater than 90 days at the time of purchase. These investments are recorded on our balance sheet as available-for-sale securities at fair value based on quoted market prices. Unrealized gains/losses resulting from changes in the fair value are recorded, net of tax, in shareholders’ equity as a component of accumulated other comprehensive income (loss). | |
Certain long-term investments included in non-current investments in marketable securities consisted of mutual fund shares held to offset liabilities to participants in the Company's deferred compensation plan. The investments are classified as long-term because the related deferred compensation liabilities are not expected to be paid within the next year. These investments are classified as trading securities and are recorded at fair value with unrealized gains and losses reported in operating expenses, which are offset against gains and losses resulting from changes in corresponding deferred compensation liabilities to participants (see Note 7 the Notes to the Consolidated Financial Statements). Investments for which it is not practical to estimate fair value are included at cost and primarily consist of investments in privately-held companies. | |
Realized gains and losses on all investments are recorded on the specific identification method and are included in interest income (expense) or other income (expense) in the period incurred. Investments with maturities greater than 12 months from the balance sheet date are classified as non-current investments, unless they are expected to be liquidated within the next 12 months; in which case, the investment is classified as current. | |
Inventories, Policy [Policy Text Block] | ' |
Inventories are stated at the lower of cost or market, with cost determined by standard cost methods, which approximate the first-in, first-out method. Inventory costs include material, labor and manufacturing overhead. Service inventories that exceed the estimated requirements for the next 12 months based on recent usage levels are reported as a long-term asset. Management has established inventory reserves based on estimates of excess and/or obsolete current and non-current inventory. | |
Manufacturing inventory is reviewed for obsolescence and excess quantities on a quarterly basis, based on estimated future use of quantities on hand, which is determined based on past usage, planned changes to products and known trends in markets and technology. Changes in support plans or technology could have a significant impact on obsolescence. | |
To support our world-wide service operations, we maintain service spare parts inventory, which consists of both consumable and repairable spare parts. Consumable service spare parts are used within our service business to replace worn or damaged parts in a system during a service call and are generally classified in current inventory as our stock of this inventory turns relatively quickly. However, if there has been no recent usage for a consumable service spare part, but the part is still necessary to support systems under service contracts, the part is considered to be non-current and included within non-current inventories within our consolidated balance sheet. Consumables are charged to cost of goods sold when issued during the service call. | |
We also maintain a substantial supply of repairable and reusable spare parts for possible use in future repairs and customer field service of our install base. We have classified this inventory as a long-term asset given these parts can be repaired and reused in the service business over many years. | |
As these service parts age over the related product group’s post-production service life, we reduce the net carrying value of our repairable and consumable spare part inventory to account for the excess that builds over the service life. The post-production service life of our systems is generally eight years and, at the end of the service life, the carrying value for these parts is reduced to zero. We also perform periodic monitoring of our installed base for premature or increased end of service life events. If required, we expense, through cost of goods sold, the remaining net carrying value of any related spare parts inventory in the period incurred. | |
Income Taxes, Policy [Policy Text Block] | ' |
We account for income taxes using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and tax bases of the assets and liabilities. We record a valuation allowance to reduce deferred tax assets to the amount expected to “more likely than not” be realized in our future tax returns. Should we determine that we would not be able to realize all or part of our remaining net deferred tax assets in the future, increases to the valuation allowance for deferred tax assets may be required. Conversely, if we determine that certain tax assets that have been reserved for may be realized in the future, we may reduce our valuation allowance in future periods. | |
Income Tax Uncertainties, Policy [Policy Text Block] | ' |
In the ordinary course of business, there is inherent uncertainty in quantifying our income tax positions. We assess our income tax positions and record tax benefits for all years subject to examination based upon management’s evaluation of the facts, circumstances and information available at the reporting date. For those tax positions where it is more likely than not that a tax benefit will be sustained, we have recorded the largest amount of tax benefit with a greater than 50% likelihood of being realized upon ultimate or effective settlement with a taxing authority that has full knowledge of all relevant information. For those income tax positions where it is not more likely than not that a tax benefit will be sustained, no tax benefit has been recognized in the financial statements. When applicable, associated interest and penalties have been recognized as a component of income tax expense. | |
Property, Plant and Equipment, Policy [Policy Text Block] | ' |
Land is stated at cost. Buildings and improvements are stated at cost and depreciated over estimated useful lives of approximately 40 years using the straight-line method. Leasehold improvements are amortized over the shorter of their economic lives or the lease term. Machinery and equipment, including systems used in production and research and development activities, are stated at cost and depreciated over estimated useful lives of approximately three to seven years using the straight-line method. | |
Demonstration systems consist primarily of internally manufactured products and related accessories that we use for marketing purposes in our demonstration laboratories (“NanoPorts”) or for trade shows. These systems are long lived in nature and are recorded as a component of property, plant and equipment. The proceeds expected to be realized when the systems are sold is estimated and the net cost is depreciated using the straight-line method over their expected useful lives of approximately three to seven years with the expense being reflected as a component of selling, general and administrative. If sold, the net book value of the system is recorded as a component of cost of good sold. | |
Other fixed assets include computer software and hardware, automobiles and furnitures and fixtures. These assets are stated at cost and are depreciated over estimated useful lives of approximately three to seven years. Maintenance and repairs are expensed as incurred. | |
On occasion, we loan systems to customers on a temporary basis while they wait for their tool to be manufactured or for evaluation. These systems are included in our finished goods inventories and the lending/evaluation periods are typically for a time period of less than one year. The sale of disposable products or services is not typically included in these arrangements. Any expense associated with these systems is recorded as a component of cost of sales. | |
Additionally, we lease systems to customers as operating or sales-type leases where we are the lessor. Under the operating method, rental revenue is recognized over the lease period. The leased asset is depreciated over the life of the lease. In addition to the depreciation charge, maintenance costs and the cost of any other services rendered under the provision of the lease that pertain to the current accounting period are charged to expense. Under the sales-type method, revenue is recorded upfront with interest income recorded over the life of the lease. The related costs are recorded upfront to match the sales revenue. | |
Lives and Recoverability of Equipment and Other Long-Lived Assets, Policy [Policy Text Block] | ' |
We evaluate the remaining life and recoverability of equipment and other assets that are to be held and used, including purchased technology and other intangible assets with finite useful lives, at least annually and whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. If there is an indication of impairment, we prepare an estimate of future, undiscounted cash flows expected to result from the use of the asset and its eventual disposition. If these cash flows are less than the carrying value of the asset, we adjust the carrying amount of the asset to its estimated fair value. Long lived assets to be disposed of by sale are valued at the lower of book value or fair value less cost to sell. | |
Intangible Assets, Policy [Policy Text Block] | ' |
We estimate the fair value of an intangible asset or asset group using the income approach and internally developed discounted cash flow models. These models include, among others, the following assumptions: projections of revenue and expenses and related cash flows based on assumed long-term growth rates and demand trends; estimated royalty, income tax, and attrition rates; and estimated discount rates. We base these assumptions on our historical data and experience, third-party appraisals, industry projections, micro and macro general economic condition projections, and our expectations. | |
Goodwill, Policy [Policy Text Block] | ' |
Goodwill represents the excess purchase price over fair value of net assets acquired. Goodwill and other identifiable intangible assets with indefinite useful lives are not amortized, but instead, are tested for impairment at least annually during the fourth quarter. In 2011, we adopted ASU 2011-08, "Intangibles - Goodwill and Other (Topic 350), Testing Goodwill for Impairment", which allows an entity to perform a qualitative assessment of the fair value of its reporting units before calculating the fair value of the reporting unit in step one of the two-step goodwill impairment model. We perform our goodwill impairment analysis at the component level, which is defined as one level below our operating segments. If, through the qualitative assessment, the entity determines that it is more likely than not that a reporting unit's fair value is greater than its carrying value, the remaining impairment steps would be unnecessary. | |
If there are indicators that goodwill has been impaired and thus the two-step goodwill impairment model is necessary, step 1 is to determine the fair value of each reporting unit and compare it to the reporting unit's carrying value. Fair value is determined based on the present value of estimated cash flows using available information regarding expected cash flows of each reporting unit, discount rates and the expected long-term cash flow growth rates. Discount rates are determined based on the cost of capital for the reporting unit. If the fair value of the reporting unit exceeds the carrying value, goodwill is not impaired and no further testing is performed. The second step is performed if the carrying value exceeds the fair value. The implied fair value of the reporting unit’s goodwill must be determined and compared to the carrying value of the goodwill. If the carrying value of a reporting unit’s goodwill exceeds its implied fair value, an impairment loss equal to the difference will be recorded. | |
Derivatives, Policy [Policy Text Block] | ' |
We use a combination of forward contracts, zero cost collar contracts, option contracts and other instruments to hedge certain anticipated foreign currency exchange transactions. When specific hedge criteria have been met, changes in fair values of hedge contracts relating to anticipated transactions are recorded in other comprehensive income rather than net income until the underlying hedged transaction affects net income. One of the criteria for this accounting treatment is that the hedge contract amounts should not be in excess of specifically identified anticipated transactions. By their nature, our estimates of anticipated transactions may fluctuate over time and may ultimately vary from actual transactions. When anticipated transaction estimates or actual transaction amounts decrease below hedged levels, or when the timing of transactions changes significantly, we reclassify a portion of the cumulative changes in fair values of the related hedge contracts from other comprehensive income to other income (expense) during the quarter in which such changes occur. | |
We also use foreign forward exchange contracts to mitigate the foreign currency exchange impact of our cash, receivables and payables denominated in foreign currencies. These derivatives do not meet the criteria for hedge accounting and, accordingly, changes in the fair value are recognized in net income in the current period. | |
Segment Reporting, Policy [Policy Text Block] | ' |
We have determined that we operate in two reportable operating segments: Industry Group and Science Group. There are no differences between the accounting policies used for our business segments compared to those used on a consolidated basis. | |
Revenue Recognition, Policy [Policy Text Block] | ' |
We recognize revenue when persuasive evidence of a contractual agreement exists, delivery has occurred or services have been rendered, the seller’s price to the buyer is fixed and determinable, and collectability is reasonably assured. | |
For products demonstrated to meet our published specifications, revenue is recognized when the title to the product and the risks and rewards of ownership pass to the customer. For products produced according to a particular customer’s specifications, revenue is recognized when the product meets the customer’s specifications and when the title and the risks and rewards of ownership have passed to the customer. In each case, the portion of revenue related to installation, of which the estimated fair value is generally 4% of the net revenue of the transaction, is deferred until such installation at the customer site and final customer acceptance are completed. For new applications of our products where performance cannot be assured prior to meeting specifications at the customer's installation site, no revenue is recognized until such specifications are met. | |
We enter into arrangements with customers whereby they purchase products, accessories and service contracts from us at the same time. For sales arrangements containing multiple elements (products or services), revenue relating to the undelivered elements is deferred at the estimated selling price of the element as determined using the sales price hierarchy established in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification ("ASC") 605-25. To be considered a separate element, the deliverable in question must represent a separate element under the accounting guidance and fulfill the following criteria: the delivered item or items must have value to the customer on a standalone basis; and, if the arrangement includes a general right of return relative to the delivered item(s), delivery or performance of the undelivered item(s) is considered probable and substantially in our control. If the arrangement does not meet all criteria above, the entire amount of the transactions is deferred until all elements are delivered. | |
For sales arrangements that contain multiple deliverables (products or services), to the extent that the deliverables within a multiple-element arrangement are not accounted for pursuant to other accounting standards, revenue is allocated among the deliverables using the selling price hierarchy established in ASC 605-25 to determine the selling price of each deliverable. The selling price hierarchy allows for the use of an estimated selling price (“ESP”) to determine the allocation of arrangement consideration to a deliverable in a multiple-element arrangement in the absence of vendor specific objective evidence (“VSOE”) or third-party evidence (“TPE”). We determine the selling price in multiple-element arrangements using VSOE or TPE if available. VSOE is determined based on the price charged for the same deliverable when sold separately and TPE is established based on the price charged by our competitors or third parties for the same deliverable. If we are unable to determine the selling price because VSOE or TPE does not exist, we determine ESP for the purposes of allocating total arrangement consideration among the elements by considering several internal and external factors such as, but not limited to, historical sales of similar products, costs incurred to manufacture the product and normal profit margins from the sale of similar products, geographical considerations and overall pricing practices. | |
These factors are subject to change as we modify our pricing practices and such changes could result in changes to determination of VSOE, TPE and ESP, which could result in our future revenue recognition from multiple-element arrangements being materially different than our results in the current period. | |
Generally, revenue from all elements in a multiple-element arrangement is recognized within 18 months of the shipment of the first item in the arrangement. | |
We provide maintenance and support services under renewable, term maintenance agreements. Maintenance and support fee revenue is recognized ratably over the contractual term, which is generally 12 months, and commences from the start date. | |
Revenue from time and materials-based service arrangements is recognized as the service is performed. Spare parts revenue is generally recognized upon shipment. | |
Deferred Revenue, Policy [Policy Text Block] | ' |
Deferred revenue represents customer deposits on equipment orders, orders awaiting customer acceptance and prepaid service contract revenue. Deferred revenue is recognized in accordance with our revenue recognition policies described above. | |
Warranty Liabilities, Policy [Policy Text Block] | ' |
Our products generally carry a one-year warranty. A reserve is established at the time of sale to cover estimated warranty costs and certain commitments for product upgrades as a component of cost of sales on our consolidated statements of operations. Our estimate of warranty cost is primarily based on our history of warranty repairs and maintenance, as applied to systems currently under warranty. For our new products without a history of known warranty costs, we estimate the expected costs based on our experience with similar product lines and technology. While most new products are extensions of existing technology, the estimate could change if new products require a significantly different level of repair and maintenance than similar products have required in the past. Our estimated warranty costs are reviewed and updated on a quarterly basis. Changes to the reserve occur as volume, product mix and warranty costs fluctuate. | |
Research and Development Costs, Policy [Policy Text Block] | ' |
Research and Development (“R&D”) costs include labor, materials, overhead and payments to third parties for research and development of new products and new software or enhancements to existing products and software and are expensed as incurred. We periodically receive funds from various organizations to subsidize our research and development. These funds are reported as an offset to research and development expense. | |
Advertising Costs, Policy [Policy Text Block] | ' |
Advertising costs are expensed as incurred and are included as a component of selling, general and administrative costs on our consolidated statements of operations. | |
Restructuring, Reorganization, Relocation and Severance Costs, Policy [Policy Text Block] | ' |
Restructuring, reorganization, relocation and severance costs are recognized and recorded at fair value as incurred. Such costs include severance and other costs related to employee terminations as well as facility costs related to future abandonment of various leased office and manufacturing sites. Also included are certain period costs to move our existing supply chain, as well as migration of certain IT systems to new platforms. Changes in our estimates could occur, and have occurred, due to fluctuations in exchange rates, the sublease of unused space, unanticipated voluntary departures before severance was required and unanticipated redeployment of employees to vacant positions. | |
Stock-based Compensation, Policy [Policy Text Block] | ' |
We measure and recognize compensation expense for all stock-based payment awards granted to our employees and directors, including employee stock options, non-vested stock and stock purchases related to our employee share purchase plan based on the estimated fair value of the award on the grant date. We utilize the Black-Scholes valuation model for valuing our stock option awards. | |
The use of the Black-Scholes valuation model to estimate the fair value of stock option awards requires us to make judgments on assumptions regarding the risk-free interest rate, expected dividend yield, expected term and expected volatility over the expected term of the award. The assumptions used in calculating the fair value of stock-based payment awards represent management’s best estimates at the time they are made, but these estimates involve inherent uncertainties and the determination of expense could be materially different in the future. | |
We amortize stock-based compensation expense on a straight-line basis over the vesting period of the individual award with estimated forfeitures considered. Vesting periods are generally four years. The exercise price of issued options equals the grant date fair value of the underlying shares and the options generally have a legal life of seven years. | |
Compensation expense is only recognized on awards that ultimately vest. Therefore, we have reduced the compensation expense to be recognized over the vesting period for anticipated future forfeitures. Forfeiture estimates are based on historical forfeiture patterns. We update our forfeiture estimates quarterly and recognize any changes to accumulated compensation expense in the period of change. If actual forfeitures differ significantly from our estimates, our results of operations could be materially impacted. | |
Foreign Currency Translation, Policy [Policy Text Block] | ' |
A large portion of our business is conducted outside of the U.S. through a number of foreign subsidiaries. Each of the foreign subsidiaries keeps its accounting records in its respective local currency. These local-currency-denominated accounting records are translated at exchange rates that fluctuate up or down from period to period and consequently affect our consolidated results of operations and financial position. | |
Assets and liabilities of foreign subsidiaries denominated in a foreign currency, where the local currency is the functional currency, are translated to U.S. dollars at the exchange rate in effect on the respective balance sheet date. Gains and losses resulting from the translation of assets, liabilities and equity are included in accumulated other comprehensive income on the consolidated balance sheet. Transactions representing revenues, costs and expenses are translated using an average rate of exchange for the period, and the related gains and losses are reported as other income (expense) on our consolidated statement of operations. | |
Marketable Securities, Policy [Policy Text Block] | ' |
We review available for sale investments in debt and equity securities for other than temporary impairment whenever the fair value of an investment is less than amortized cost and evidence indicates that an investment’s carrying amount is not recoverable within a reasonable period of time. In the evaluation of whether an impairment is “other-than-temporary,” we consider our ability and intent to hold the investment until the market price recovers, the reasons for the impairment, compliance with our investment policy, the severity and duration of the impairment and expected future performance. Unrealized losses on our corporate notes and bonds and government-backed securities are mainly due to interest rate movements, and no unrealized losses of any significance existed for a period in excess of 12 months. Our investments classified as trading securities, such as assets related to our deferred compensation plan, are carried on the balance sheet at fair value. | |
Cost Method Investments, Policy [Policy Text Block] | ' |
For investments in small privately-held companies, which are recorded at cost, it is often not practical to estimate fair value. In order to assess whether impairments exist that are “other-than-temporary,” we reviewed recent interim financial statements and held discussions with these entities’ management about their current financial conditions and future economic outlooks. We also considered our willingness to support future funding requirements as well as our intention and/or ability to hold these investments long-term. | |
Intangible Assets, Policy [Policy Text Block] | ' |
Patents, trademarks and other are amortized under the straight-line method over their estimated useful lives of 2 to 15 years. Customer relationships are amortized under the straight-line method over their estimated useful lives of 5 to 10 years. Developed technology is amortized under the straight-line method over the estimated useful life of the related technology, which ranges from 5.5 to 10 years. Note issuance costs were amortized over the life of the related debt, which was 7 years. |
Summary_of_Significant_Account2
Summary of Significant Accounting Policies (Tables) | 12 Months Ended | |||||||||||
Dec. 31, 2013 | ||||||||||||
Accounting Policies [Abstract] | ' | |||||||||||
Schedule of Allowance for Doubtful Accounts Activity [Table Text Block] | ' | |||||||||||
Activity within our accounts receivable allowance was as follows (in thousands): | ||||||||||||
Year Ended | ||||||||||||
2013 | 2012 | 2011 | ||||||||||
Balance, beginning of period | $ | 2,718 | $ | 5,553 | $ | 5,685 | ||||||
Expense (reversal) | 473 | (154 | ) | (18 | ) | |||||||
Write-offs | (263 | ) | (2,732 | ) | (25 | ) | ||||||
Translation adjustments | 41 | 51 | (89 | ) | ||||||||
Balance, end of period | $ | 2,969 | $ | 2,718 | $ | 5,553 | ||||||
Earnings_Per_Share_Tables
Earnings Per Share (Tables) | 12 Months Ended | ||||||||||||||||||||||||||||||||
Dec. 31, 2013 | |||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | ' | ||||||||||||||||||||||||||||||||
Earnings Per Share Reconciliation | ' | ||||||||||||||||||||||||||||||||
Following is a reconciliation of basic earnings per share (“EPS”) and diluted EPS (in thousands, except per share amounts): | |||||||||||||||||||||||||||||||||
Year Ended | |||||||||||||||||||||||||||||||||
2013 | 2012 | 2011 | |||||||||||||||||||||||||||||||
Net | Shares | Per Share | Net | Shares | Per Share | Net | Shares | Per Share | |||||||||||||||||||||||||
Income | Amount | Income | Amount | Income | Amount | ||||||||||||||||||||||||||||
Basic EPS | $ | 126,673 | 40,446 | $ | 3.13 | $ | 114,920 | 38,065 | $ | 3.02 | $ | 103,637 | 38,384 | $ | 2.7 | ||||||||||||||||||
Dilutive effect of 2.875% convertible debt | 780 | 1,287 | (0.08 | ) | 1,819 | 3,033 | (0.18 | ) | 1,808 | 3,033 | (0.15 | ) | |||||||||||||||||||||
Dilutive effect of stock options, restricted stock units, and shares issuable to Philips | — | 662 | (0.04 | ) | — | 630 | (0.04 | ) | — | 630 | (0.04 | ) | |||||||||||||||||||||
Diluted EPS | $ | 127,453 | 42,395 | $ | 3.01 | $ | 116,739 | 41,728 | $ | 2.8 | $ | 105,445 | 42,047 | $ | 2.51 | ||||||||||||||||||
Schedule of Antidilutive Securities Excluded from Computation of Diluted Earnings Per Share | ' | ||||||||||||||||||||||||||||||||
The following table sets forth the schedule of anti-dilutive securities excluded from the computation of diluted EPS (number of shares, in thousands): | |||||||||||||||||||||||||||||||||
Year Ended | |||||||||||||||||||||||||||||||||
2013 | 2012 | 2011 | |||||||||||||||||||||||||||||||
Stock options | 142 | 279 | 358 | ||||||||||||||||||||||||||||||
Restricted stock units | 33 | 59 | 322 | ||||||||||||||||||||||||||||||
Changes_in_Accumulated_Other_C1
Changes in Accumulated Other Comprehensive Income by Component (Tables) | 12 Months Ended | |||||||||||||||||||
Dec. 31, 2013 | ||||||||||||||||||||
Changes in Accumulated Other Comprehensive Income [Abstract] | ' | |||||||||||||||||||
Schedule of Accumulated Other Comprehensive Income | ' | |||||||||||||||||||
The following table illustrates the disclosure of changes in the balances of each component of accumulated other comprehensive income ("AOCI"), as well as details the effect of reclassifications out of AOCI on the line items in the Consolidated Statements of Operations by component (net of tax, in thousands): | ||||||||||||||||||||
Year Ended December 31, 2013 | ||||||||||||||||||||
Foreign Currency Items | Unrealized Gains and Losses on Available-for-Sale Securities | Defined Benefit Pension Items | Gains and Losses on Cash Flow Hedges | Total | ||||||||||||||||
Beginning Balance | $ | 38,890 | $ | 4 | $ | (819 | ) | $ | 481 | $ | 38,556 | |||||||||
Other comprehensive income before reclassifications | 9,975 | (15 | ) | 267 | (2,492 | ) | 7,735 | |||||||||||||
Amounts reclassified from AOCI to: | ||||||||||||||||||||
Revenue | — | — | — | (33 | ) | (33 | ) | |||||||||||||
Cost of goods sold | — | — | — | 790 | 790 | |||||||||||||||
Other income (expense) | — | — | — | 80 | 80 | |||||||||||||||
Total reclassifications out of AOCI | — | — | — | 837 | 837 | |||||||||||||||
Net current period other comprehensive income | 9,975 | (15 | ) | 267 | (1,655 | ) | 8,572 | |||||||||||||
Ending balance | $ | 48,865 | $ | (11 | ) | $ | (552 | ) | $ | (1,174 | ) | $ | 47,128 | |||||||
Inventories_Tables
Inventories (Tables) | 12 Months Ended | |||||||
Dec. 31, 2013 | ||||||||
Inventory Disclosure [Abstract] | ' | |||||||
Schedule of Inventories | ' | |||||||
Inventories consisted of the following (in thousands): | ||||||||
December 31, | ||||||||
2013 | 2012 | |||||||
Raw materials and assembled parts | $ | 61,235 | $ | 67,985 | ||||
Service inventories, estimated current requirements | 15,197 | 15,898 | ||||||
Work-in-process | 75,883 | 81,104 | ||||||
Finished goods | 29,410 | 27,553 | ||||||
Total current inventories | $ | 181,725 | $ | 192,540 | ||||
Non-current inventories | $ | 62,104 | $ | 65,116 | ||||
Investments_Tables
Investments (Tables) | 12 Months Ended | |||||||||||||||||||||||||||||||
Dec. 31, 2013 | ||||||||||||||||||||||||||||||||
Investments [Abstract] | ' | |||||||||||||||||||||||||||||||
Schedule of Available-for-sale Securities Reconciliation [Table Text Block] | ' | |||||||||||||||||||||||||||||||
Investments held consisted of the following (in thousands): | ||||||||||||||||||||||||||||||||
December 31, 2013 | ||||||||||||||||||||||||||||||||
Amortized | Unrealized | Unrealized | Estimated | |||||||||||||||||||||||||||||
cost | gains | losses | fair value | |||||||||||||||||||||||||||||
Available for sale marketable securities: | ||||||||||||||||||||||||||||||||
U.S. treasury notes | $ | 10,130 | $ | — | $ | (2 | ) | $ | 10,128 | |||||||||||||||||||||||
Agency bonds(1) | 37,996 | — | (35 | ) | 37,961 | |||||||||||||||||||||||||||
Commercial paper | 39,987 | — | — | 39,987 | ||||||||||||||||||||||||||||
Certificates of deposit | 7,786 | — | — | 7,786 | ||||||||||||||||||||||||||||
Municipal bonds | 49,296 | 24 | (1 | ) | 49,319 | |||||||||||||||||||||||||||
Corporate bond | 5,002 | — | (1 | ) | 5,001 | |||||||||||||||||||||||||||
Total available for sale marketable securities | 150,197 | 24 | (39 | ) | 150,182 | |||||||||||||||||||||||||||
Trading Securities: | ||||||||||||||||||||||||||||||||
Equity securities - mutual funds | 5,287 | — | — | 5,287 | ||||||||||||||||||||||||||||
Cost Method Investments(2) | 608 | — | — | 608 | ||||||||||||||||||||||||||||
Total Investments | $ | 156,092 | $ | 24 | $ | (39 | ) | $ | 156,077 | |||||||||||||||||||||||
December 31, 2012 | ||||||||||||||||||||||||||||||||
Amortized | Unrealized | Unrealized | Estimated | |||||||||||||||||||||||||||||
cost | gains | losses | fair value | |||||||||||||||||||||||||||||
Available for sale marketable securities: | ||||||||||||||||||||||||||||||||
U.S. treasury notes | $ | 60,785 | $ | 4 | $ | (3 | ) | $ | 60,786 | |||||||||||||||||||||||
Agency bonds(1) | 31,153 | 4 | — | 31,157 | ||||||||||||||||||||||||||||
Commercial paper | 5,000 | — | — | 5,000 | ||||||||||||||||||||||||||||
Certificates of deposit | 5,494 | — | — | 5,494 | ||||||||||||||||||||||||||||
Municipal bonds | 3,227 | 1 | — | 3,228 | ||||||||||||||||||||||||||||
Total available for sale marketable securities | 105,659 | 9 | (3 | ) | 105,665 | |||||||||||||||||||||||||||
Trading Securities: | ||||||||||||||||||||||||||||||||
Equity securities - mutual funds | 3,046 | — | — | 3,046 | ||||||||||||||||||||||||||||
Cost Method Investments(2) | 608 | — | — | 608 | ||||||||||||||||||||||||||||
Total Investments | $ | 109,313 | $ | 9 | $ | (3 | ) | $ | 109,319 | |||||||||||||||||||||||
(1) | Agency bonds are securities backed by U.S. government-sponsored entities. | |||||||||||||||||||||||||||||||
(2) | Investments for which it is not practical to estimate fair value are included at cost and primarily consist of investments in privately-held companies. | |||||||||||||||||||||||||||||||
Investments by Balance Sheet Grouping [Table Text Block] | ' | |||||||||||||||||||||||||||||||
Investments were included in the following captions on the balance sheet as follows (in thousands): | ||||||||||||||||||||||||||||||||
December 31, 2013 | December 31, 2012 | |||||||||||||||||||||||||||||||
Short-term | Long-term | Other | Total | Short-term | Long-term | Other | Total | |||||||||||||||||||||||||
investments | investments | assets | investments | investments | assets | |||||||||||||||||||||||||||
Available for sale marketable securities: | ||||||||||||||||||||||||||||||||
U.S. treasury notes | $ | 10,128 | $ | — | $ | — | $ | 10,128 | $ | 60,786 | $ | — | $ | — | $ | 60,786 | ||||||||||||||||
Agency bonds | 10,995 | 26,966 | — | 37,961 | 10,148 | 21,009 | — | 31,157 | ||||||||||||||||||||||||
Commercial paper | 39,987 | — | — | 39,987 | 5,000 | — | — | 5,000 | ||||||||||||||||||||||||
Certificates of deposit | 5,802 | 1,984 | — | 7,786 | 3,598 | 1,896 | — | 5,494 | ||||||||||||||||||||||||
Municipal bonds | 41,279 | 8,040 | — | 49,319 | — | 3,228 | — | 3,228 | ||||||||||||||||||||||||
Corporate bond | — | 5,001 | — | 5,001 | — | — | — | — | ||||||||||||||||||||||||
Total fixed maturity securities | 108,191 | 41,991 | — | 150,182 | 79,532 | 26,133 | — | 105,665 | ||||||||||||||||||||||||
Trading Securities: | ||||||||||||||||||||||||||||||||
Equity securities - mutual funds | — | 5,287 | — | 5,287 | — | 3,046 | — | 3,046 | ||||||||||||||||||||||||
Cost Method Investments | — | — | 608 | 608 | — | — | 608 | 608 | ||||||||||||||||||||||||
Total Investments | $ | 108,191 | $ | 47,278 | $ | 608 | $ | 156,077 | $ | 79,532 | $ | 29,179 | $ | 608 | $ | 109,319 | ||||||||||||||||
Investments Classified by Contractual Maturity Date [Table Text Block] | ' | |||||||||||||||||||||||||||||||
Contractual maturities or expected liquidation dates of available-for-sale fixed maturity securities at December 31, 2013 were as follows (in thousands): | ||||||||||||||||||||||||||||||||
Amortized Cost | Fair Value | |||||||||||||||||||||||||||||||
Due in 1 year or less | $ | 108,183 | $ | 108,191 | ||||||||||||||||||||||||||||
Due in 1-5 years | 42,014 | 41,991 | ||||||||||||||||||||||||||||||
Total | $ | 150,197 | $ | 150,182 | ||||||||||||||||||||||||||||
Property_Plant_and_Equipment_T
Property, Plant and Equipment (Tables) | 12 Months Ended | |||||||
Dec. 31, 2013 | ||||||||
Property, Plant and Equipment [Abstract] | ' | |||||||
Schedule of Property, Plant and Equipment [Table Text Block] | ' | |||||||
Property, plant and equipment consisted of the following (in thousands): | ||||||||
December 31, | ||||||||
2013 | 2012 | |||||||
Land | $ | 25,535 | $ | 7,806 | ||||
Buildings and improvements | 36,778 | 21,645 | ||||||
Leasehold improvements | 23,948 | 16,503 | ||||||
Machinery and equipment | 103,180 | 108,982 | ||||||
Demonstration systems | 44,700 | 29,986 | ||||||
Other fixed assets | 49,093 | 46,510 | ||||||
Gross property, plant and equipment | 283,234 | 231,432 | ||||||
Accumulated depreciation | (125,405 | ) | (121,560 | ) | ||||
Total property, plant and equipment, net | $ | 157,829 | $ | 109,872 | ||||
Goodwill_and_Other_Intangible_1
Goodwill and Other Intangible Assets (Tables) | 12 Months Ended | |||||||||||||||
Dec. 31, 2013 | ||||||||||||||||
Goodwill and Intangible Assets Disclosure [Abstract] | ' | |||||||||||||||
Schedule of Goodwill Activity | ' | |||||||||||||||
The roll-forward of activity related to our goodwill was as follows (in thousands): | ||||||||||||||||
Year Ended | ||||||||||||||||
2013 | 2012 | |||||||||||||||
Balance, beginning of period | $ | 131,320 | $ | 58,053 | ||||||||||||
Additions | 3,268 | 69,398 | ||||||||||||||
Goodwill adjustments | 1,564 | 3,869 | ||||||||||||||
Balance, end of period | $ | 136,152 | $ | 131,320 | ||||||||||||
Schedule of Finite-Lived Intangible Assets by Major Class | ' | |||||||||||||||
The gross amount of our other intangible assets and the related accumulated amortization were as follows (in thousands): | ||||||||||||||||
December 31, | ||||||||||||||||
2013 | 2012 | |||||||||||||||
Patents, trademarks and other | $ | 24,327 | $ | 22,047 | ||||||||||||
Accumulated amortization | (9,296 | ) | (5,743 | ) | ||||||||||||
Net patents, trademarks and other | 15,031 | 16,304 | ||||||||||||||
Customer relationships | 21,650 | 20,305 | ||||||||||||||
Accumulated amortization | (3,547 | ) | (1,171 | ) | ||||||||||||
Net customer relationships | 18,103 | 19,134 | ||||||||||||||
Developed technology | 18,161 | 17,686 | ||||||||||||||
Accumulated amortization | (4,098 | ) | (1,771 | ) | ||||||||||||
Net developed technology | 14,063 | 15,915 | ||||||||||||||
Note issuance costs | 2,445 | 2,445 | ||||||||||||||
Accumulated amortization | (2,445 | ) | (2,299 | ) | ||||||||||||
Net note issuance costs | — | 146 | ||||||||||||||
Total intangible assets included in other long-term assets | $ | 47,197 | $ | 51,499 | ||||||||||||
Schedule of Amortization Expense by Major Class | ' | |||||||||||||||
Amortization expense was as follows (in thousands): | ||||||||||||||||
Year Ended | ||||||||||||||||
2013 | 2012 | 2011 | ||||||||||||||
Patents, trademarks and other | $ | 3,553 | $ | 1,993 | $ | 1,342 | ||||||||||
Customer relationships | 2,376 | 1,168 | 3 | |||||||||||||
Developed technology | 2,327 | 1,716 | 55 | |||||||||||||
Note issuance costs | 146 | 350 | 350 | |||||||||||||
Total amortization expense | $ | 8,402 | $ | 5,227 | $ | 1,750 | ||||||||||
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense | ' | |||||||||||||||
Expected amortization, without consideration for foreign currency effects, is as follows over the next five years and thereafter (in thousands): | ||||||||||||||||
Patents, | Customer Relationships | Developed Technology | Total | |||||||||||||
Trademarks | ||||||||||||||||
and Other | ||||||||||||||||
2014 | $ | 3,234 | $ | 2,420 | $ | 2,291 | $ | 7,945 | ||||||||
2015 | 3,019 | 2,420 | 2,291 | 7,730 | ||||||||||||
2016 | 2,757 | 2,420 | 2,291 | 7,468 | ||||||||||||
2017 | 2,214 | 2,072 | 2,010 | 6,296 | ||||||||||||
2018 | 1,646 | 1,988 | 1,847 | 5,481 | ||||||||||||
Thereafter | 2,161 | 6,783 | 3,333 | 12,277 | ||||||||||||
Total future amortization expense | $ | 15,031 | $ | 18,103 | $ | 14,063 | $ | 47,197 | ||||||||
Credit_Facilities_and_Restrict1
Credit Facilities and Restricted Cash (Tables) | 12 Months Ended | |||
Dec. 31, 2013 | ||||
Credit Facilities And Restricted Cash | ' | |||
Schedule of Letters of Credit and Restricted Cash | ' | |||
The following table sets forth information related to guarantees and letters of credit (in thousands): | ||||
December 31, | ||||
2013 | ||||
Guarantees and letters of credit outstanding | $ | 51,892 | ||
Amount secured by restricted cash deposits: | ||||
Current | $ | 18,798 | ||
Long-term | 32,718 | |||
Total secured by restricted cash | $ | 51,516 | ||
Warranty_Reserves_Tables
Warranty Reserves (Tables) | 12 Months Ended | |||||||||||
Dec. 31, 2013 | ||||||||||||
Product Warranties Disclosures [Abstract] | ' | |||||||||||
Schedule of Warranty Reserve Activity | ' | |||||||||||
The following is a summary of warranty reserve activity (in thousands): | ||||||||||||
Year Ended | ||||||||||||
2013 | 2012 | 2011 | ||||||||||
Balance, beginning of period | $ | 12,049 | $ | 11,683 | $ | 8,648 | ||||||
Reductions for warranty costs incurred | (13,058 | ) | (11,958 | ) | (8,991 | ) | ||||||
Warranties issued | 13,677 | 12,302 | 12,229 | |||||||||
Translation and changes in estimates | 37 | 22 | (203 | ) | ||||||||
Balance, end of period | $ | 12,705 | $ | 12,049 | $ | 11,683 | ||||||
Convertible_Notes_Tables
Convertible Notes (Tables) | 12 Months Ended | |||||||||||||||
Dec. 31, 2013 | ||||||||||||||||
Convertible Subordinated Debt [Abstract] | ' | |||||||||||||||
Schedule of Convertible Note Redemptions [Table Text Block] | ' | |||||||||||||||
Prior to conversion, we redeemed the following amounts of our 2.875% Convertible Subordinated Notes: | ||||||||||||||||
Date | Amount | Redemption | Redemption | Related Note | ||||||||||||
Redeemed | Price | Discount | Issuance Costs | |||||||||||||
Written Off | ||||||||||||||||
Feb-09 | $ | 15,000,000 | 86.5 | % | $ | 2,025,000 | $ | 250,154 | ||||||||
24-Jun-10 | 7,940,000 | 98.9 | 89,325 | 90,904 | ||||||||||||
29-Jun-10 | 1,200,000 | 99 | 12,000 | 13,703 | ||||||||||||
8-Jul-10 | 1,848,000 | 99.25 | 13,860 | 20,546 | ||||||||||||
Total for 2010 | 10,988,000 | 115,185 | 125,153 | |||||||||||||
Total | $ | 25,988,000 | $ | 2,140,185 | $ | 375,307 | ||||||||||
Income_Taxes_Tables
Income Taxes (Tables) | 12 Months Ended | |||||||||||
Dec. 31, 2013 | ||||||||||||
Income Tax Disclosure [Abstract] | ' | |||||||||||
Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block] | ' | |||||||||||
Income before income taxes included the following components (in thousands): | ||||||||||||
Year Ended | ||||||||||||
2013 | 2012 | 2011 | ||||||||||
U.S. | $ | 32,549 | $ | 26,640 | $ | 14,189 | ||||||
Foreign | 119,053 | 113,908 | 108,676 | |||||||||
Total | $ | 151,602 | $ | 140,548 | $ | 122,865 | ||||||
Schedule of Components of Income Tax Expense [Table Text Block] | ' | |||||||||||
Income tax expense consisted of the following (in thousands): | ||||||||||||
Year Ended | ||||||||||||
2013 | 2012 | 2011 | ||||||||||
Current: | ||||||||||||
Federal | $ | (851 | ) | $ | 8,173 | $ | 7,767 | |||||
State | 419 | 475 | 395 | |||||||||
Foreign | 16,513 | 13,870 | 18,559 | |||||||||
Total current income tax expense | 16,081 | 22,518 | 26,721 | |||||||||
U.S. deferred expense (benefit) | 12,645 | 4,285 | (6,266 | ) | ||||||||
Foreign deferred benefit | (3,797 | ) | (1,175 | ) | (1,227 | ) | ||||||
Income tax expense | $ | 24,929 | $ | 25,628 | $ | 19,228 | ||||||
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] | ' | |||||||||||
The effective income tax rate applied to net income varied from the U.S. federal statutory rate due to the following (in thousands): | ||||||||||||
Year Ended | ||||||||||||
2013 | 2012 | 2011 | ||||||||||
Tax expense at U.S. federal statutory rates | $ | 53,061 | $ | 49,192 | $ | 43,003 | ||||||
Increase (decrease) resulting from: | ||||||||||||
State income taxes, net of federal benefit | 857 | 1,126 | 723 | |||||||||
Foreign tax benefit | (25,263 | ) | (26,181 | ) | (20,515 | ) | ||||||
Research and experimentation benefit | (5,966 | ) | (758 | ) | (2,908 | ) | ||||||
Foreign tax credit benefit | (2,152 | ) | (2,738 | ) | (4,465 | ) | ||||||
Tax audit settlements and lapses of statutes of limitations | (70 | ) | (439 | ) | (509 | ) | ||||||
Stock compensation | 2,658 | 2,134 | 1,683 | |||||||||
Non-deductible items | 2,132 | 3,100 | 1,597 | |||||||||
Other | (328 | ) | 192 | 619 | ||||||||
Income tax expense | $ | 24,929 | $ | 25,628 | $ | 19,228 | ||||||
Schedule of Deferred Tax Assets and Liabilities, Balance Sheet Classification [Table Text Block] | ' | |||||||||||
Net deferred tax assets (liabilities) were classified on the balance sheet as follows (in thousands): | ||||||||||||
December 31, | ||||||||||||
2013 | 2012 | |||||||||||
Deferred tax assets – current | $ | 15,114 | $ | 12,245 | ||||||||
Deferred tax assets – non-current | 1,751 | 5,092 | ||||||||||
Deferred tax liabilities – current | (9 | ) | (93 | ) | ||||||||
Deferred tax liabilities – non-current | (8,931 | ) | (17,588 | ) | ||||||||
Net deferred tax assets (liabilities) | $ | 7,925 | $ | (344 | ) | |||||||
Valuation allowance | $ | 2,723 | $ | 2,081 | ||||||||
Schedule of Deferred Tax Assets and Liabilities | ' | |||||||||||
The tax effects of temporary differences that gave rise to significant portions of deferred tax assets and deferred tax liabilities were as follows (in thousands): | ||||||||||||
December 31, | ||||||||||||
2013 | 2012 | |||||||||||
Deferred tax assets: | ||||||||||||
Accrued liabilities and reserves | $ | 15,804 | $ | 13,239 | ||||||||
Revenue recognition | 340 | 3,707 | ||||||||||
Tax credit and loss carryforwards | 8,063 | 8,497 | ||||||||||
Fixed assets and intangibles | 546 | 765 | ||||||||||
Unrealized investment | 765 | 2,538 | ||||||||||
Stock compensation | 2,151 | 1,815 | ||||||||||
Other assets | 1,501 | 665 | ||||||||||
Gross deferred tax assets | 29,170 | 31,226 | ||||||||||
Valuation allowance | (2,723 | ) | (2,081 | ) | ||||||||
Net deferred tax assets | 26,447 | 29,145 | ||||||||||
Deferred tax liabilities: | ||||||||||||
Fixed assets and intangibles | (17,965 | ) | (20,697 | ) | ||||||||
Revenue recognition | (19 | ) | (4,991 | ) | ||||||||
Other liabilities | (538 | ) | (3,801 | ) | ||||||||
Total deferred tax liabilities | (18,522 | ) | (29,489 | ) | ||||||||
Net deferred tax assets (liabilities) | $ | 7,925 | $ | (344 | ) | |||||||
Unrecognized Tax Benefits Rollforward | ' | |||||||||||
A rollforward of our unrecognized tax benefits, including interest and penalties, was as follows (in thousands): | ||||||||||||
Year Ended | ||||||||||||
2013 | 2012 | 2011 | ||||||||||
Unrecognized tax benefits, beginning of period | $ | 25,135 | $ | 16,041 | $ | 7,156 | ||||||
Increases for tax positions taken in current period | 1,197 | — | 542 | |||||||||
Increases for tax positions taken in prior periods | 1,701 | 9,965 | 10,502 | |||||||||
Decreases for tax positions taken in prior periods | (3,997 | ) | (620 | ) | (1,723 | ) | ||||||
Decreases for lapses in statutes of limitations | (70 | ) | (251 | ) | (436 | ) | ||||||
Unrecognized tax benefits, end of period | $ | 23,966 | $ | 25,135 | $ | 16,041 | ||||||
Schedule of Interest and Penalties Included in Income Tax Expense [Table Text Block] | ' | |||||||||||
Tax expense included the following relating to interest and penalties (in thousands): | ||||||||||||
Year Ended | ||||||||||||
2013 | 2012 | 2011 | ||||||||||
Benefit for lapses of statutes of limitations and settlement with taxing authorities | $ | (24 | ) | $ | (88 | ) | $ | (124 | ) | |||
Accruals for current and prior periods | 1,698 | 652 | 293 | |||||||||
Total interest and penalties | $ | 1,674 | $ | 564 | $ | 169 | ||||||
Open Tax Years By Major Tax Jurisdiction | ' | |||||||||||
For our major tax jurisdictions, the following years were open for examination by the tax authorities as of December 31, 2013: | ||||||||||||
Jurisdiction | Open Tax Years | |||||||||||
U.S. | 2010 and forward | |||||||||||
The Netherlands | 2011 and forward | |||||||||||
Czech Republic | 2011 and forward |
Restructuring_Reorganization_R1
Restructuring, Reorganization, Relocation and Severance (Tables) | 12 Months Ended | |||||||||||||||||||||||
Dec. 31, 2013 | ||||||||||||||||||||||||
Restructuring Cost and Reserve [Line Items] | ' | |||||||||||||||||||||||
Schedule of Restructuring Reserve by Type of Cost | ' | |||||||||||||||||||||||
The following tables summarize the charges, expenditures, write-offs and adjustments related to our restructuring, reorganization, relocation and severance accrual (in thousands): | ||||||||||||||||||||||||
Year Ended December 31, 2013 | Group Structure Reorganization | Total | ||||||||||||||||||||||
Beginning accrued liability | $ | 2,692 | $ | 2,692 | ||||||||||||||||||||
Charged to expense, net | 1,090 | 1,090 | ||||||||||||||||||||||
Expenditures | (3,782 | ) | (3,782 | ) | ||||||||||||||||||||
Write-offs and adjustments | 50 | 50 | ||||||||||||||||||||||
Ending accrued liability | $ | 50 | $ | 50 | ||||||||||||||||||||
Year Ended December 31, 2012 | Severance, outplacement and related benefits for terminated employees | Manufacturing Transfer | Group Structure Reorganization | Total | ||||||||||||||||||||
Beginning accrued liability | $ | 113 | $ | 2,100 | $ | — | $ | 2,213 | ||||||||||||||||
Charged to expense, net | — | — | 2,859 | 2,859 | ||||||||||||||||||||
Expenditures | — | (2,100 | ) | (254 | ) | (2,354 | ) | |||||||||||||||||
Write-offs and adjustments | (113 | ) | — | 87 | (26 | ) | ||||||||||||||||||
Ending accrued liability | $ | — | $ | — | $ | 2,692 | $ | 2,692 | ||||||||||||||||
Year Ended December 31, 2011 | Product line transfer and training of Brno employees | Severance, outplacement and related benefits for terminated employees | IT system upgrades | Abandoned leases, leasehold improvements and facilities | Manufacturing Transfer | Total | ||||||||||||||||||
Beginning accrued liability | $ | — | $ | 4,832 | $ | 20 | $ | 32 | $ | — | $ | 4,884 | ||||||||||||
Charged to expense, net | 963 | 184 | — | (32 | ) | 2,100 | 3,215 | |||||||||||||||||
Expenditures | (963 | ) | (5,083 | ) | — | — | — | (6,046 | ) | |||||||||||||||
Write-offs and adjustments | — | 180 | (20 | ) | — | — | 160 | |||||||||||||||||
Ending accrued liability | $ | — | $ | 113 | $ | — | $ | — | $ | 2,100 | $ | 2,213 | ||||||||||||
April 2010 Restructuring Plan [Member] | ' | |||||||||||||||||||||||
Restructuring Cost and Reserve [Line Items] | ' | |||||||||||||||||||||||
Schedule of Restructuring and Related Costs | ' | |||||||||||||||||||||||
Information for costs related to the April 2010 restructuring plan is as follows (in thousands): | ||||||||||||||||||||||||
Year Ended | ||||||||||||||||||||||||
Costs Incurred | 2013 | 2012 | 2011 | Life of Plan | ||||||||||||||||||||
Severance costs related to work force reduction and reorganization | $ | — | $ | — | $ | 184 | $ | 6,617 | ||||||||||||||||
Product line transfer, training of Brno employees and facility build-out in Brno | — | — | 963 | 1,835 | ||||||||||||||||||||
Total costs incurred | $ | — | $ | — | $ | 1,147 | $ | 8,452 | ||||||||||||||||
Lease_Obligations_Tables
Lease Obligations (Tables) | 12 Months Ended | |||
Dec. 31, 2013 | ||||
Lease Obligations [Abstract] | ' | |||
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block] | ' | |||
The approximate future minimum rental payments due under these agreements as of December 31, 2013, were as follows (in thousands): | ||||
Minimum Rental Payment | ||||
2014 | $ | 10,997 | ||
2015 | 8,171 | |||
2016 | 6,883 | |||
2017 | 5,803 | |||
2018 | 4,811 | |||
Thereafter | 48,722 | |||
Total | $ | 85,387 | ||
StockBased_Compensation_Tables
Stock-Based Compensation (Tables) | 12 Months Ended | |||||||||||
Dec. 31, 2013 | ||||||||||||
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | ' | |||||||||||
Schedule of Information Related to Stock-Based Compensation Plans | ' | |||||||||||
The following table sets forth certain information regarding the 1995 Plan: | ||||||||||||
December 31, | ||||||||||||
2013 | ||||||||||||
Shares available for grant | 1,998,881 | |||||||||||
Shares of common stock reserved for issuance | 3,487,290 | |||||||||||
Schedule of Options Outstanding and Exercisable | ' | |||||||||||
The following table sets forth certain information regarding all options outstanding and exercisable: | ||||||||||||
December 31, 2013 | ||||||||||||
Options Outstanding | Options Exercisable | |||||||||||
Number | 751,853 | 232,828 | ||||||||||
Weighted average exercise price | $ | 50.18 | $ | 31.8 | ||||||||
Aggregate intrinsic value | $ 29.5 million | $ 13.4 million | ||||||||||
Weighted average remaining contractual term | 5.1 years | 3.8 years | ||||||||||
Schedule of Restricted Stock Units Nonvested and Expected to Vest | ' | |||||||||||
The following table sets forth certain information regarding all RSUs nonvested and expected to vest: | ||||||||||||
December 31, 2013 | ||||||||||||
RSUs Nonvested | RSUs Expected to Vest | |||||||||||
Number | 745,060 | 637,692 | ||||||||||
Weighted average grant date per share fair value | $ | 57.6 | $ | 56.75 | ||||||||
Aggregate intrinsic value | $ 65.8 million | $ 57.0 million | ||||||||||
Weighted average remaining term to vest | 1.7 years | 1.6 years | ||||||||||
Schedule of Stock Option Activity | ' | |||||||||||
Activity under these plans was as follows (share amounts in thousands): | ||||||||||||
Year Ended December 31, 2013 | ||||||||||||
Shares Subject to Options | Weighted Average Exercise Price | |||||||||||
Balance, beginning of period | 870 | $ | 35.81 | |||||||||
Granted | 198 | 82.11 | ||||||||||
Forfeited | (47 | ) | 37.38 | |||||||||
Expired | (4 | ) | 15.56 | |||||||||
Exercised | (265 | ) | 29.69 | |||||||||
Balance, end of period | 752 | 50.18 | ||||||||||
Schedule of Restricted Stock Unit Activity | ' | |||||||||||
Year Ended December 31, 2013 | ||||||||||||
Restricted Stock Units | Weighted Average Grant Date Per Share Fair Value | |||||||||||
Balance, beginning of period | 871 | $ | 41.69 | |||||||||
Granted | 244 | 83.58 | ||||||||||
Forfeited | (61 | ) | 41.14 | |||||||||
Vested | (309 | ) | 37 | |||||||||
Balance, end of period | 745 | 57.6 | ||||||||||
Stock-Based Compensation Disclosures | ' | |||||||||||
Certain information regarding our stock-based compensation was as follows (in thousands): | ||||||||||||
Year Ended | ||||||||||||
2013 | 2012 | 2011 | ||||||||||
Weighted average grant-date fair value of stock options granted | $ | 16,283 | $ | 12,279 | $ | 11,703 | ||||||
Weighted average grant-date fair value of restricted stock units | 20,415 | 20,461 | 15,499 | |||||||||
Total intrinsic value of stock options exercised | 13,169 | 6,293 | 10,550 | |||||||||
Fair value of restricted stock units vested | 11,452 | 9,113 | 8,120 | |||||||||
Cash received from stock options exercised and shares purchased under all stock-based arrangements | 16,545 | 13,131 | 24,382 | |||||||||
Tax benefit realized for stock options | 6,495 | 3,137 | 2,918 | |||||||||
Schedule of Stock-Based Compensation Expense | ' | |||||||||||
Our stock-based compensation expense was included in our Consolidated Statements of Operations as follows (in thousands): | ||||||||||||
Year Ended | ||||||||||||
2013 | 2012 | 2011 | ||||||||||
Cost of sales | $ | 2,427 | $ | 1,858 | $ | 1,511 | ||||||
Research and development | 2,156 | 1,903 | 1,873 | |||||||||
Selling, general and administrative | 13,744 | 10,393 | 7,727 | |||||||||
Total stock-based compensation | $ | 18,327 | $ | 14,154 | $ | 11,111 | ||||||
Schedule of Stock-Based Compensation Valuation Assumptions | ' | |||||||||||
The following weighted average assumptions were used in determining fair value pursuant to the Black-Scholes option pricing model: | ||||||||||||
Year Ended | ||||||||||||
2013 | 2012 | 2011 | ||||||||||
Risk-free interest rate | 0.07% - 1.72% | 0.13% - 0.81% | 0.06% - 2.02% | |||||||||
Dividend yield | 0.44% - 0.59% | 0% - 0.72% | — | % | ||||||||
Expected term: | ||||||||||||
Option plans | 3.1 - 5.1 years | 5.3 - 5.5 years | 5.5 - 5.7 years | |||||||||
Employee share purchase plan | 6 months | 6 months | 6 months | |||||||||
Volatility | 23% - 43% | 36% - 55% | 36% - 55% | |||||||||
Discount for post vesting restrictions | — | % | — | % | — | % |
RelatedParty_Activity_Tables
Related-Party Activity (Tables) | 12 Months Ended | |||||||||||
Dec. 31, 2013 | ||||||||||||
Related Party Transactions [Abstract] | ' | |||||||||||
Schedule of Transactions with Related Parties | ' | |||||||||||
Transactions with these related parties were as follows (in thousands): | ||||||||||||
Year Ended | ||||||||||||
Sales to Related Parties | 2013 | 2012 | 2011 | |||||||||
Product sales: | ||||||||||||
Applied Materials, Inc. | $ | 4,656 | $ | 981 | $ | 3,594 | ||||||
Lattice Semiconductor Corporation | 5 | — | 122 | |||||||||
Cascade Microtech, Inc. | — | 4 | — | |||||||||
Oregon Health and Science University | 555 | — | — | |||||||||
Total product sales to related parties | 5,216 | 985 | 3,716 | |||||||||
Service sales: | ||||||||||||
Applied Materials, Inc. | 719 | 554 | 459 | |||||||||
Lattice Semiconductor Corporation | 12 | — | — | |||||||||
Cascade Microtech, Inc. | 33 | 33 | 39 | |||||||||
Oregon Health and Science University | 85 | — | — | |||||||||
Total service sales to related parties | 849 | 587 | 498 | |||||||||
Total sales to related parties | $ | 6,065 | $ | 1,572 | $ | 4,214 | ||||||
Purchases from Related Parties | ||||||||||||
TMC BV | $ | 580 | $ | 127 | $ | 109 | ||||||
Cascade Microtech, Inc. | — | — | 1 | |||||||||
Oregon Health and Science University | 353 | — | — | |||||||||
Total purchases from related parties | $ | 933 | $ | 127 | $ | 110 | ||||||
Schedule of Amounts Due From (To) Related Parties | ' | |||||||||||
Amounts due from (to) related parties were as follows (in thousands): | ||||||||||||
December 31, | ||||||||||||
2013 | ||||||||||||
Applied Materials, Inc. | $ | 46 | ||||||||||
Cascade Microtech, Inc. | 8 | |||||||||||
Oregon Health and Science University | 1 | |||||||||||
TMC BV | (403 | ) | ||||||||||
Due to related parties, net | $ | (348 | ) |
Segment_and_Geographic_Informa1
Segment and Geographic Information (Tables) | 12 Months Ended | |||||||||||||||||||||||||||||
Dec. 31, 2013 | ||||||||||||||||||||||||||||||
Segment Reporting [Abstract] | ' | |||||||||||||||||||||||||||||
Schedule of Sales to External Customers and Gross Profit by Segment | ' | |||||||||||||||||||||||||||||
The following tables summarize various financial amounts for each of our business segments (in thousands): | ||||||||||||||||||||||||||||||
Year Ended | ||||||||||||||||||||||||||||||
2013 | 2012 | 2011 | ||||||||||||||||||||||||||||
Sales to External Customers: | ||||||||||||||||||||||||||||||
Industry Group | $ | 427,731 | $ | 433,424 | $ | 376,533 | ||||||||||||||||||||||||
Science Group | 499,723 | 458,314 | 449,893 | |||||||||||||||||||||||||||
Total | $ | 927,454 | $ | 891,738 | $ | 826,426 | ||||||||||||||||||||||||
Gross Profit: | ||||||||||||||||||||||||||||||
Industry Group | $ | 222,675 | $ | 220,267 | $ | 185,156 | ||||||||||||||||||||||||
Science Group | 216,110 | 195,363 | 182,210 | |||||||||||||||||||||||||||
Total | $ | 438,785 | $ | 415,630 | $ | 367,366 | ||||||||||||||||||||||||
Schedule of Goodwill and Total Assets by Segment | ' | |||||||||||||||||||||||||||||
December 31, | December 31, | |||||||||||||||||||||||||||||
2013 | 2012 | |||||||||||||||||||||||||||||
Goodwill: | ||||||||||||||||||||||||||||||
Industry Group | $ | 51,532 | $ | 53,572 | ||||||||||||||||||||||||||
Science Group | 84,620 | 77,748 | ||||||||||||||||||||||||||||
Total | $ | 136,152 | $ | 131,320 | ||||||||||||||||||||||||||
Total Assets: | ||||||||||||||||||||||||||||||
Industry Group | $ | 297,987 | $ | 293,115 | ||||||||||||||||||||||||||
Science Group | 365,571 | 401,795 | ||||||||||||||||||||||||||||
Corporate and Eliminations | 762,526 | 539,313 | ||||||||||||||||||||||||||||
Total | $ | 1,426,084 | $ | 1,234,223 | ||||||||||||||||||||||||||
Schedule of Sales by Geographic Region [Table Text Block] | ' | |||||||||||||||||||||||||||||
The following table summarizes sales by geographic region (in thousands): | ||||||||||||||||||||||||||||||
Year Ended | ||||||||||||||||||||||||||||||
2013 | 2012 | 2011 | ||||||||||||||||||||||||||||
Product Sales | Service Sales | Total | Product Sales | Service Sales | Total | Product Sales | Service Sales | Total | ||||||||||||||||||||||
U.S. and Canada | $ | 167,876 | $ | 92,759 | $ | 260,635 | $ | 200,778 | $ | 90,942 | $ | 291,720 | $ | 179,126 | $ | 78,118 | $ | 257,244 | ||||||||||||
Europe | 205,857 | 64,803 | 270,660 | 185,598 | 59,124 | 244,722 | 206,994 | 54,319 | 261,313 | |||||||||||||||||||||
Asia-Pacific Region and Rest of World | 335,705 | 60,454 | 396,159 | 305,120 | 50,176 | 355,296 | 268,479 | 39,390 | 307,869 | |||||||||||||||||||||
Consolidated net sales | $ | 709,438 | $ | 218,016 | $ | 927,454 | $ | 691,496 | $ | 200,242 | $ | 891,738 | $ | 654,599 | $ | 171,827 | $ | 826,426 | ||||||||||||
Geographic Schedule of Long-Lived Assets [Table Text Block] | ' | |||||||||||||||||||||||||||||
Our long-lived assets were geographically located as follows (in thousands): | ||||||||||||||||||||||||||||||
December 31, | December 31, | |||||||||||||||||||||||||||||
2013 | 2012 | |||||||||||||||||||||||||||||
United States | $ | 77,639 | $ | 74,319 | ||||||||||||||||||||||||||
The Netherlands | 65,570 | 32,679 | ||||||||||||||||||||||||||||
The Czech Republic | 22,950 | 12,019 | ||||||||||||||||||||||||||||
Other | 42,272 | 46,258 | ||||||||||||||||||||||||||||
Total | $ | 208,431 | $ | 165,275 | ||||||||||||||||||||||||||
Fair_Value_Measurements_of_Ass1
Fair Value Measurements of Assets and Liabilities (Tables) | 12 Months Ended | ||||||||||||
Dec. 31, 2013 | |||||||||||||
Fair Value Disclosures [Abstract] | ' | ||||||||||||
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis | ' | ||||||||||||
Following are the disclosures related to the fair value of our financial assets and (liabilities) (in thousands): | |||||||||||||
December 31, 2013 | Level 1 | Level 2 | Level 3 | Total | |||||||||
Available for sale marketable securities: | |||||||||||||
U.S. treasury notes | $ | 10,128 | $ | — | $ | — | $ | 10,128 | |||||
Agency bonds | — | 37,961 | — | 37,961 | |||||||||
Commercial paper | — | 39,987 | — | 39,987 | |||||||||
Certificates of deposit | — | 7,786 | — | 7,786 | |||||||||
Municipal bonds | — | 49,319 | — | 49,319 | |||||||||
Corporate bond | — | 5,001 | — | 5,001 | |||||||||
Trading securities: | |||||||||||||
Equity securities – mutual funds | 5,287 | — | — | 5,287 | |||||||||
Derivative contracts, net | — | (1,113 | ) | — | (1,113 | ) | |||||||
Total | $ | 15,415 | $ | 138,941 | $ | — | $ | 154,356 | |||||
December 31, 2012 | Level 1 | Level 2 | Level 3 | Total | |||||||||
Available for sale marketable securities: | |||||||||||||
U.S. treasury notes | $ | 60,786 | $ | — | $ | — | $ | 60,786 | |||||
Agency bonds | — | 31,157 | — | 31,157 | |||||||||
Commercial paper | — | 5,000 | — | 5,000 | |||||||||
Certificates of deposit | — | 5,494 | — | 5,494 | |||||||||
Municipal bonds | — | 3,228 | — | 3,228 | |||||||||
Trading securities: | |||||||||||||
Equity securities – mutual funds | 3,046 | — | — | 3,046 | |||||||||
Derivative contracts, net | — | 1,655 | — | 1,655 | |||||||||
Total | $ | 63,832 | $ | 46,534 | $ | — | $ | 110,366 | |||||
Derivative_Instruments_Tables
Derivative Instruments (Tables) | 12 Months Ended | |||||||||||||||||||
Dec. 31, 2013 | ||||||||||||||||||||
Derivative Instruments and Hedging Activities Disclosure [Abstract] | ' | |||||||||||||||||||
Schedule of Notional Amounts of Outstanding Derivative Positions | ' | |||||||||||||||||||
The aggregate notional amount of outstanding derivative contracts were as follows (in thousands): | ||||||||||||||||||||
December 31, | December 31, | |||||||||||||||||||
2013 | 2012 | |||||||||||||||||||
Cash flow hedges | $ | 208,446 | $ | 165,000 | ||||||||||||||||
Balance sheet hedges | 172,947 | 225,924 | ||||||||||||||||||
Total outstanding derivative contracts | $ | 381,393 | $ | 390,924 | ||||||||||||||||
Schedule of Gain (Loss) Attributable to Foreign Exchange Rate Fluctuations | ' | |||||||||||||||||||
Changes in fair value of derivatives entered into to mitigate the foreign exchange risks related to these balance sheet items are recorded in other income (expense) together with the transaction gain or loss from the respective balance sheet position as follows (in thousands): | ||||||||||||||||||||
Year Ended | ||||||||||||||||||||
2013 | 2012 | 2011 | ||||||||||||||||||
Foreign currency loss, inclusive of the impact of derivatives | $ | (2,808 | ) | $ | (5,675 | ) | $ | (2,222 | ) | |||||||||||
Schedule of Derivatives Instruments, Offsetting in Balance Sheet | ' | |||||||||||||||||||
Our derivative instruments are subject to master netting arrangements and are presented net in our balance sheet. We do not have any financial collateral related to these netting arrangements. The effect of these netting arrangements on our balance sheet is as follows (in thousands): | ||||||||||||||||||||
Offsetting of Derivative Assets | Offsetting of Derivative Liabilities | |||||||||||||||||||
December 31, 2013 | Gross Amounts of Recognized Assets | Gross Amounts Offset in the Balance Sheet | Net Amounts Presented in Other Current Assets | Gross Amounts of Recognized Liabilities | Gross Amounts Offset in the Balance Sheet | Net Amounts Presented in Other Current Liabilities | ||||||||||||||
Foreign exchange contracts designated as hedging instruments | $ | — | $ | — | $ | — | $ | 4,362 | $ | (3,042 | ) | $ | 1,320 | |||||||
Foreign exchange contracts not designated as hedging instruments | 2,171 | (698 | ) | 1,473 | 2,916 | (1,650 | ) | 1,266 | ||||||||||||
Total | $ | 2,171 | $ | (698 | ) | $ | 1,473 | $ | 7,278 | $ | (4,692 | ) | $ | 2,586 | ||||||
Offsetting of Derivative Assets | Offsetting of Derivative Liabilities | |||||||||||||||||||
December 31, 2012 | Gross Amounts of Recognized Assets | Gross Amounts Offset in the Balance Sheet | Net Amounts Presented in Other Current Assets | Gross Amounts of Recognized Liabilities | Gross Amounts Offset in the Balance Sheet | Net Amounts Presented in Other Current Liabilities | ||||||||||||||
Foreign exchange contracts designated as hedging instruments | $ | 3,019 | $ | (1,492 | ) | $ | 1,527 | $ | — | $ | — | $ | — | |||||||
Foreign exchange contracts not designated as hedging instruments | 2,725 | (1,589 | ) | 1,136 | 4,289 | (3,281 | ) | 1,008 | ||||||||||||
Total | $ | 5,744 | $ | (3,081 | ) | $ | 2,663 | $ | 4,289 | $ | (3,281 | ) | $ | 1,008 | ||||||
Schedule of Derivative Instruments, Gain (Loss) in Statement of Operations | ' | |||||||||||||||||||
The effect of derivative instruments was as follows (in thousands): | ||||||||||||||||||||
Year Ended | ||||||||||||||||||||
Foreign Exchange Contracts in Cash Flow Hedging Relationships | 2013 | 2012 | 2011 | |||||||||||||||||
Amount of gain/(loss): | ||||||||||||||||||||
Recognized in OCI (effective portion) | $ | (1,934 | ) | $ | 8,032 | $ | 108 | |||||||||||||
Reclassified from accumulated OCI into revenue (effective portion) | 33 | — | — | |||||||||||||||||
Reclassified from accumulated OCI into cost of sales (effective portion) | (790 | ) | (2,511 | ) | 3,558 | |||||||||||||||
Recognized in other, net (ineffective portion and amount excluded from effectiveness testing) | (80 | ) | 9 | 83 | ||||||||||||||||
Foreign Exchange Contracts Not in Cash Flow Hedging Relationships | ||||||||||||||||||||
Amount of gain/(loss): | ||||||||||||||||||||
Recognized in other, net | $ | (4,802 | ) | $ | (4,882 | ) | $ | (6,181 | ) |
Summary_of_Significant_Account3
Summary of Significant Accounting Policies (Details) (USD $) | 12 Months Ended | ||
Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | |
country | |||
Accounting Policies [Line Items] | ' | ' | ' |
Number of countries in which entity operates | 50 | ' | ' |
Allowance for Doubtful Accounts Activity [Roll Forward] | ' | ' | ' |
Balance, beginning of period | $2,718,000 | $5,553,000 | $5,685,000 |
Expense (reversal) | 473,000 | -154,000 | -18,000 |
Write-offs | -263,000 | -2,732,000 | -25,000 |
Translation adjustments | 41,000 | 51,000 | -89,000 |
Balance, end of period | 2,969,000 | 2,718,000 | 5,553,000 |
Asset impairment charges | 0 | 0 | 1,434,000 |
Goodwill, impairment loss | 0 | 0 | ' |
Revenue recognition, installation deferral percentage | 4.00% | ' | ' |
Research and development subsidies | 5,300,000 | 7,300,000 | 5,300,000 |
Advertising expense | $4,100,000 | $3,900,000 | $3,200,000 |
Stock options, vesting period | '4 years | ' | ' |
Stock options, average legal life | 7 | ' | ' |
Service Inventory [Member] | ' | ' | ' |
Allowance for Doubtful Accounts Activity [Roll Forward] | ' | ' | ' |
Post-production service lIfe | '8 years | ' | ' |
Building and Building Improvements [Member] | ' | ' | ' |
Allowance for Doubtful Accounts Activity [Roll Forward] | ' | ' | ' |
Property, plant and equipment, estimated useful life | '40 years | ' | ' |
Machinery and Equipment [Member] | Minimum [Member] | ' | ' | ' |
Allowance for Doubtful Accounts Activity [Roll Forward] | ' | ' | ' |
Property, plant and equipment, estimated useful life | '3 years | ' | ' |
Machinery and Equipment [Member] | Maximum [Member] | ' | ' | ' |
Allowance for Doubtful Accounts Activity [Roll Forward] | ' | ' | ' |
Property, plant and equipment, estimated useful life | '7 years | ' | ' |
Demonstration Systems [Member] | Minimum [Member] | ' | ' | ' |
Allowance for Doubtful Accounts Activity [Roll Forward] | ' | ' | ' |
Property, plant and equipment, estimated useful life | '3 years | ' | ' |
Demonstration Systems [Member] | Maximum [Member] | ' | ' | ' |
Allowance for Doubtful Accounts Activity [Roll Forward] | ' | ' | ' |
Property, plant and equipment, estimated useful life | '7 years | ' | ' |
Other Fixed Assets [Member] | Minimum [Member] | ' | ' | ' |
Allowance for Doubtful Accounts Activity [Roll Forward] | ' | ' | ' |
Property, plant and equipment, estimated useful life | '3 years | ' | ' |
Other Fixed Assets [Member] | Maximum [Member] | ' | ' | ' |
Allowance for Doubtful Accounts Activity [Roll Forward] | ' | ' | ' |
Property, plant and equipment, estimated useful life | '7 years | ' | ' |
Earnings_Per_Share_EPS_Reconci
Earnings Per Share - EPS Reconciliation (Details) (USD $) | 12 Months Ended | ||
In Thousands, except Per Share data, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Earnings Per Share Reconciliation | ' | ' | ' |
Basic EPS - net income | $126,673 | $114,920 | $103,637 |
Basic EPS - shares | 40,446 | 38,065 | 38,384 |
Basic EPS - per share amount | $3.13 | $3.02 | $2.70 |
Dilutive effect of 2.875% convertible debt - net income | 780 | 1,819 | 1,808 |
Dilutive effect of 2.875% convertible debt - shares | 1,287 | 3,033 | 3,033 |
Dilutive effect of 2.875% convertible debt - per share amount | ($0.08) | ($0.18) | ($0.15) |
Dilutive effect of stock options, restricted stock units, and shares issuable to Philips - net income | 0 | 0 | 0 |
Dilutive effect of stock options, restricted stock units, and shares issuable to Philips - shares | 662 | 630 | 630 |
Dilutive effect of stock options, restricted stock units, and shares issuable to Philips - per share amount | ($0.04) | ($0.04) | ($0.04) |
Diluted EPS - net income | $127,453 | $116,739 | $105,445 |
Diluted EPS - shares | 42,395 | 41,728 | 42,047 |
Diluted EPS - per share amount | $3.01 | $2.80 | $2.51 |
Earnings_Per_Share_Antidilutiv
Earnings Per Share - Anti-dilutive Securities (Details) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Stock Options [Member] | ' | ' | ' |
Antidilutive Securities Excluded from Computation of Diluted Earnings Per Share [Line Items] | ' | ' | ' |
Antidilutive Securities Excluded from Computation of Diluted EPS | 142 | 279 | 358 |
Restricted Stock Units [Member] | ' | ' | ' |
Antidilutive Securities Excluded from Computation of Diluted Earnings Per Share [Line Items] | ' | ' | ' |
Antidilutive Securities Excluded from Computation of Diluted EPS | 33 | 59 | 322 |
Changes_in_Accumulated_Other_C2
Changes in Accumulated Other Comprehensive Income by Component (Details) (USD $) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Accumulated Other Comprehensive Income, Net of Tax [Roll Forward] | ' | ' | ' |
Beginning balance | $38,556 | ' | ' |
Other comprehensive income before reclassifications | 7,735 | ' | ' |
Cost of goods sold | -488,669 | -476,108 | -459,060 |
Other income (expense) | -4,586 | -7,539 | -4,186 |
Net current period other comprehensive income | 8,572 | ' | ' |
Ending balance | 47,128 | 38,556 | ' |
Reclassification out of Accumulated Other Comprehensive Income [Member] | ' | ' | ' |
Accumulated Other Comprehensive Income, Net of Tax [Roll Forward] | ' | ' | ' |
Revenues | -33 | ' | ' |
Cost of goods sold | 790 | ' | ' |
Other income (expense) | 80 | ' | ' |
Total reclassification out of AOCI | 837 | ' | ' |
Accumulated Translation Adjustment [Member] | ' | ' | ' |
Accumulated Other Comprehensive Income, Net of Tax [Roll Forward] | ' | ' | ' |
Beginning balance | 38,890 | ' | ' |
Other comprehensive income before reclassifications | 9,975 | ' | ' |
Net current period other comprehensive income | 9,975 | ' | ' |
Ending balance | 48,865 | ' | ' |
Accumulated Translation Adjustment [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member] | ' | ' | ' |
Accumulated Other Comprehensive Income, Net of Tax [Roll Forward] | ' | ' | ' |
Revenues | 0 | ' | ' |
Cost of goods sold | 0 | ' | ' |
Other income (expense) | 0 | ' | ' |
Total reclassification out of AOCI | 0 | ' | ' |
Accumulated Net Unrealized Investment Gain (Loss) [Member] | ' | ' | ' |
Accumulated Other Comprehensive Income, Net of Tax [Roll Forward] | ' | ' | ' |
Beginning balance | 4 | ' | ' |
Other comprehensive income before reclassifications | -15 | ' | ' |
Net current period other comprehensive income | -15 | ' | ' |
Ending balance | -11 | ' | ' |
Accumulated Net Unrealized Investment Gain (Loss) [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member] | ' | ' | ' |
Accumulated Other Comprehensive Income, Net of Tax [Roll Forward] | ' | ' | ' |
Revenues | 0 | ' | ' |
Cost of goods sold | 0 | ' | ' |
Other income (expense) | 0 | ' | ' |
Total reclassification out of AOCI | 0 | ' | ' |
Accumulated Defined Benefit Plans Adjustment [Member] | ' | ' | ' |
Accumulated Other Comprehensive Income, Net of Tax [Roll Forward] | ' | ' | ' |
Beginning balance | -819 | ' | ' |
Other comprehensive income before reclassifications | 267 | ' | ' |
Net current period other comprehensive income | 267 | ' | ' |
Ending balance | -552 | ' | ' |
Accumulated Defined Benefit Plans Adjustment [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member] | ' | ' | ' |
Accumulated Other Comprehensive Income, Net of Tax [Roll Forward] | ' | ' | ' |
Revenues | 0 | ' | ' |
Cost of goods sold | 0 | ' | ' |
Other income (expense) | 0 | ' | ' |
Total reclassification out of AOCI | 0 | ' | ' |
Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member] | ' | ' | ' |
Accumulated Other Comprehensive Income, Net of Tax [Roll Forward] | ' | ' | ' |
Beginning balance | 481 | ' | ' |
Other comprehensive income before reclassifications | -2,492 | ' | ' |
Net current period other comprehensive income | -1,655 | ' | ' |
Ending balance | -1,174 | ' | ' |
Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member] | ' | ' | ' |
Accumulated Other Comprehensive Income, Net of Tax [Roll Forward] | ' | ' | ' |
Revenues | -33 | ' | ' |
Cost of goods sold | 790 | ' | ' |
Other income (expense) | 80 | ' | ' |
Total reclassification out of AOCI | $837 | ' | ' |
Factoring_of_Accounts_Receivab1
Factoring of Accounts Receivable (Details) (USD $) | 12 Months Ended | |
In Millions, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 |
Factoring of Accounts Receivable [Abstract] | ' | ' |
Accounts receivable sold without recourse | $9.90 | $0 |
Inventories_Details
Inventories (Details) (USD $) | Dec. 31, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
Inventory Disclosure [Abstract] | ' | ' |
Raw materials and assembled parts | $61,235 | $67,985 |
Service inventories, estimated current requirements | 15,197 | 15,898 |
Work-in-process | 75,883 | 81,104 |
Finished goods | 29,410 | 27,553 |
Total current inventories | 181,725 | 192,540 |
Non-current inventories | $62,104 | $65,116 |
Investments_Amortized_Costs_an
Investments - Amortized Costs and Estimated Fair Values (Details) (USD $) | 12 Months Ended | |||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | ||
Schedule of Investments [Line Items] | ' | ' | ||
Total investments, amortized cost | $156,092 | $109,313 | ||
Total investments, gross unrealized gains | 24 | 9 | ||
Total investments, gross unrealized losses | -39 | -3 | ||
Total investments, fair value | 156,077 | 109,319 | ||
Realized investment gains (losses) | 0 | 0 | ||
Total available for sale marketable securities [Member] | ' | ' | ||
Schedule of Investments [Line Items] | ' | ' | ||
Marketable Securities | 150,182 | 105,665 | ||
Available-for-sale securities, amortized cost | 150,197 | 105,659 | ||
Available-for-sale securities, gross unrealized gains | 24 | 9 | ||
Available-for-sale securities, gross unrealized losses | -39 | -3 | ||
Available-for-sale securities, fair value | 150,182 | 105,665 | ||
U.S. treasury notes [Member] | ' | ' | ||
Schedule of Investments [Line Items] | ' | ' | ||
Marketable Securities | 10,128 | 60,786 | ||
Available-for-sale securities, amortized cost | 10,130 | 60,785 | ||
Available-for-sale securities, gross unrealized gains | 0 | 4 | ||
Available-for-sale securities, gross unrealized losses | -2 | -3 | ||
Available-for-sale securities, fair value | 10,128 | 60,786 | ||
Agency bonds [Member] | ' | ' | ||
Schedule of Investments [Line Items] | ' | ' | ||
Marketable Securities | 37,961 | 31,157 | ||
Available-for-sale securities, amortized cost | 37,996 | [1] | 31,153 | [1] |
Available-for-sale securities, gross unrealized gains | 0 | [1] | 4 | [1] |
Available-for-sale securities, gross unrealized losses | -35 | [1] | 0 | [1] |
Available-for-sale securities, fair value | 37,961 | [1] | 31,157 | [1] |
Commercial paper [Member] | ' | ' | ||
Schedule of Investments [Line Items] | ' | ' | ||
Marketable Securities | 39,987 | 5,000 | ||
Available-for-sale securities, amortized cost | 39,987 | 5,000 | ||
Available-for-sale securities, gross unrealized gains | 0 | 0 | ||
Available-for-sale securities, gross unrealized losses | 0 | 0 | ||
Available-for-sale securities, fair value | 39,987 | 5,000 | ||
Certificates of deposit [Member] | ' | ' | ||
Schedule of Investments [Line Items] | ' | ' | ||
Marketable Securities | 7,786 | 5,494 | ||
Available-for-sale securities, amortized cost | 7,786 | 5,494 | ||
Available-for-sale securities, gross unrealized gains | 0 | 0 | ||
Available-for-sale securities, gross unrealized losses | 0 | 0 | ||
Available-for-sale securities, fair value | 7,786 | 5,494 | ||
Municipal bonds [Member] | ' | ' | ||
Schedule of Investments [Line Items] | ' | ' | ||
Marketable Securities | 49,319 | 3,228 | ||
Available-for-sale securities, amortized cost | 49,296 | 3,227 | ||
Available-for-sale securities, gross unrealized gains | 24 | 1 | ||
Available-for-sale securities, gross unrealized losses | -1 | 0 | ||
Available-for-sale securities, fair value | 49,319 | 3,228 | ||
Corporate Debt Securities [Member] | ' | ' | ||
Schedule of Investments [Line Items] | ' | ' | ||
Marketable Securities | 5,001 | 0 | ||
Available-for-sale securities, amortized cost | 5,002 | ' | ||
Available-for-sale securities, gross unrealized gains | 0 | ' | ||
Available-for-sale securities, gross unrealized losses | -1 | ' | ||
Available-for-sale securities, fair value | 5,001 | ' | ||
Equity securities - mutual funds [Member] | ' | ' | ||
Schedule of Investments [Line Items] | ' | ' | ||
Marketable Securities | 5,287 | 3,046 | ||
Trading securities, amortized cost | 5,287 | 3,046 | ||
Trading securities, gross unrealized gains | 0 | 0 | ||
Trading securities, gross unrealized losses | 0 | 0 | ||
Trading securities, fair value | 5,287 | 3,046 | ||
Cost-method investments [Member] | ' | ' | ||
Schedule of Investments [Line Items] | ' | ' | ||
Cost method investments | 608 | [2] | 608 | [2] |
Cost method investments, gross unrealized gains | 0 | [2] | 0 | [2] |
Cost method investments, gross unrealized losses | 0 | [2] | 0 | [2] |
Cost method investments, fair value | $608 | [2] | $608 | [2] |
[1] | Agency bonds are securities backed by U.S. government-sponsored entities. | |||
[2] | Investments for which it is not practical to estimate fair value are included at cost and primarily consist of investments in privately-held companies. |
Investments_Classification_Det
Investments - Classification (Details) (USD $) | Dec. 31, 2013 | Dec. 31, 2012 | ||
In Thousands, unless otherwise specified | ||||
Investment [Line Items] | ' | ' | ||
Total investments, fair value | $156,077 | $109,319 | ||
Total fixed maturity securities [Member] | ' | ' | ||
Investment [Line Items] | ' | ' | ||
Marketable securities | 150,182 | 105,665 | ||
U.S. treasury notes [Member] | ' | ' | ||
Investment [Line Items] | ' | ' | ||
Marketable securities | 10,128 | 60,786 | ||
Agency bonds [Member] | ' | ' | ||
Investment [Line Items] | ' | ' | ||
Marketable securities | 37,961 | 31,157 | ||
Commercial paper [Member] | ' | ' | ||
Investment [Line Items] | ' | ' | ||
Marketable securities | 39,987 | 5,000 | ||
Certificates of deposit [Member] | ' | ' | ||
Investment [Line Items] | ' | ' | ||
Marketable securities | 7,786 | 5,494 | ||
Municipal bonds [Member] | ' | ' | ||
Investment [Line Items] | ' | ' | ||
Marketable securities | 49,319 | 3,228 | ||
Corporate Debt Securities [Member] | ' | ' | ||
Investment [Line Items] | ' | ' | ||
Marketable securities | 5,001 | 0 | ||
Equity securities - mutual funds [Member] | ' | ' | ||
Investment [Line Items] | ' | ' | ||
Marketable securities | 5,287 | 3,046 | ||
Cost-method investments [Member] | ' | ' | ||
Investment [Line Items] | ' | ' | ||
Cost method investments | 608 | [1] | 608 | [1] |
Short-term investments [Member] | ' | ' | ||
Investment [Line Items] | ' | ' | ||
Total investments, fair value | 108,191 | 79,532 | ||
Short-term investments [Member] | Total fixed maturity securities [Member] | ' | ' | ||
Investment [Line Items] | ' | ' | ||
Marketable securities | 108,191 | 79,532 | ||
Short-term investments [Member] | U.S. treasury notes [Member] | ' | ' | ||
Investment [Line Items] | ' | ' | ||
Marketable securities | 10,128 | 60,786 | ||
Short-term investments [Member] | Agency bonds [Member] | ' | ' | ||
Investment [Line Items] | ' | ' | ||
Marketable securities | 10,995 | 10,148 | ||
Short-term investments [Member] | Commercial paper [Member] | ' | ' | ||
Investment [Line Items] | ' | ' | ||
Marketable securities | 39,987 | 5,000 | ||
Short-term investments [Member] | Certificates of deposit [Member] | ' | ' | ||
Investment [Line Items] | ' | ' | ||
Marketable securities | 5,802 | 3,598 | ||
Short-term investments [Member] | Municipal bonds [Member] | ' | ' | ||
Investment [Line Items] | ' | ' | ||
Marketable securities | 41,279 | 0 | ||
Short-term investments [Member] | Corporate Debt Securities [Member] | ' | ' | ||
Investment [Line Items] | ' | ' | ||
Marketable securities | 0 | 0 | ||
Short-term investments [Member] | Equity securities - mutual funds [Member] | ' | ' | ||
Investment [Line Items] | ' | ' | ||
Marketable securities | 0 | 0 | ||
Short-term investments [Member] | Cost-method investments [Member] | ' | ' | ||
Investment [Line Items] | ' | ' | ||
Cost method investments | 0 | 0 | ||
Long-term investments [Member] | ' | ' | ||
Investment [Line Items] | ' | ' | ||
Total investments, fair value | 47,278 | 29,179 | ||
Long-term investments [Member] | Total fixed maturity securities [Member] | ' | ' | ||
Investment [Line Items] | ' | ' | ||
Marketable securities | 41,991 | 26,133 | ||
Long-term investments [Member] | U.S. treasury notes [Member] | ' | ' | ||
Investment [Line Items] | ' | ' | ||
Marketable securities | 0 | 0 | ||
Long-term investments [Member] | Agency bonds [Member] | ' | ' | ||
Investment [Line Items] | ' | ' | ||
Marketable securities | 26,966 | 21,009 | ||
Long-term investments [Member] | Commercial paper [Member] | ' | ' | ||
Investment [Line Items] | ' | ' | ||
Marketable securities | 0 | 0 | ||
Long-term investments [Member] | Certificates of deposit [Member] | ' | ' | ||
Investment [Line Items] | ' | ' | ||
Marketable securities | 1,984 | 1,896 | ||
Long-term investments [Member] | Municipal bonds [Member] | ' | ' | ||
Investment [Line Items] | ' | ' | ||
Marketable securities | 8,040 | 3,228 | ||
Long-term investments [Member] | Corporate Debt Securities [Member] | ' | ' | ||
Investment [Line Items] | ' | ' | ||
Marketable securities | 5,001 | 0 | ||
Long-term investments [Member] | Equity securities - mutual funds [Member] | ' | ' | ||
Investment [Line Items] | ' | ' | ||
Marketable securities | 5,287 | 3,046 | ||
Long-term investments [Member] | Cost-method investments [Member] | ' | ' | ||
Investment [Line Items] | ' | ' | ||
Cost method investments | 0 | 0 | ||
Other assets [Member] | ' | ' | ||
Investment [Line Items] | ' | ' | ||
Total investments, fair value | 608 | 608 | ||
Other assets [Member] | Total fixed maturity securities [Member] | ' | ' | ||
Investment [Line Items] | ' | ' | ||
Marketable securities | 0 | 0 | ||
Other assets [Member] | U.S. treasury notes [Member] | ' | ' | ||
Investment [Line Items] | ' | ' | ||
Marketable securities | 0 | 0 | ||
Other assets [Member] | Agency bonds [Member] | ' | ' | ||
Investment [Line Items] | ' | ' | ||
Marketable securities | 0 | 0 | ||
Other assets [Member] | Commercial paper [Member] | ' | ' | ||
Investment [Line Items] | ' | ' | ||
Marketable securities | 0 | 0 | ||
Other assets [Member] | Certificates of deposit [Member] | ' | ' | ||
Investment [Line Items] | ' | ' | ||
Marketable securities | 0 | 0 | ||
Other assets [Member] | Municipal bonds [Member] | ' | ' | ||
Investment [Line Items] | ' | ' | ||
Marketable securities | 0 | 0 | ||
Other assets [Member] | Corporate Debt Securities [Member] | ' | ' | ||
Investment [Line Items] | ' | ' | ||
Marketable securities | 0 | 0 | ||
Other assets [Member] | Equity securities - mutual funds [Member] | ' | ' | ||
Investment [Line Items] | ' | ' | ||
Marketable securities | 0 | 0 | ||
Other assets [Member] | Cost-method investments [Member] | ' | ' | ||
Investment [Line Items] | ' | ' | ||
Cost method investments | $608 | $608 | ||
[1] | Investments for which it is not practical to estimate fair value are included at cost and primarily consist of investments in privately-held companies. |
Investments_Contractual_Maturi
Investments - Contractual Maturities (Details) (Total available for sale marketable securities [Member], USD $) | Dec. 31, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
Total available for sale marketable securities [Member] | ' | ' |
Available-for-sale Securities, Schedule of Contractual Maturities [Line Items] | ' | ' |
Due in 1 year or less, amortized cost | $108,183 | ' |
Due in 1-5 years, amortized cost | 42,014 | ' |
Available-for-sale securities, amortized cost | 150,197 | 105,659 |
Due in 1 year or less, fair value | 108,191 | ' |
Due in 1-5 years, fair value | 41,991 | ' |
Available-for-sale securities, fair value | $150,182 | $105,665 |
Property_Plant_and_Equipment_D
Property, Plant and Equipment (Details) (USD $) | Dec. 31, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
Property, Plant and Equipment, Net, by Type [Abstract] | ' | ' |
Gross property, plant and equipment | $283,234 | $231,432 |
Accumulated depreciation | -125,405 | -121,560 |
Total property, plant and equipment, net | 157,829 | 109,872 |
Land [Member] | ' | ' |
Property, Plant and Equipment, Net, by Type [Abstract] | ' | ' |
Gross property, plant and equipment | 25,535 | 7,806 |
Building and Building Improvements [Member] | ' | ' |
Property, Plant and Equipment, Net, by Type [Abstract] | ' | ' |
Gross property, plant and equipment | 36,778 | 21,645 |
Leasehold Improvements [Member] | ' | ' |
Property, Plant and Equipment, Net, by Type [Abstract] | ' | ' |
Gross property, plant and equipment | 23,948 | 16,503 |
Machinery and Equipment [Member] | ' | ' |
Property, Plant and Equipment, Net, by Type [Abstract] | ' | ' |
Gross property, plant and equipment | 103,180 | 108,982 |
Demonstration Systems [Member] | ' | ' |
Property, Plant and Equipment, Net, by Type [Abstract] | ' | ' |
Gross property, plant and equipment | 44,700 | 29,986 |
Other Fixed Assets [Member] | ' | ' |
Property, Plant and Equipment, Net, by Type [Abstract] | ' | ' |
Gross property, plant and equipment | $49,093 | $46,510 |
Goodwill_and_Other_Intangible_2
Goodwill and Other Intangible Assets - Goodwill (Details) (USD $) | 12 Months Ended | |
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 |
Goodwill [Roll Forward] | ' | ' |
Goodwill, beginning of period | $131,320 | $58,053 |
Additions | 3,268 | 69,398 |
Goodwill adjustments | 1,564 | 3,869 |
Goodwill, end of period | $136,152 | $131,320 |
Goodwill_and_Other_Intangible_3
Goodwill and Other Intangible Assets - Acquisition Information (Details) (nanoTechnology Systems Pty. Ltd. [Member], USD $) | Aug. 09, 2013 |
In Millions, unless otherwise specified | |
nanoTechnology Systems Pty. Ltd. [Member] | ' |
Business Acquisition [Line Items] | ' |
Percentage of voting interests acquired | 100.00% |
Acquisition Purchase Price | $3.60 |
Goodwill_and_Other_Intangible_4
Goodwill and Other Intangible Assets - Intangible Assets (Details) (USD $) | Dec. 31, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
Finite-Lived Intangible Assets [Line Items] | ' | ' |
Finite-lived intangible assets, accumulated amortization | ($19,385) | ($10,984) |
Finite-lived intangible assets, net | 47,197 | 51,499 |
Patents, trademarks and other [Member] | ' | ' |
Finite-Lived Intangible Assets [Line Items] | ' | ' |
Finite-lived intangible assets, gross | 24,327 | 22,047 |
Finite-lived intangible assets, accumulated amortization | -9,296 | -5,743 |
Finite-lived intangible assets, net | 15,031 | 16,304 |
Customer relationships [Member] | ' | ' |
Finite-Lived Intangible Assets [Line Items] | ' | ' |
Finite-lived intangible assets, gross | 21,650 | 20,305 |
Finite-lived intangible assets, accumulated amortization | -3,547 | -1,171 |
Finite-lived intangible assets, net | 18,103 | 19,134 |
Developed technology [Member] | ' | ' |
Finite-Lived Intangible Assets [Line Items] | ' | ' |
Finite-lived intangible assets, gross | 18,161 | 17,686 |
Finite-lived intangible assets, accumulated amortization | -4,098 | -1,771 |
Finite-lived intangible assets, net | 14,063 | 15,915 |
Note issuance costs [Member] | ' | ' |
Finite-Lived Intangible Assets [Line Items] | ' | ' |
Finite-lived intangible assets, gross | 2,445 | 2,445 |
Finite-lived intangible assets, accumulated amortization | -2,445 | -2,299 |
Finite-lived intangible assets, net | $0 | $146 |
Goodwill_and_Other_Intangible_5
Goodwill and Other Intangible Assets - Amortization of Intangibles (Details) (USD $) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Finite-Lived Intangible Assets [Line Items] | ' | ' | ' |
Finite-lived intangible assets, amortization expense | $8,402 | $5,227 | $1,750 |
Finite-Lived Intangible Assets, Future Amortization Expense [Abstract] | ' | ' | ' |
2014 expected amortization | 7,945 | ' | ' |
2015 expected amortization | 7,730 | ' | ' |
2016 expected amortization | 7,468 | ' | ' |
2017 expected amortization | 6,296 | ' | ' |
2018 expected amortization | 5,481 | ' | ' |
Expected amortization thereafter | 12,277 | ' | ' |
Total expected amortization expense | 47,197 | 51,499 | ' |
Asset impairment charges | 0 | 0 | 1,434 |
Patents, trademarks and other [Member] | ' | ' | ' |
Finite-Lived Intangible Assets [Line Items] | ' | ' | ' |
Finite-lived intangible assets, amortization expense | 3,553 | 1,993 | 1,342 |
Finite-Lived Intangible Assets, Future Amortization Expense [Abstract] | ' | ' | ' |
2014 expected amortization | 3,234 | ' | ' |
2015 expected amortization | 3,019 | ' | ' |
2016 expected amortization | 2,757 | ' | ' |
2017 expected amortization | 2,214 | ' | ' |
2018 expected amortization | 1,646 | ' | ' |
Expected amortization thereafter | 2,161 | ' | ' |
Total expected amortization expense | 15,031 | 16,304 | ' |
Customer relationships [Member] | ' | ' | ' |
Finite-Lived Intangible Assets [Line Items] | ' | ' | ' |
Finite-lived intangible assets, amortization expense | 2,376 | 1,168 | 3 |
Finite-Lived Intangible Assets, Future Amortization Expense [Abstract] | ' | ' | ' |
2014 expected amortization | 2,420 | ' | ' |
2015 expected amortization | 2,420 | ' | ' |
2016 expected amortization | 2,420 | ' | ' |
2017 expected amortization | 2,072 | ' | ' |
2018 expected amortization | 1,988 | ' | ' |
Expected amortization thereafter | 6,783 | ' | ' |
Total expected amortization expense | 18,103 | 19,134 | ' |
Developed technology [Member] | ' | ' | ' |
Finite-Lived Intangible Assets [Line Items] | ' | ' | ' |
Finite-lived intangible assets, amortization expense | 2,327 | 1,716 | 55 |
Finite-Lived Intangible Assets, Future Amortization Expense [Abstract] | ' | ' | ' |
2014 expected amortization | 2,291 | ' | ' |
2015 expected amortization | 2,291 | ' | ' |
2016 expected amortization | 2,291 | ' | ' |
2017 expected amortization | 2,010 | ' | ' |
2018 expected amortization | 1,847 | ' | ' |
Expected amortization thereafter | 3,333 | ' | ' |
Total expected amortization expense | 14,063 | 15,915 | ' |
Note issuance costs [Member] | ' | ' | ' |
Finite-Lived Intangible Assets [Line Items] | ' | ' | ' |
Finite-lived intangible assets, useful life | '7 years | ' | ' |
Finite-lived intangible assets, amortization expense | 146 | 350 | 350 |
Finite-Lived Intangible Assets, Future Amortization Expense [Abstract] | ' | ' | ' |
Total expected amortization expense | $0 | $146 | ' |
Minimum [Member] | Patents, trademarks and other [Member] | ' | ' | ' |
Finite-Lived Intangible Assets [Line Items] | ' | ' | ' |
Finite-lived intangible assets, useful life | '2 years | ' | ' |
Minimum [Member] | Customer relationships [Member] | ' | ' | ' |
Finite-Lived Intangible Assets [Line Items] | ' | ' | ' |
Finite-lived intangible assets, useful life | '5 years | ' | ' |
Minimum [Member] | Developed technology [Member] | ' | ' | ' |
Finite-Lived Intangible Assets [Line Items] | ' | ' | ' |
Finite-lived intangible assets, useful life | '5 years 6 months | ' | ' |
Maximum [Member] | Patents, trademarks and other [Member] | ' | ' | ' |
Finite-Lived Intangible Assets [Line Items] | ' | ' | ' |
Finite-lived intangible assets, useful life | '15 years | ' | ' |
Maximum [Member] | Customer relationships [Member] | ' | ' | ' |
Finite-Lived Intangible Assets [Line Items] | ' | ' | ' |
Finite-lived intangible assets, useful life | '10 years | ' | ' |
Maximum [Member] | Developed technology [Member] | ' | ' | ' |
Finite-Lived Intangible Assets [Line Items] | ' | ' | ' |
Finite-lived intangible assets, useful life | '10 years | ' | ' |
Credit_Facilities_and_Restrict2
Credit Facilities and Restricted Cash (Details) (USD $) | 12 Months Ended |
Dec. 31, 2013 | |
Revolving Credit Facility [Member] | ' |
Line of Credit Facility [Line Items] | ' |
Line of credit facility, current borrowing capacity | $100,000,000 |
Line of credit facility, additional borrowing capacity | 50,000,000 |
Line of credit facility, maximum borrowing capacity | 150,000,000 |
Credit Facility, Subfacility [Member] | ' |
Line of Credit Facility [Line Items] | ' |
Line of credit facility, current borrowing capacity | 50,000,000 |
Credit Agreement [Member] | ' |
Line of Credit Facility [Line Items] | ' |
Line of credit facility, expiration date | 1-Apr-16 |
Line of credit facility, commitment fee description | 'The Credit Agreement contains quarterly commitment fees that vary based on borrowings outstanding. |
Line of credit facility, interest rate description | 'The revolving loans under the Credit Agreement will generally bear interest, at our option, at either (i)B the alternate base rate, which is defined as a rate per annum equal to the higher of (a)B the Prime Rate in effect on such day, (b) the Federal Funds Effective Rate in effect on such day plus 1/2 of 1%, and (c) the LIBO Rate for an Interest Period of one month plus 1.50%, or (ii)B a floating per annum rate based on LIBOR (based on one, two, three or six-month interest periods) plus a margin equal to between 1.00% and 2.00%, depending on our leverage ratio as of the fiscal quarter most recently ended. A default interest rate shall apply on all obligations during an event of default under the Credit Agreement, at a rate per annum equal to 2.00% above the applicable interest rate. |
Line of credit facility, revolving credit, description | 'Revolving loans may be borrowed, repaid and reborrowed and voluntarily prepaid at any time without premium or penalty. |
Line of credit facility, collateral | 'The obligations under the Credit Agreement are guaranteed by our present and future material domestic subsidiaries. In addition, obligations outstanding under the Credit Agreement are secured by substantially all of our assets and the assets of our material domestic subsidiaries. |
Line of credit facility, covenant terms | 'The Credit Agreement contains customary covenants for a credit facility of this size and type, that include, among others, covenants that limit our ability to incur indebtedness, create liens, merge or consolidate, dispose of assets, make investments, enter into swap agreements, pay dividends or make distributions, enter into transactions with affiliates, enter into restrictive agreements and enter into sale and leaseback transactions. The Credit Agreement provides for financial covenants that require us to maintain a minimum interest coverage ratio and limit the maximum leverage that we can maintain at any one time. |
Line of credit facility, amount outstanding | $0 |
Debt Instrument, Default Interest Rate | 2.00% |
Credit Agreement [Member] | Federal Funds Effective Rate [Member] | ' |
Line of Credit Facility [Line Items] | ' |
Debt Instrument, Basis Spread on Variable Rate | 0.50% |
Credit Agreement [Member] | LIBOR [Member] | ' |
Line of Credit Facility [Line Items] | ' |
Debt Instrument, Basis Spread on Variable Rate | 1.50% |
Credit Agreement [Member] | LIBOR Plus Rate Based on Leverage Ratio [Member] | Minimum [Member] | ' |
Line of Credit Facility [Line Items] | ' |
Debt Instrument, Basis Spread on Variable Rate | 1.00% |
Credit Agreement [Member] | LIBOR Plus Rate Based on Leverage Ratio [Member] | Maximum [Member] | ' |
Line of Credit Facility [Line Items] | ' |
Debt Instrument, Basis Spread on Variable Rate | 2.00% |
Credit_Facilities_and_Restrict3
Credit Facilities and Restricted Cash - Letters of Credit and Restricted Cash (Details) (USD $) | Dec. 31, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
CREDIT FACILITIES AND RESTRICTED CASH [Abstract] | ' | ' |
Guarantees and letters of credit outstanding | $51,892 | ' |
Short-term restricted cash | 18,798 | 14,522 |
Long-term restricted cash | 32,718 | 27,425 |
Total secured by restricted cash | $51,516 | ' |
Warranty_Reserves_Details
Warranty Reserves (Details) (USD $) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Product Warranty Reserve Activity [Roll Forward] | ' | ' | ' |
Balance, beginning of period | $12,049 | $11,683 | $8,648 |
Reductions for warranty costs incurred | -13,058 | -11,958 | -8,991 |
Warranties issued | 13,677 | 12,302 | 12,229 |
Translation and changes in estimates | 37 | 22 | -203 |
Balance, end of period | $12,705 | $12,049 | $11,683 |
Convertible_Notes_Debt_Instrum
Convertible Notes - Debt Instruments (Details) (USD $) | 12 Months Ended | 3 Months Ended | 12 Months Ended | 12 Months Ended | |||||
Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Dec. 31, 2013 | Dec. 31, 2013 | |
Convertible Subordinated Debt [Member] | Convertible Subordinated Debt [Member] | Convertible Subordinated Debt [Member] | Convertible Subordinated Debt [Member] | Convertible Subordinated Debt [Member] | Converted Into Cash [Member] | ||||
Debt Instrument [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Convertible notes, issuance date | ' | ' | ' | ' | 19-May-06 | ' | ' | ' | ' |
Convertible notes, face amount at issuance | ' | ' | ' | ' | $115,000,000 | ' | ' | ' | ' |
Convertible notes, stated interest rate | ' | ' | ' | ' | ' | ' | ' | 2.88% | ' |
Convertible notes, maturity date | ' | ' | ' | ' | 1-Jun-13 | ' | ' | ' | ' |
Convertible notes, issuance costs at time of issuance | ' | ' | ' | ' | 3,100,000 | ' | ' | ' | ' |
Convertible notes, amortization of issuance costs | ' | ' | ' | 100,000 | ' | ' | ' | ' | ' |
Convertible notes, amount | ' | ' | ' | ' | ' | 1,000 | 1,000 | ' | ' |
Shares issued during period for debt conversion | 3,000,000 | ' | ' | ' | ' | 34 | 34 | ' | ' |
Convertible notes, amount converted | 89,000,000 | ' | ' | ' | ' | ' | ' | ' | 100,000 |
Convertible notes, noncash amount converted | $88,937,000 | $0 | $0 | ' | ' | ' | ' | ' | ' |
Convertible_Notes_Schedule_of_
Convertible Notes - Schedule of Convertible Note Redemptions (Details) (Convertible Subordinated Debt [Member], USD $) | 0 Months Ended | 1 Months Ended | 12 Months Ended | |||
Jul. 08, 2010 | Jun. 29, 2010 | Jun. 24, 2010 | Feb. 28, 2009 | Dec. 31, 2013 | Dec. 31, 2010 | |
Convertible Subordinated Debt [Member] | ' | ' | ' | ' | ' | ' |
Redemptions of Convertible Notes | ' | ' | ' | ' | ' | ' |
Convertible notes, redeemed | $1,848,000 | $1,200,000 | $7,940,000 | $15,000,000 | $25,988,000 | $10,988,000 |
Convertible notes, redemption price | 99.25% | 99.00% | 98.90% | 86.50% | ' | ' |
Convertible notes, redemption discount | 13,860 | 12,000 | 89,325 | 2,025,000 | 2,140,185 | 115,185 |
Convertible note redemption, related note issuance costs written off | $20,546 | $13,703 | $90,904 | $250,154 | $375,307 | $125,153 |
Income_Taxes_Details
Income Taxes (Details) (USD $) | 12 Months Ended | ||
Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | |
Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest [Abstract] | ' | ' | ' |
Income before income taxes, U.S. | $32,549,000 | $26,640,000 | $14,189,000 |
Income before income taxes, foreign | 119,053,000 | 113,908,000 | 108,676,000 |
Income before income taxes | 151,602,000 | 140,548,000 | 122,865,000 |
Current: | ' | ' | ' |
Income tax expense, federal | -851,000 | 8,173,000 | 7,767,000 |
Income tax expense, state | 419,000 | 475,000 | 395,000 |
Income tax expense, foreign | 16,513,000 | 13,870,000 | 18,559,000 |
Total current income tax expense | 16,081,000 | 22,518,000 | 26,721,000 |
U.S. deferred expense (benefit) | 12,645,000 | 4,285,000 | -6,266,000 |
Foreign deferred benefit | -3,797,000 | -1,175,000 | -1,227,000 |
Total income tax expense | 24,929,000 | 25,628,000 | 19,228,000 |
Tax benefit from stock options exercised | 6,400,000 | 3,100,000 | 2,900,000 |
Deferred tax benefit recorded in other comprehensive income | ($1,100,000) | ($3,000,000) | ($3,000,000) |
Income_Taxes_Effective_Income_
Income Taxes - Effective Income Tax Rate Reconciliation (Details) (USD $) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Effective Income Tax Rate Reconciliation, Amount [Abstract] | ' | ' | ' |
Tax expense at U.S. federal statutory rates | $53,061 | $49,192 | $43,003 |
Increase (decrease) resulting from: | ' | ' | ' |
State income taxes, net of federal benefit | 857 | 1,126 | 723 |
Foreign tax benefit | -25,263 | -26,181 | -20,515 |
Research and experimentation benefit | -5,966 | -758 | -2,908 |
Foreign tax credit benefit | -2,152 | -2,738 | -4,465 |
Tax audit settlements and lapses of statutes of limitations | -70 | -439 | -509 |
Stock compensation | 2,658 | 2,134 | 1,683 |
Non-deductible items | 2,132 | 3,100 | 1,597 |
Other | -328 | 192 | 619 |
Total income tax expense | $24,929 | $25,628 | $19,228 |
Income_Taxes_Deferred_Income_T
Income Taxes - Deferred Income Tax Assets and Liabilities (Details) (USD $) | Dec. 31, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
Deferred Income Taxes [Abstract] | ' | ' |
Deferred tax assets - current | $15,114 | $12,245 |
Deferred tax assets - noncurrent | 1,751 | 5,092 |
Deferred tax liabilities - current | -9 | -93 |
Deferred tax liabilities - noncurrent | -8,931 | -17,588 |
Net deferred tax assets (liabilities) | 7,925 | -344 |
Valuation allowance | 2,723 | 2,081 |
Deferred tax assets: | ' | ' |
Accrued liabilities and reserves | 15,804 | 13,239 |
Revenue recognition | 340 | 3,707 |
Tax credit and loss carryforwards | 8,063 | 8,497 |
Fixed assets and intangibles | 546 | 765 |
Unrealized investment | 765 | 2,538 |
Stock compensation | 2,151 | 1,815 |
Other assets | 1,501 | 665 |
Gross deferred tax assets | 29,170 | 31,226 |
Valuation allowance | 2,723 | 2,081 |
Net deferred tax assets | 26,447 | 29,145 |
Deferred tax liabilities: | ' | ' |
Fixed assets and intangibles | -17,965 | -20,697 |
Revenue recognition | -19 | -4,991 |
Other liabilities | -538 | -3,801 |
Total deferred tax liabilities | ($18,522) | ($29,489) |
Income_Taxes_Tax_Credit_Carryf
Income Taxes - Tax Credit Carryforwards (Details) (USD $) | 12 Months Ended |
In Millions, unless otherwise specified | Dec. 31, 2013 |
Tax Credit Carryforward [Line Items] | ' |
Operating Loss Carryforwards, Expiration Date | 31-Dec-31 |
Alternative minimum tax credit carryforwards | $0.70 |
Cumulative undistributed foreign earnings | 331.3 |
Research and development tax credit carryforward [Member] | Minimum [Member] | ' |
Tax Credit Carryforward [Line Items] | ' |
Tax credit carryforward, expiration dates | 31-Dec-14 |
Research and development tax credit carryforward [Member] | Maximum [Member] | ' |
Tax Credit Carryforward [Line Items] | ' |
Tax credit carryforward, expiration dates | 31-Dec-33 |
Domestic Tax Authority [Member] | ' |
Tax Credit Carryforward [Line Items] | ' |
Operating Loss Carryforwards | 0.2 |
Domestic Tax Authority [Member] | Research and development tax credit carryforward [Member] | ' |
Tax Credit Carryforward [Line Items] | ' |
Research and development tax credit carryforwards | 2.9 |
Foreign Tax Authority [Member] | ' |
Tax Credit Carryforward [Line Items] | ' |
Operating Loss Carryforwards | 14.6 |
Foreign Tax Authority [Member] | Research and development tax credit carryforward [Member] | ' |
Tax Credit Carryforward [Line Items] | ' |
Research and development tax credit carryforwards | $0.20 |
Income_Taxes_Unrecognized_Tax_
Income Taxes - Unrecognized Tax Benefits (Details) (USD $) | 12 Months Ended | ||
Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | |
Income Tax Contingency [Line Items] | ' | ' | ' |
Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities | $3,700,000 | ' | ' |
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] | ' | ' | ' |
Unrecognized tax benefits, beginning of period | 25,135,000 | 16,041,000 | 7,156,000 |
Increases for tax positions taken in current period | 1,197,000 | 0 | 542,000 |
Increases for tax positions taken in prior periods | 1,701,000 | 9,965,000 | 10,502,000 |
Decreases for tax positions taken in prior periods | -3,997,000 | -620,000 | -1,723,000 |
Decreases for lapses in statutes of limitations | -70,000 | -251,000 | -436,000 |
Unrecognized tax benefits, end of period | 23,966,000 | 25,135,000 | 16,041,000 |
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued [Abstract] | ' | ' | ' |
Benefit for lapses of statutes of limitations and settlement with taxing authorities | -24,000 | -88,000 | -124,000 |
Accruals for current and prior periods | 1,698,000 | 652,000 | 293,000 |
Total interest and penalties | 1,674,000 | 564,000 | 169,000 |
United States [Member] | ' | ' | ' |
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued [Abstract] | ' | ' | ' |
Tax years open for examination, by major tax jurisdiction | '2010 | ' | ' |
The Netherlands [Member] | ' | ' | ' |
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued [Abstract] | ' | ' | ' |
Tax years open for examination, by major tax jurisdiction | '2011 | ' | ' |
Czech Republic [Member] | ' | ' | ' |
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued [Abstract] | ' | ' | ' |
Tax years open for examination, by major tax jurisdiction | '2011 | ' | ' |
Other Noncurrent Liabilities [Member] | ' | ' | ' |
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] | ' | ' | ' |
Unrecognized tax benefits, end of period | $23,800,000 | $15,700,000 | ' |
Income_Taxes_Additional_Disclo
Income Taxes - Additional Disclosures (Details) (USD $) | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Dec. 31, 2010 |
Income Tax Contingency [Line Items] | ' | ' | ' | ' |
Unrecognized tax benefits | $23,966,000 | $25,135,000 | $16,041,000 | $7,156,000 |
Unrecognized tax benefits which could be realized within the next 12 months, minimum | 0 | ' | ' | ' |
Unrecognized tax benefits which could be realized within the next 12 months, maximum | 4,000,000 | ' | ' | ' |
Unrecognized tax benefits, income tax penalties and interest accrued | 3,700,000 | 2,000,000 | ' | ' |
Other Noncurrent Liabilities [Member] | ' | ' | ' | ' |
Income Tax Contingency [Line Items] | ' | ' | ' | ' |
Unrecognized tax benefits | $23,800,000 | $15,700,000 | ' | ' |
Restructuring_Reorganization_R2
Restructuring, Reorganization, Relocation and Severance (Details) (USD $) | 12 Months Ended | 3 Months Ended | 12 Months Ended | |||||||||||||||||||||||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Dec. 31, 2011 | Dec. 31, 2012 | Dec. 31, 2011 | Dec. 31, 2011 | Dec. 31, 2011 | Dec. 31, 2011 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Dec. 31, 2013 |
Product Line Transfer [Member] | Employee Severance [Member] | Employee Severance [Member] | Manufacturing transfer and shift of supply chain [Member] | IT System Upgrade [Member] | Abandoned Leases and Facilities [Member] | Manufacturing Transfer [Member] | Group Structure Reorganization [Member] | Group Structure Reorganization [Member] | Group Structure Reorganization [Member] | Group Structure Reorganization [Member] | Manufacturing Transfer Plan [Member] | Manufacturing Transfer Plan [Member] | April 2010 Restructuring Plan [Member] | April 2010 Restructuring Plan [Member] | April 2010 Restructuring Plan [Member] | April 2010 Restructuring Plan [Member] | April 2010 Restructuring Plan [Member] | April 2010 Restructuring Plan [Member] | April 2010 Restructuring Plan [Member] | April 2010 Restructuring Plan [Member] | April 2010 Restructuring Plan [Member] | Sales [Member] | ||||
Manufacturing Transfer [Member] | Manufacturing Transfer [Member] | Product Line Transfer [Member] | Product Line Transfer [Member] | Product Line Transfer [Member] | Employee Severance [Member] | Employee Severance [Member] | Employee Severance [Member] | Largest contract manufacturer [Member] | ||||||||||||||||||
Restructuring Cost and Reserve [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Restructuring, reorganization, relocation and severance | $1,090 | $2,859 | $3,215 | $963 | $0 | $184 | $2,100 | $0 | ($32) | $0 | $1,090 | $2,859 | $2,900 | $1,100 | $0 | $0 | $0 | $0 | $1,147 | $0 | $0 | $963 | $0 | $0 | $184 | ' |
Expected additional cost of restructuring plan | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Cost incurred - life of plan | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 8,452 | ' | ' | 1,835 | ' | ' | 6,617 | ' | ' | ' |
Restructuring Reserve [Roll Forward] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Beginning accrued liability | 2,692 | 2,213 | 4,884 | 0 | 113 | 4,832 | 0 | 20 | 32 | 2,100 | 2,692 | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Charged to expense, net | 1,090 | 2,859 | 3,215 | 963 | 0 | 184 | 2,100 | 0 | -32 | 0 | 1,090 | 2,859 | 2,900 | 1,100 | 0 | 0 | 0 | 0 | 1,147 | 0 | 0 | 963 | 0 | 0 | 184 | ' |
Expenditures | -3,782 | -2,354 | -6,046 | -963 | 0 | -5,083 | 0 | 0 | 0 | -2,100 | -3,782 | -254 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Write-offs and adjustments | 50 | -26 | 160 | 0 | -113 | 180 | 0 | -20 | 0 | 0 | 50 | 87 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Ending accrued liability | $50 | $2,692 | $2,213 | $0 | $0 | $113 | $2,100 | $0 | $0 | $0 | $50 | $2,692 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Concentration Risk, Percentage | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 10.00% |
Commitments_and_Contingencies_
Commitments and Contingencies - Purchase Obligations (Details) (Inventories [Member], USD $) | 12 Months Ended |
In Millions, unless otherwise specified | Dec. 31, 2013 |
Inventories [Member] | ' |
Unrecorded Unconditional Purchase Obligation [Line Items] | ' |
Non-cancelable purchase orders | $81.10 |
Purchase commitment, maximum expiration date | 'second quarter of 2016 |
Lease_Obligations_Details
Lease Obligations (Details) (USD $) | 12 Months Ended | ||
Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | |
Lease Obligations [Abstract] | ' | ' | ' |
Lease Expiration Date | 31-Dec-33 | ' | ' |
Rent expense | $7,400,000 | $8,500,000 | $7,500,000 |
2014 minimum rental payment | 10,997,000 | ' | ' |
2015 minimum rental payment | 8,171,000 | ' | ' |
2016 minimum rental payment | 6,883,000 | ' | ' |
2017 minimum rental payment | 5,803,000 | ' | ' |
2018 minimum rental payment | 4,811,000 | ' | ' |
Minimum rental payment thereafter | 48,722,000 | ' | ' |
Total minimum rental payment | $85,387,000 | ' | ' |
Shareholders_Equity_Details
Shareholders' Equity (Details) (USD $) | 12 Months Ended | ||
In Thousands, except Share data, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Other Ownership Interests [Line Items] | ' | ' | ' |
Class of Warrant or Right, Redemption Price of Rights | 0.001 | ' | ' |
Preferred Stock Rights Plan, Description | 'On JulyB 21, 2005, the Board of Directors adopted a Preferred Stock Rights Plan.B Pursuant to the Preferred Stock Rights Plan, we distributed Rights as a dividend at the rate of one Right for each share of our common stock held by shareholders of record as of the close of business on AugustB 12, 2005. The Rights expire on AugustB 12, 2015, unless redeemed or exchanged. The Rights are not exercisable until the earlier of: (1)B 10 days (or such later date as may be determined by the Board of Directors) following an announcement that a person or group has acquired beneficial ownership of 20% of our common stock or (2) 10 days (or such later date as may be determined by the Board of Directors) following the announcement of a tender offer which would result in a person or group obtaining beneficial ownership of 20% or more of our outstanding common stock, subject to certain exceptions (the earlier of such dates being called the Distribution Date). The Rights are initially exercisable for one-thousandth of a share of our Series A Preferred Stock at a price of $120 per one-thousandth share, subject to adjustment. However, if: (1) after the Distribution Date we are acquired in certain types of transactions, or (2) any person or group (with limited exceptions) acquires beneficial ownership of 20% of our common stock, then holders of Rights (other than the 20% holder) will be entitled to receive, upon exercise of the Right, common stock (or in case we are completely acquired, common stock of the acquirer) having a market value of two times the exercise price of the Right. Philips Business Electronics International B.V., or any of its affiliates, shall not be considered for the 20% calculation so long as it does not acquire 30% or more of our common shares. We are entitled to redeem the Rights, for $0.001 per Right, at the discretion of the Board of Directors, until certain specified times. We may also require the exchange of Rights, at a rate of one share of common stock for each Right, under certain circumstances. We also have the ability to amend the Rights, subject to certain limitations. | ' | ' |
PEO Combination, Description | 'On February 21, 1997, we acquired substantially all of the assets and liabilities of the electron optics business of Koninklijke Philips Electronics N.V. (the bPEO Combinationb), in a transaction accounted for as a reverse acquisition. As part of the PEO Combination, we agreed to issue to Philips additional shares of our common stock whenever stock options that were outstanding on the date of the closing of the PEO Combination are exercised. Any such additional shares are issued at a rate of approximately 1.22 shares to Philips for each share issued on exercise of these options. We receive no additional consideration for these shares issued to Philips under this agreement. | ' | ' |
Shares reserved for future issuance | 3,487,290 | ' | ' |
Number of shares authorized to be repurchased | 4,000,000 | ' | ' |
Number of shares repurchased | 0 | 20,500 | 1,654,000 |
Value of shares repurchased | $900 | $891 | $50,000 |
Average cost per share of share repurchases | $43.41 | ' | $30.19 |
Remaining number of shares authorized to be repurchased | 2,119,800 | ' | ' |
Philips [Member] | ' | ' | ' |
Other Ownership Interests [Line Items] | ' | ' | ' |
Class of Warrant or Right, Change in Beneficial Ownership, Threshold Percentage | 30.00% | ' | ' |
Shares issued during period, other | 0 | 0 | 0 |
Shares reserved for future issuance | 165,000 | ' | ' |
Person or Group Acquiring Beneficial Ownership [Member] | ' | ' | ' |
Other Ownership Interests [Line Items] | ' | ' | ' |
Class of Warrant or Right, Exercise Period Subsequent to Beneficial Ownership Change | '10 days | ' | ' |
Class of Warrant or Right, Change in Beneficial Ownership, Threshold Percentage | 20.00% | ' | ' |
Tender Offer For Change in Beneficial Ownership [Member] | ' | ' | ' |
Other Ownership Interests [Line Items] | ' | ' | ' |
Class of Warrant or Right, Exercise Period Subsequent to Beneficial Ownership Change | '10 days | ' | ' |
Class of Warrant or Right, Change in Beneficial Ownership, Threshold Percentage | 20.00% | ' | ' |
Series A Preferred Stock [Member] | ' | ' | ' |
Other Ownership Interests [Line Items] | ' | ' | ' |
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right | 0.001 | ' | ' |
Class of Warrant or Right, Exercise Price of Rights | $120 | ' | ' |
StockBased_Compensation_Detail
Stock-Based Compensation (Details) (USD $) | 12 Months Ended | |
In Millions, except Share data, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' |
Shares Available for Grant | 1,998,881 | ' |
Shares of common stock reserved for issuance | 3,487,290 | ' |
Restricted Stock Units Nonvested and Expected to Vest | ' | ' |
Total compensation cost not yet recognized | $47.70 | ' |
Total compensation cost not yet recognized - period for recognition | '2 years | ' |
Employee Share Purchase Plan [Member] | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' |
Shares issued under the Employee Share Purchase Plan | 163,143 | ' |
Stock Options [Member] | ' | ' |
Options Outstanding and Exercisable: | ' | ' |
Options outstanding, number | 751,853 | 870,000 |
Options exercisable, number | 232,828 | ' |
Options outstanding, weighted average exercise price | $50.18 | $35.81 |
Options exercisable, weighted average exercise price | $31.80 | ' |
Options outstanding, aggregate intrinsic value | 29.5 | ' |
Options exercisable, aggregate intrinsic value | 13.4 | ' |
Options outstanding, weighted average remaining contractual term (in years) | '5 years 1 month 6 days | ' |
Options exercisable, weighted average remaining contractual term (in years) | '3 years 9 months 18 days | ' |
Restricted Stock Units [Member] | ' | ' |
Restricted Stock Units Nonvested and Expected to Vest | ' | ' |
Restricted stock units nonvested, number | 745,060 | 871,000 |
Restricted stock units expected to vest, number | 637,692 | ' |
Restricted stock units nonvested, weighted average grant date per share fair value | $57.60 | $41.69 |
Restricted stock units expected to vest, weighted average grant date per share fair value | $56.75 | ' |
Restricted stock units nonvested, aggregate intrinsic value | 65.8 | ' |
Restricted stock units expected to vest, aggregate intrinsic value | $57 | ' |
Restricted stock units nonvested, weighted average remaining term to vest (in years) | '1 year 8 months 12 days | ' |
Restricted stock units expected to vest, weighted average remaining term to vest (in years) | '1 year 7 months 6 days | ' |
Stock Incentive Plan [Member] | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' |
Number of Shares Authorized | 11,000,000 | 10,750,000 |
Employee Share Purchase Plan [Member] | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' |
Number of Shares Authorized | 3,950,000 | 3,700,000 |
Discount from market price under the Employee Share Purchase Plan | 15.00% | ' |
Maximum number of shares that can be purchased per employee in the Employee Share Purchase Plan | 500 | ' |
Employee share purchase plan, weighted average purchase price per share | $52.60 | ' |
Employee share purchase plan, weighted average discount per share | $27.36 | ' |
Employee stock purchase plan, remaining number of shares authorized to be purchased | 911,568 | ' |
StockBased_Compensation_Rollfo
Stock-Based Compensation - Rollforward of Share Activity (Details) (USD $) | 12 Months Ended |
Dec. 31, 2013 | |
Stock Options [Member] | ' |
Share activity [Line Items] | ' |
Options outstanding, beginning of period | 870,000 |
Options granted | 198,000 |
Option forfeitures | -47,000 |
Option expirations | -4,000 |
Options exercised | -265,000 |
Options outstanding, end of period | 751,853 |
Weighted average exercise price of options, beginning of period | $35.81 |
Weighted average exercise price of options granted | $82.11 |
Weighted average exercise price of options forfeited | $37.38 |
Weighted average exercise price of option expriations | $15.56 |
Weighted average exercise price of options exercised | $29.69 |
Weighted average exercise price of options, end of period | $50.18 |
Restricted Stock Units (RSUs) [Member] | ' |
Share activity [Line Items] | ' |
Restricted stock units unvested, beginning of period | 871,000 |
Restricted stock units granted | 244,000 |
Restricted stock units forfeited | -61,000 |
Restricted stock units vested | -309,000 |
Restricted stock units unvested, end of period | 745,060 |
Weighted average grant date fair value of restricted stock units, beginning of period | $41.69 |
Weighted average grant date fair value of restricted stock units granted | $83.58 |
Weighted average grant date fair value restricted stock units forfeited | $41.14 |
Weighted average grant date fair value of restricted stock unit vests | $37 |
Weighted average grant date fair value of restricted stock units, end of period | $57.60 |
StockBased_Compensation_Additi
Stock-Based Compensation - Additional disclosures (Details) (USD $) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' |
Total intrinsic value of stock options exercised | $13,169 | $6,293 | $10,550 |
Fair value of restricted stock units vested | 11,452 | 9,113 | 8,120 |
Cash received from stock options exercised and shares purchased under all stock-based arrangements | 16,545 | 13,131 | 24,382 |
Tax benefit realized for stock options | 6,495 | 3,137 | 2,918 |
Stock Options [Member] | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' |
Weighted average grant-date fair value | 16,283 | 12,279 | 11,703 |
Restricted Stock Units [Member] | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' |
Weighted average grant-date fair value | $20,415 | $20,461 | $15,499 |
StockBased_Compensation_Alloca
Stock-Based Compensation - Allocation in Income Statement (Details) (USD $) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ' | ' | ' |
Stock-based compensation expense | $18,327 | $14,154 | $11,111 |
Cost of Sales [Member] | ' | ' | ' |
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ' | ' | ' |
Stock-based compensation expense | 2,427 | 1,858 | 1,511 |
Research and Development Expense [Member] | ' | ' | ' |
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ' | ' | ' |
Stock-based compensation expense | 2,156 | 1,903 | 1,873 |
Selling, General and Administrative [Member] | ' | ' | ' |
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ' | ' | ' |
Stock-based compensation expense | 13,744 | 10,393 | 7,727 |
Inventory [Member] | ' | ' | ' |
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ' | ' | ' |
Stock-based compensation expense | 0 | 0 | 0 |
Fixed Assets [Member] | ' | ' | ' |
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ' | ' | ' |
Stock-based compensation expense | $0 | $0 | $0 |
StockBased_Compensation_Assump
Stock-Based Compensation - Assumptions (Details) | 12 Months Ended | ||
Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract] | ' | ' | ' |
Risk-free interest rate, minimum | 0.07% | 0.13% | 0.06% |
Risk-free interest rate, maximum | 1.72% | 0.81% | 2.02% |
Volatility, minimum | 23.00% | 36.00% | 36.00% |
Volatility, maximum | 43.00% | 55.00% | 55.00% |
Discount for post vesting restrictions | 0.00% | 0.00% | 0.00% |
Employee Share Purchase Plan [Member] | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract] | ' | ' | ' |
Expected term | '0 years 6 months | '0 years 6 months | '0 years 6 months |
Minimum [Member] | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract] | ' | ' | ' |
Dividend yield | 0.44% | 0.00% | 0.00% |
Maximum [Member] | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract] | ' | ' | ' |
Dividend yield | 0.59% | 0.72% | 0.00% |
Stock Options [Member] | Minimum [Member] | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract] | ' | ' | ' |
Expected term | '3 years 1 month | '5 years 4 months | '5 years 6 months |
Stock Options [Member] | Maximum [Member] | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract] | ' | ' | ' |
Expected term | '5 years 1 month | '5 years 6 months | '5 years 8 months |
Employee_Benefit_Plans_Details
Employee Benefit Plans (Details) (USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Employee Benefit Plans [Line Items] | ' | ' | ' |
Pension expense | $6.50 | $5.60 | $4.70 |
Incentive compensation expense | 12.8 | 13.2 | 24.7 |
Defined Contribution Plan, Employer Matching Contribution, Percent of Match | 100.00% | ' | ' |
Defined Contribution Plan, Employer Matching Contribution, Percent of employee's gross pay | 3.00% | ' | ' |
Deferred compensation plan assets | 5.3 | 3 | ' |
Deferred compensation plan liability | 5.3 | 3 | ' |
Locations Outside The U.S. and Netherlands [Member] | ' | ' | ' |
Employee Benefit Plans [Line Items] | ' | ' | ' |
Plan costs for defined contribution plans | 3.6 | 3.6 | 2.2 |
United States [Member] | ' | ' | ' |
Employee Benefit Plans [Line Items] | ' | ' | ' |
Plan costs for defined contribution plans | $2.10 | $1.80 | $1.50 |
RelatedParty_Activity_Details
Related-Party Activity (Details) (USD $) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Related Party Transaction [Line Items] | ' | ' | ' |
Product sales to related parties | $5,216 | $985 | $3,716 |
Service sales to related parties | 849 | 587 | 498 |
Total sales to related parties | 6,065 | 1,572 | 4,214 |
Purchases from related parties | 933 | 127 | 110 |
Applied Materials [Member] | ' | ' | ' |
Related Party Transaction [Line Items] | ' | ' | ' |
Product sales to related parties | 4,656 | 981 | 3,594 |
Service sales to related parties | 719 | 554 | 459 |
Lattice Semiconductor [Member] | ' | ' | ' |
Related Party Transaction [Line Items] | ' | ' | ' |
Product sales to related parties | 5 | 0 | 122 |
Service sales to related parties | 12 | 0 | 0 |
Cascade Microtech [Member] | ' | ' | ' |
Related Party Transaction [Line Items] | ' | ' | ' |
Product sales to related parties | 0 | 4 | 0 |
Service sales to related parties | 33 | 33 | 39 |
Purchases from related parties | 0 | 0 | 1 |
Oregon Health and Science University [Member] | ' | ' | ' |
Related Party Transaction [Line Items] | ' | ' | ' |
Product sales to related parties | 555 | 0 | 0 |
Service sales to related parties | 85 | 0 | 0 |
Purchases from related parties | 353 | 0 | 0 |
TMC BV [Member] | ' | ' | ' |
Related Party Transaction [Line Items] | ' | ' | ' |
Purchases from related parties | $580 | $127 | $109 |
RelatedParty_Activity_Schedule
Related-Party Activity - Schedule of Amounts Due From (To) Related Parties (Details) (USD $) | Dec. 31, 2013 |
In Thousands, unless otherwise specified | |
Related Party Transaction [Line Items] | ' |
Due from (to) related party | ($348) |
Applied Materials [Member] | ' |
Related Party Transaction [Line Items] | ' |
Due from (to) related party | 46 |
Cascade Microtech [Member] | ' |
Related Party Transaction [Line Items] | ' |
Due from (to) related party | 8 |
Oregon Health and Science University [Member] | ' |
Related Party Transaction [Line Items] | ' |
Due from (to) related party | 1 |
TMC BV [Member] | ' |
Related Party Transaction [Line Items] | ' |
Due from (to) related party | ($403) |
Segment_and_Geographic_Informa2
Segment and Geographic Information - Segment Information (Details) (USD $) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Segment Reporting Information [Line Items] | ' | ' | ' |
Sales to external customers | $927,454 | $891,738 | $826,426 |
Gross profit | 438,785 | 415,630 | 367,366 |
Industry [Member] | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' |
Sales to external customers | 427,731 | 433,424 | 376,533 |
Gross profit | 222,675 | 220,267 | 185,156 |
Science [Member] | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' |
Sales to external customers | 499,723 | 458,314 | 449,893 |
Gross profit | 216,110 | 195,363 | 182,210 |
Customer Concentration Risk [Member] | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' |
Concentration Risk Number of Customers Accounting For More Than Ten Percent of Revenue | ' | 0 | 0 |
Sales to external customers | ' | 0 | 0 |
Customer Concentration Risk [Member] | Industry [Member] | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' |
Concentration Risk Number of Customers Accounting For More Than Ten Percent of Revenue | 1 | ' | ' |
Concentration Risk, Percentage | 10.40% | ' | ' |
Sales to external customers | $96,000 | ' | ' |
Segment_and_Geographic_Informa3
Segment and Geographic Information - Assets (Details) (USD $) | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
In Thousands, unless otherwise specified | |||
Segment and Geographical Information - Assets [Line Items] | ' | ' | ' |
Goodwill | $136,152 | $131,320 | $58,053 |
Total Assets | 1,426,084 | 1,234,223 | ' |
Long-Lived Assets | 208,431 | 165,275 | ' |
United States [Member] | ' | ' | ' |
Segment and Geographical Information - Assets [Line Items] | ' | ' | ' |
Long-Lived Assets | 77,639 | 74,319 | ' |
The Netherlands [Member] | ' | ' | ' |
Segment and Geographical Information - Assets [Line Items] | ' | ' | ' |
Long-Lived Assets | 65,570 | 32,679 | ' |
CZECH REPUBLIC | ' | ' | ' |
Segment and Geographical Information - Assets [Line Items] | ' | ' | ' |
Long-Lived Assets | 22,950 | 12,019 | ' |
Other Geographical Regions [Member] | ' | ' | ' |
Segment and Geographical Information - Assets [Line Items] | ' | ' | ' |
Long-Lived Assets | 42,272 | 46,258 | ' |
Industry [Member] | ' | ' | ' |
Segment and Geographical Information - Assets [Line Items] | ' | ' | ' |
Goodwill | 51,532 | 53,572 | ' |
Total Assets | 297,987 | 293,115 | ' |
Science [Member] | ' | ' | ' |
Segment and Geographical Information - Assets [Line Items] | ' | ' | ' |
Goodwill | 84,620 | 77,748 | ' |
Total Assets | 365,571 | 401,795 | ' |
Intersegment Eliminations [Member] | ' | ' | ' |
Segment and Geographical Information - Assets [Line Items] | ' | ' | ' |
Total Assets | $762,526 | $539,313 | ' |
Segment_and_Geographic_Informa4
Segment and Geographic Information - Geographic Information (Details) (USD $) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Revenues from External Customers and Long-Lived Assets [Line Items] | ' | ' | ' |
Product sales | $709,438 | $691,496 | $654,599 |
Service sales | 218,016 | 200,242 | 171,827 |
Total sales | 927,454 | 891,738 | 826,426 |
U.S. and Canada [Member] | ' | ' | ' |
Revenues from External Customers and Long-Lived Assets [Line Items] | ' | ' | ' |
Product sales | 167,876 | 200,778 | 179,126 |
Service sales | 92,759 | 90,942 | 78,118 |
Total sales | 260,635 | 291,720 | 257,244 |
Europe [Member] | ' | ' | ' |
Revenues from External Customers and Long-Lived Assets [Line Items] | ' | ' | ' |
Product sales | 205,857 | 185,598 | 206,994 |
Service sales | 64,803 | 59,124 | 54,319 |
Total sales | 270,660 | 244,722 | 261,313 |
Asia Pacific Region and Rest of World [Member] | ' | ' | ' |
Revenues from External Customers and Long-Lived Assets [Line Items] | ' | ' | ' |
Product sales | 335,705 | 305,120 | 268,479 |
Service sales | 60,454 | 50,176 | 39,390 |
Total sales | $396,159 | $355,296 | $307,869 |
Fair_Value_of_Assets_and_Liabi
Fair Value of Assets and Liabilities - Securities (Details) (USD $) | Dec. 31, 2013 | Dec. 31, 2012 | ||
In Thousands, unless otherwise specified | ||||
U.S. treasury notes [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available for sale marketable securities | $10,128 | $60,786 | ||
Agency bonds [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available for sale marketable securities | 37,961 | [1] | 31,157 | [1] |
Commercial paper [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available for sale marketable securities | 39,987 | 5,000 | ||
Certificates of deposit [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available for sale marketable securities | 7,786 | 5,494 | ||
Municipal bonds [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available for sale marketable securities | 49,319 | 3,228 | ||
Corporate Debt Securities [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available for sale marketable securities | 5,001 | ' | ||
Estimate of Fair Value, Fair Value Disclosure [Member] | Fair Value, Measurements, Recurring [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Equity securities - mutual funds | 5,287 | 3,046 | ||
Derivative contracts, net | -1,113 | 1,655 | ||
Assets, fair value | 154,356 | 110,366 | ||
Estimate of Fair Value, Fair Value Disclosure [Member] | U.S. treasury notes [Member] | Fair Value, Measurements, Recurring [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available for sale marketable securities | 10,128 | 60,786 | ||
Estimate of Fair Value, Fair Value Disclosure [Member] | Agency bonds [Member] | Fair Value, Measurements, Recurring [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available for sale marketable securities | 37,961 | 31,157 | ||
Estimate of Fair Value, Fair Value Disclosure [Member] | Commercial paper [Member] | Fair Value, Measurements, Recurring [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available for sale marketable securities | 39,987 | 5,000 | ||
Estimate of Fair Value, Fair Value Disclosure [Member] | Certificates of deposit [Member] | Fair Value, Measurements, Recurring [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available for sale marketable securities | 7,786 | 5,494 | ||
Estimate of Fair Value, Fair Value Disclosure [Member] | Municipal bonds [Member] | Fair Value, Measurements, Recurring [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available for sale marketable securities | 49,319 | 3,228 | ||
Estimate of Fair Value, Fair Value Disclosure [Member] | Corporate Debt Securities [Member] | Fair Value, Measurements, Recurring [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available for sale marketable securities | 5,001 | ' | ||
Fair Value, Inputs, Level 1 [Member] | Fair Value, Measurements, Recurring [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Equity securities - mutual funds | 5,287 | 3,046 | ||
Derivative contracts, net | 0 | 0 | ||
Assets, fair value | 15,415 | 63,832 | ||
Fair Value, Inputs, Level 1 [Member] | U.S. treasury notes [Member] | Fair Value, Measurements, Recurring [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available for sale marketable securities | 10,128 | 60,786 | ||
Fair Value, Inputs, Level 1 [Member] | Agency bonds [Member] | Fair Value, Measurements, Recurring [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available for sale marketable securities | 0 | 0 | ||
Fair Value, Inputs, Level 1 [Member] | Commercial paper [Member] | Fair Value, Measurements, Recurring [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available for sale marketable securities | 0 | 0 | ||
Fair Value, Inputs, Level 1 [Member] | Certificates of deposit [Member] | Fair Value, Measurements, Recurring [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available for sale marketable securities | 0 | 0 | ||
Fair Value, Inputs, Level 1 [Member] | Municipal bonds [Member] | Fair Value, Measurements, Recurring [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available for sale marketable securities | 0 | 0 | ||
Fair Value, Inputs, Level 2 [Member] | Fair Value, Measurements, Recurring [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Equity securities - mutual funds | 0 | 0 | ||
Derivative contracts, net | -1,113 | 1,655 | ||
Assets, fair value | 138,941 | 46,534 | ||
Fair Value, Inputs, Level 2 [Member] | U.S. treasury notes [Member] | Fair Value, Measurements, Recurring [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available for sale marketable securities | 0 | 0 | ||
Fair Value, Inputs, Level 2 [Member] | Agency bonds [Member] | Fair Value, Measurements, Recurring [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available for sale marketable securities | 37,961 | 31,157 | ||
Fair Value, Inputs, Level 2 [Member] | Commercial paper [Member] | Fair Value, Measurements, Recurring [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available for sale marketable securities | 39,987 | 5,000 | ||
Fair Value, Inputs, Level 2 [Member] | Certificates of deposit [Member] | Fair Value, Measurements, Recurring [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available for sale marketable securities | 7,786 | 5,494 | ||
Fair Value, Inputs, Level 2 [Member] | Municipal bonds [Member] | Fair Value, Measurements, Recurring [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available for sale marketable securities | 49,319 | 3,228 | ||
Fair Value, Inputs, Level 2 [Member] | Corporate Debt Securities [Member] | Fair Value, Measurements, Recurring [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available for sale marketable securities | 5,001 | ' | ||
Fair Value, Inputs, Level 3 [Member] | Fair Value, Measurements, Recurring [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Equity securities - mutual funds | 0 | 0 | ||
Derivative contracts, net | 0 | 0 | ||
Assets, fair value | 0 | 0 | ||
Fair Value, Inputs, Level 3 [Member] | U.S. treasury notes [Member] | Fair Value, Measurements, Recurring [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available for sale marketable securities | 0 | 0 | ||
Fair Value, Inputs, Level 3 [Member] | Agency bonds [Member] | Fair Value, Measurements, Recurring [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available for sale marketable securities | 0 | 0 | ||
Fair Value, Inputs, Level 3 [Member] | Commercial paper [Member] | Fair Value, Measurements, Recurring [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available for sale marketable securities | 0 | 0 | ||
Fair Value, Inputs, Level 3 [Member] | Certificates of deposit [Member] | Fair Value, Measurements, Recurring [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available for sale marketable securities | 0 | 0 | ||
Fair Value, Inputs, Level 3 [Member] | Municipal bonds [Member] | Fair Value, Measurements, Recurring [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available for sale marketable securities | $0 | $0 | ||
[1] | Agency bonds are securities backed by U.S. government-sponsored entities. |
Derivative_Instruments_Details
Derivative Instruments (Details) (USD $) | 12 Months Ended | |
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 |
Derivative [Line Items] | ' | ' |
Total outstanding derivative contracts | $381,393 | $390,924 |
Outstanding derivative contracts maturity, maximum | '1 year 3 months 0 days | ' |
Cash Flow Hedges [Member] | ' | ' |
Derivative [Line Items] | ' | ' |
Total outstanding derivative contracts | 208,446 | 165,000 |
Balance Sheet Hedges [Member] | ' | ' |
Derivative [Line Items] | ' | ' |
Total outstanding derivative contracts | $172,947 | $225,924 |
Derivative_Instruments_Balance
Derivative Instruments - Balance Sheet Location (Details) (Foreign Exchange Contract [Member], USD $) | Dec. 31, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
Other Current Assets [Member] | ' | ' |
Derivatives, Fair Value [Line Items] | ' | ' |
Gross amounts of recognized assets | $2,171 | $5,744 |
Gross amounts offset in the balance sheet | -698 | -3,081 |
Net amounts presented in other current assets | 1,473 | 2,663 |
Other Current Liabilities [Member] | ' | ' |
Derivatives, Fair Value [Line Items] | ' | ' |
Gross amounts of recognized liabilities | 7,278 | 4,289 |
Gross amounts offset in the balance sheet | -4,692 | -3,281 |
Net amounts presented in other current liabilities | 2,586 | 1,008 |
Designated as Hedging Instrument [Member] | Other Current Assets [Member] | ' | ' |
Derivatives, Fair Value [Line Items] | ' | ' |
Gross amounts of recognized assets | 0 | 3,019 |
Gross amounts offset in the balance sheet | 0 | -1,492 |
Net amounts presented in other current assets | 0 | 1,527 |
Designated as Hedging Instrument [Member] | Other Current Liabilities [Member] | ' | ' |
Derivatives, Fair Value [Line Items] | ' | ' |
Gross amounts of recognized liabilities | 4,362 | 0 |
Gross amounts offset in the balance sheet | -3,042 | 0 |
Net amounts presented in other current liabilities | 1,320 | 0 |
Not Designated as Hedging Instrument [Member] | Other Current Assets [Member] | ' | ' |
Derivatives, Fair Value [Line Items] | ' | ' |
Gross amounts of recognized assets | 2,171 | 2,725 |
Gross amounts offset in the balance sheet | -698 | -1,589 |
Net amounts presented in other current assets | 1,473 | 1,136 |
Not Designated as Hedging Instrument [Member] | Other Current Liabilities [Member] | ' | ' |
Derivatives, Fair Value [Line Items] | ' | ' |
Gross amounts of recognized liabilities | 2,916 | 4,289 |
Gross amounts offset in the balance sheet | -1,650 | -3,281 |
Net amounts presented in other current liabilities | $1,266 | $1,008 |
Derivative_Instruments_Effect_
Derivative Instruments - Effect on Income Statement (Details) (USD $) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Derivative Instruments, Gain (Loss) [Line Items] | ' | ' | ' |
Foreign currency loss, inclusive of the impact of derivatives | ($2,808) | ($5,675) | ($2,222) |
Foreign Exchange Contract [Member] | Other Comprehensive Income (Loss) [Member] | Cash Flow Hedges [Member] | ' | ' | ' |
Derivative Instruments, Gain (Loss) [Line Items] | ' | ' | ' |
Recognized in AOCI (effective portion) | -1,934 | 8,032 | 108 |
Foreign Exchange Contract [Member] | Sales Revenue, Net [Member] | Cash Flow Hedges [Member] | ' | ' | ' |
Derivative Instruments, Gain (Loss) [Line Items] | ' | ' | ' |
Reclassified from AOCI into cost of sales (effective portion) | 33 | 0 | 0 |
Foreign Exchange Contract [Member] | Cost of Sales [Member] | Cash Flow Hedges [Member] | ' | ' | ' |
Derivative Instruments, Gain (Loss) [Line Items] | ' | ' | ' |
Reclassified from AOCI into cost of sales (effective portion) | -790 | -2,511 | 3,558 |
Foreign Exchange Contract [Member] | Other Income Expense Net [Member] | Not Designated as Hedging Instrument [Member] | ' | ' | ' |
Derivative Instruments, Gain (Loss) [Line Items] | ' | ' | ' |
Recognized in other, net | -4,802 | -4,882 | -6,181 |
Foreign Exchange Contract [Member] | Other Income Expense Net [Member] | Cash Flow Hedges [Member] | ' | ' | ' |
Derivative Instruments, Gain (Loss) [Line Items] | ' | ' | ' |
Recognized in other, net (ineffective portion and amount excluded from effectiveness testing) | ($80) | $9 | $83 |
Subsequent_Event_Subsequent_Ev
Subsequent Event Subsequent Event (Details) (Lithicon AS [Member], Lithicon AS [Member], USD $) | Dec. 31, 2013 |
In Millions, unless otherwise specified | |
Lithicon AS [Member] | Lithicon AS [Member] | ' |
Subsequent Event [Line Items] | ' |
Percentage of voting interests acquired | 100.00% |
Acquisition Purchase Price | $68 |